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Abstract 
Enantiopure carbonyl compounds bearing tetrasubstituted α-stereogenic centers are 
versatile building blocks for the synthesis of pharmaceuticals, fragrances, and natural products. 
The direct synthesis of such motifs via asymmetric α-functionalization of the corresponding 
ketones is a major challenge in both metal- and organocatalysis. In this work we report on 
development of enol catalysis, a novel strategy allowing the direct enantioselective α-
functionalization of carbonyl compounds via Brønsted acid promoted enolization. Within this 
thesis, we established the generality of this strategy in a variety of enantioselective C–C, C–N 
and C–O bond forming reactions using simple α-branched and unbranched ketones as substrates. 
Along the same line of research we developed a highly enantioselective Robinson annulation of 
1,3-diketones that afforded derivatives of the synthetically valuable Wieland–Miescher ketone. 
Furthermore, this strategy was successfully applied to direct α-amination and α-hydroxylation 
reactions using either diazocarboxylates or nitrosobenzene as reagents. And finally, we 
discovered that enol catalysis enables serendipitously-discovered α-aryloxylation of ketones 
using 1,4-benzoquinones. Taken together, this work has established enol catalysis as a generic 
enantioselective and scalable methodology applicable to a broad scope of challenges of organic 
synthesis. 
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Kurzzusammenfassung 
 Enantiomerenreine Carbonylverbindungen mit tetrasubstituierten α-Stereozentren sind 
vielseitige Bausteine für die Synthese von Pharmazeutika, Duftstoffen und Naturstoffen. Die 
direkte Synthese solcher Motive durch asymmetrische α-Funktionalisierung der entsprechenden 
Ketone ist eine große Herausforderung in der Metall- sowie Organokatalyse. In dieser Arbeit 
berichten wir über die Entwicklung der Enolkatalyse, einer neuartigen Strategie, welche die 
direkte enantioselektive α-Funktionalisierung von Carbonylverbindungen durch Brønsted-Säure 
katalysierte Enolisierung ermöglicht. Im Rahmen dieser Arbeit haben wir die allgemeine 
Anwendbarkeit dieser Strategie in einer Vielzahl von enantioselektiven C–C, C–N und C–O 
bindungsknüpfenden Reaktionen unter Verwendung einfacher α-verzweigter und unverzweigter 
Ketone untersucht. Zunächst berichten wir über eine enantioselektive Robinson-Anellierung von 
1,3-Diketonen. Darüber hinaus wurde diese Strategie erfolgreich auf direkte α-Aminierungs- und 
α-Hydroxylierungsreaktionen angewendet. Abschließend wird über die zufällige Entdeckung 
einer direkten α-Aryloxylierung von Ketonen berichtet. Zusammengefasst erweitert diese Arbeit 
Anwendungsbereich der Enolkatalyse und etabliert diese als allgemeingültiges Konzept, welches 
auf eine Vielzahl von Herausforderungen der organischen Synthese anwendbar ist. 
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1 Introduction 
1.1 Asymmetric Organocatalysis 
The increased demand of pharmaceutical, agrochemical or food industry for 
enantiomerically pure compounds has inspired generations of chemists to develop efficient and 
highly enantioselective synthetic methods. Due to obvious limitations of traditional approaches, 
such as resolution of racemic mixtures or use of chiral pool materials, modern strategies focus on 
asymmetric catalysis and these efforts have been acknowledged with the Nobel Prize awarded to 
William Knowles, Ryoji Noyori and K. Barry Sharpless in 2001.
[1]
  
 
Scheme 1.1: Pioneering work in a) enamine and b) iminum catalysis. 
Until the beginning of the 21
st
 century the field of asymmetric catalysis was dominated by 
bio- and transition metal catalysts and despite early examples the idea that small organic 
molecules could catalyze enantioselective reactions was regarded as highly exotic.
[2]
 However, in 
2000 List
[3]
 and, independently MacMillan
[4]
 demonstrated the application of chiral secondary 
amines as catalysts for the activation of aldehydes and ketones (Scheme 1.1). List et al. reported 
direct aldol reactions of acetone and aldehydes catalyzed by L-proline. The reactions proceed via 
in situ generated enamine intermediates, which, due to their energetically increased highest 
occupied molecular orbitals (HOMO) are better nucleophiles compared to corresponding enols 
(Scheme 1.1 a). It was also suggested that the carboxylic acid moiety of proline additionally 
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activates the electrophile via Brønsted acid catalysis. MacMillan reported a chiral 
imidazolidinone-catalyzed Diels-Alder reaction of enals, proceeding via an in situ formed 
iminium intermediate. Electron density is removed from the enals double bond, decreasing the 
energy level of their lowest unoccupied molecular orbital (LUMO) and thus making it a better 
electrophile (Scheme 1.1 b). In the following two decades the field of organocatalysis has 
established itself, as the third pillar of homogeneous catalysis, complementing bio- and transition 
metal catalysis.
[5]
  
Interactions of functional groups with organic catalysts can be explained by Lewis and 
Brønsted acid-base theories. In line with this concept Seayad and List suggested a simple 
classification of organocatalysts.
[6]
 Accordingly, organocatalysts can be classified in four 
categories: Lewis bases (electron donors, e.g. enamine/iminium catalysis), Lewis acids (electron 
acceptors) and Brønsted acid (proton donors) or bases (proton acceptors). However, 
bifunctionality of catalysts is common and plays a key role in numerous transformations (Figure 
1.1).
[7]
 
 
Figure 1.1: Examples of bifunctional organocatalysts. 
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1.2 Asymmetric Brønsted Acid Catalysis 
By definition Brønsted acids are chemical species which can donate a proton to a 
corresponding Brønsted base, however it can also be considered as the smallest possible electron 
acceptor and therefore as a Lewis acid.
[8]
 Accordingly, a common strategy in Brønsted acid 
catalysis is LUMO lowering via protonation of an electrophile.
[9]
 Depending on the pKa-
differences between catalyst and substrate, acid catalysis is further divided into two classes 
(Figure 1.2). In general acid catalysis small pKa difference results in partial protonation of the 
substrate through hydrogen-bonding. In specific acid catalysis the pKa difference is sufficient to 
fully protonate the substrate and leads to the formation of ion pairs.
[10]
 However, both scenarios 
are borderline and often an accurate distinction can be challenging.
[11]
 
 
Figure 1.2: Activation modes in Brønsted acid catalysis. 
Although hydrogen bonding is a fundamental activation mechanism in enzyme catalysis, 
examples utilizing this concept in asymmetric catalysis were only published relatively recently. A 
pioneering study is the asymmetric Strecker reaction catalyzed by a chiral thiourea as a dual 
hydrogen bond donor reported by Jacobsen et al. in 1998 (Figure 1.3).
[12]
 Five years later Rawal 
group reported the application of a chiral TADDOL in asymmetric hetero Diels–Alder reactions 
of aldehydes and activated dienes.
[13]
 Despite these early studies, it took several years to fully 
recognize the generality and true mechanistic nature of this approach.
[14]
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Figure 1.3: Hydrogen-bonding catalysts reported by Jacobsen and Rawal.
[12-13]
 
In 2004 Akiyama
[15]
 and subsequently Terada
[16]
 reported the development and 
application of BINOL-derived strong phosphoric acids in asymmetric catalysis (Figure 1.4). 
Although Ishihara group later showed that the catalytic species in Teradas report was not the free 
acid, but the corresponding calcium salt formed during purification,
[17]
 the last decade has proven 
that their early studies on Brønsted acid-catalyzed Mannich reactions with silyl ketene acetals and 
β-diketones have started a new era in asymmetric catalysis. 
 
Figure 1.4: BINOL-derived phosphoric catalysts reported by Akiyma and Terada. 
Because of their straight-forward synthesis, the field of asymmetric Brønsted-acid 
catalysis is dominated by BINOL-derived phosphoric acids, with TRIP (1a) being the most 
successfully applied catalyst.
[9, 18]
 However, various derivatives and modifications of phosphoric 
acids have been reported. A selection of common catalyst structures is outlined below. 
A selection of backbone modifications is shown in Figure 1.5. TADDOL-derived 
phosphoric acids 2 were reported by Akiyama et al. in the context of enantioselective Mannich 
reactions using silyl enol ethers as nucleophiles.
[19]
 In 2006 Gong et al. reported the application 
of hydrogenated H8-BINOL derived phosphoric acids 3 in asymmetric Biginelli reactions.
[20]
 
VAPOL-derived phosphoric acids 4 were applied to enantioselective additions of electron-poor 
amines to carbamate protected imines by the Antilla group.
[21]
 Recently, Akiyama reported the 
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development of biphenol-derived acids 5 as efficient catalysts for asymmetric 
tetrahydroquinoline synthesis.
[22]
 SPINOL derived catalysts 6, which in contrast to previously 
reported structures are not axially chiral, were reported independently by List and Wang groups 
as highly efficient catalysts for enantioselective acetalizations and Friedel-Crafts reactions, 
respectively.
[23]
  
 
Figure 1.5: Chiral backbones for asymmetric phosphoric acids. 
Modifications of the backbone do not necessary affect the catalysts acidity. Since it is 
however often correlated with the activity, modifications of the phosphoric acid moiety itself 
towards more acidic derivatives were developed (Figure 1.6). In 2006 Yamamoto reported N-
triflyl phosphoramides 7 and their application in asymmetric Diels–Alder reactions.[24] Compared 
to the corresponding phosphoric acids these compounds are significantly more acidic (pKa 
(MeCN)
[25]
 ~13–14 vs 6–7, respectively) and have been widely applied.[9] BINOL-derived 
dithiophosphoric acids 8 were developed by the Blanchet group and later applied to 
hydroamination reactions by Toste et al.
[26]
 The List group recently developed chiral 
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disulfonimids 9 (DSI), which are not only highly acidic Brønsted acids but could also be applied 
as precatalysts in Lewis acid organocatalysis.
[27]
 
 
Figure 1.6: Selected examples of chiral BINOL-derived Brønsted acids with increased acidity. 
To activate small and unbiased molecules, List group developed highly confined dimeric 
imidodiphosphates 10 (IDP) and used them in a variety of reactions, such as asymmetric 
acetalizations or sulfoxidations (Figure 1.7).
[28]
 Furthermore, List group demonstrated that the 
acidity of these confined catalysts could be increased by formal substitution of the phosphor-
oxygen double bond to N-triflate groups, giving access to two new structural motifs: imino-
imidodiphosphates 11 (iIDP)
[29]
 and highly acidic imidodiphosphorimidates 12 (IDPI).
[30]
 
Recently, the latter found impressive applications in catalytic asymmetric hetero-Diels–Alder 
reactions and hydroalkoxylations of unactivated alkenes.
[31]
  
 
Figure 1.7: Recently developed highly confined Brønsted acids. 
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2 Background 
2.1 Enols 
Chemistry of the carbonyl group is the basis of organic synthesis. Due to the large 
difference in the electronegativity of carbon and oxygen, the πC=O and π*C=O orbitals are not only 
lower in energy compared to the corresponding πC=C and π*C=C orbitals, but also the anti-bonding 
π*C=O orbital is distorted towards oxygen (Figure 2.1). This generates a partial positive charge on 
the carbon atom thus making carbonyl groups highly susceptible to nucleophilic attacks.
[32]
 Since 
the bond polarization is correlated to the (formal) charge, the electrophilicity can be further 
increased by the coordination of Lewis acids to the non-bonding nO-orbitals. 
 
Figure 2.1: Molecular orbitals of C=O π bonds.[32] 
At the same time, carbonyls are also good nucleophiles. Already in 1904 Lapworth 
studied the kinetic of acetone halogenation. He reported that the apparent rates of first order 
kinetics were independent from the used halogen or its concentration. Whereas the rates were 
very low in neutral solutions the addition of mineral acids dramatically accelerated the reaction. 
Since these reactions were not affected by light and did not occur with “paraffins”, he concluded 
that the “enolic form” of the ketone must be involved in the reaction mechanism. He further 
argued that the formation of this compound was rate limiting.
[33]
 
 
Figure 2.2: Thermodynamic data of keto-enol tautomers. Adapted from
[34]
 
A plausible explanation for the observed kintetics is that because of the highly polarized 
C=O double bond carbonyl compounds are rather C–H acidic. Their pKa values vary within the 
range from 7.7 (α-nitro acetophenone, DMSO) up to 26.5 (acetone, DMSO).[35] This mean that 
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they could be deprotonated by many common bases, but also that they are present in chemical 
equilibrium with their corresponding enol-tautomers. Tautomers are interconverting isomers 
which differ by the placement of an atom or a group, most commonly a proton. Because of 
thermodynamic reasons the keto-tautomer is ca. 11–14 kcal mol-1 more stable than the 
corresponding enol-tautomer (Figure 2.2).
[34]
 Dominance of the keto-form could be revered by 
certain structural features, such as extended conjugation. Equilibrium constants of simple ketones 
suggest a typical enol concentration of 0.1 to 10 ppm (Figure 2.3 a).
[36]
 Nevertheless, if the 
corresponding protonation (ketonization) is kinetically blocked, the equilibrium can be 
completely shifted towards the enol-form. (Figure 2.3 b).
[37]
 
 
Figure 2.3: a) Equilibrium constants for keto-enol tautomerizations of selected carbonyl 
compounds (pK). The lower the number, the more the equilibrium is shifted towards the enol 
tautomer. b) Selected examples of stable simple enols.
[37]
 
The interconversion between both tautomers can be catalyzed by both acids (Brønsted and 
Lewis) and bases and is very slow in neutral solutions (Figure 2.4). In the base-catalyzed 
mechanism, initial deprotonation at the α-position yields the corresponding enolate, which is 
subsequently protonated and produces the enol-tautomer. Whereas C–H abstraction is slow and 
therefore rate-limiting, the last protonation step is very fast. In contrast, the acid-catalyzed 
enolization is initiated by fast and reversible protonation of the carbonyl oxygen followed by 
rate-determining deprotonation.
[34, 36a]
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Figure 2.4: Mechanism of a) acid-catalyzed and b) base-catalyzed keto-enol tautomerization of 
acetone. 
Unsymmetrically substituted ketones (e.g. ethyl methyl ketone) could yield a mixture of 
isomers. Under basic conditions the regioselectivity (kinetic vs. thermodynamic enolate) is 
influenced by the base and temperature: bulky bases and lower temperatures preferentially lead to 
the kinetic enolate, whereas high temperatures give the thermodynamic product (Figure 2.5 a). 
However, under acidic conditions the formation of more substituted enol is preferred (Figure 2.5 
b). This could be explained by the Hammond postulate: Since bond energies of enols are higher 
than of the corresponding carbonyls, the tautomerization must proceed via a transition state 
which sterically resembles the products.
[38]
 Hyperconjugation, which preferentially stabilizes 
more substituted enols, is also stabilizing the corresponding transition states. Since this is also 
influenced by sterics, a bulky substituent could inverse the selectivity.
[39]
 An additional challenge 
is the control of E/Z-geometry of enol and enolates that requires empirical adjustments to for the 
impact of sterics, solvents, bases and additives (Figure 2.5 c). 
By their reactivity enols are comparable to enolates. The reactive orbitals (HOMO) of 
enolates suggested that the net negative charge is unequally distributed between the three atoms 
and while the oxygen atom attracts more of the charge the carbon atom has more of the HOMO 
(Scheme 2.6). This explains why hard electrophiles (e.g. anhydrides) preferentially react at 
oxygen atoms, whereas soft electrophiles (e.g. vinyl ketones) react at carbon atoms (HSAB 
theory).
[34]
  
Enols and enolates are key intermediates in a wide range of synthetically useful α-
functionalization reactions of carbonyls, such as α-halogenations, aldol reactions/condensations, 
Michael additions or Claisen condensations, to mention only a few.
[34]
 It is therefore not 
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surprising that their selective preparation is a key for direct and enantioselective α-
functionalization. Considering the topics discussed in this thesis, the following sections will give 
a comprehensive overview of common enantioselective methods developed for the direct α-
functionalization of ketones. 
 
Figure 2.5: Regioselectivity of enol(ate) formation under a) basic and b) acidic conditions. c) 
(E)- vs (Z)-enol(ate). Equilibrium constants according to
[36b]
  
 
 
Figure 2.6: HOMO orbitals of enolates. 
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2.2 Direct Asymmetric α-Functionalization of Ketones 
Because of its simplicity the direct α-functionalization of ketones is the most straight-
forward approach towards the synthesis of their α-mono- and α,α-disubstituted analogues. For 
long time most enantioselective approaches were taking advantage of either chiral pool materials 
or chiral auxiliaries and catalytic transformations were only realized by employing enol-
surrogates, e.g. corresponding enol ethers or esters, or activated substrates equipped with 
additional activating electron-withdrawing groups. At the end of the 20
th
 century, methods of 
direct functionalization of ketones by in situ generation of catalytic amounts of enol/enolate-
equivalents were developed. Besides their great potential, only few of them enable the synthesis 
of tertiary/quarernary stereocenters starting from unactivated α-branched carbonyl compounds. 
The following section will give a brief overview over common synthetic catalytic strategies 
(excluding biocatalytic approaches) and their application in asymmetric aldol, Mannich or 
amination reactions. Some strategies, such as phase-transfer catalysis (PTC), are not considered 
here since they require (over)stoichiometric amounts of reagent for catalysts turnover (e.g. bases). 
2.2.1 Activation via Cooperative Lewis Acid/Brønsted Base Catalysis 
Its concept relies upon the cooperative interaction of a Lewis-acidic site of the catalyst 
lowering the LUMO of the acceptor by coordination and the Brønsted-basic site activating the 
donor through formation of the corresponding enolate. Close proximity of both reactive sites 
ensures both high reactivity and selectivity.  
The first example of a catalytic system that relies on this activation mode was reported by 
Shibasaki in 1997 (Figure 2.7).
[40]
 They found that 20 mol% of the previously developed 
bifunctional complex 13
[41]
 enabled the direct aldol reaction of simple ketones and aldehydes in 
good yields (up to 90%) and good to excellent enantioselectivities (er from 72:28 to 97:3). 
Branching at the α-position was required for both reactivity and selectivity: Reactions with 
unbranched aldehydes resulted in diminished yields and enantiomeric excess. Notable limitations, 
such as the requirement of high amount of donor and the overall low reactivity (3–11.5 d reaction 
time) were circumvented in later publications.
[42]
 Over the following two decades these catalytic 
systems were broadly used in the field, including industrial scale applications.
[43]
 Although 
attempts to use α-hydroxy ketones as the starting materials, the Shibasaki system is restricted to 
the activation of simple unbranched ketones.
[44]
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The Trost group reported a catalytic system based on a similar concept: The binuclear 
complex (14) obtained upon treatment of the corresponding substituted phenol with 2 equivalents 
of Et2Zn enabled direct dia- and enantioselective aldol reactions (Figure 2.7).
[45]
 The Zn-
ProPhenol system has proven to be a highly successful tool for enantio- and diastreoselective 
aldol reactions, Mannich reactions, Henry reactions, conjugate additions and alkyne additions.
[46]
 
More recently, it was successfully applied to direct Mannich and α-amination reactions of 
challenging α-alkyl ketones (Scheme 2.12 a).[47] At the same time, enolate regioselectivity 
remained unclear, since only indanone and tetralone analogous were employed as starting 
materials. 
 Conceptionally similar, yet less popular systems for direct aldol reactions of ketones were 
developed by Nishiyama
[48]
 and Mahrwald.
[49]
 Feng et al. reported that an in situ generated chiral 
Scandium-based Lewis acid in combination with catalytic amounts of a Brønsted-base (Li2CO3) 
enabled direct enantioselective amination of cyclic ketones using α-diazoesters as electrophilic 
nitrogen reagents.
[50]
 The group of Wasa recently reported the application of chiral frustrated 
Lewis acid/Brønsted base complexes for direct amination and Mannich reactions of ketones.
[51]
 
However, these systems did not functionalize α-substituted ketones.  
 
Figure 2.7: Selected examples of catalytic cooperative Lewis-acid/Brønsted-base systems 
disclosed for the activation of ketones. 
2.2.2 Activation by Strong Brønsted Bases 
Due to the low acidity of unactivated ketones (their pKa values are within the range of 20 
to 28) chiral Brønsted base catalysts were only applied to activated α-substituted ketones.[52] 
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However, Terada et al. recently published a new class of chiral guanidine-derived 
organosuperbase precursors, which upon activation with Na/LHMDS enable direct electrophilic 
amination of α-alkyl substituted indanone and tetralone analogues (Figure 2.8 and Scheme 
2.12b).
[53]
  
 
Figure 2.8: Chiral organosuperbase by Terada.
[53a]
 
2.2.3 Activation by Lewis Base Catalysis 
The major disadvantage shared by all previously reported systems is that they are highly 
air and water sensitive and should be handled under inert gas atmosphere. Although the proline-
catalyzed Hajos–Parrish–Eder–Sauer–Wiechert reaction attracted a lot of attention, it remained 
largely undervalued by the scientific community because of its misinterpreted mechanism and a 
common notion that enantioselective reactions ultimately require transition metal catalysis. 
However, in 2000 List et al. reported proline-catalyzed enantioselective direct aldol reactions 
(Scheme 1.1 a).
[3]
 Later not only the generality of enamine catalysis, named after its reactive 
intermediate, was established and organocatalysis has become an important branch of 
homogeneous catalysis.
[54]
  
Nowadays, chiral secondary amines are the catalysts of choice for enantioselective α-
functionalization of linear aldehydes and ketones.
[54a, 54b]
 Because of the strong steric hindrance in 
the enamine intermediate the use of disubstituted aldehydes was challenging, however it was 
subsequently achieved by using chrial primary amines.
[55]
 The use of simple α-branched ketones 
was not reported with the only exceptions of reports by Carter and Toste groups. In 2012, Cater 
group reported conjugate additions of α-branched cyclic ketones to unsaturated esters, sulfons, 
nitriles and carbamates catalyzed by thiourea-based primary amine 16, proposing a cooperative 
enamine/Brønsted acid activation mode (Scheme 2.1 a).
[56]
 Toste et al. reported the direct α-
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fluorination of α-branched ketones enabled by a combination of enamine catalysis and chiral 
anion phase-transfer catalysis (Scheme 2.1 b).
[57]
  
 
Scheme 2.1: Direct α-functionalization of branched ketones by a) Carter and b) Toste. 
2.2.4 Functionalization via Brønsted Acid Catalysis 
 Although the tautomerization of carbonyl compounds can be catalyzed by Brønsted acids, 
only few examples of Brønsted acid-catalyzed enolizations were reported in the context of 
asymmetric α-functionalization of ketones. In 2006 Rueping and Gong independently reported 
enantioselective aza-Diels–Alder reactions of cyclic enones and imines.[58] Whereas Rueping et 
al. used a combination of chiral phosphoric acid and acetic acid and proposed that the former 
activates the imine by protonation and the latter is responsible for ketone enolization, Gong et al. 
showed that just a catalytic amount of a chiral phosphoric acid suffices for the reaction. Shortly 
after, Gong et al. extended this catalytic system to a one-pot three-component Mannich reaction 
of unbranched cyclohexanone-derivatives, aromatic aldehydes and aniline.
[59]
 Although 
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mechanisms involving phosphoric acid-catalyzed enolizations have been proposed, these 
reactions could potentially also proceed via enamine intermediates. 
 Even more clear example was provided by Akiyama et al. who showed that methyl 
ketones can undergo phosphoric acid-catalyzed enolization in an enantioselective aldol reaction 
of meso-1,3-diones (Scheme 2.8).
[60]
 Acid-catalyzed α-alkylations of unbranched ketones was 
reported by Guo and Peng.
[61]
 According to the proposed mechanism, the phosphoric acids 
promoted enolization of the corresponding ketone and simultaneously activated the electrophile 
by protonation. 
Acetophenones as well as indanone- and tetralone-derived ketones are challenging 
substrates for enamine catalysis, presumably because of a twisted and, conceivably, less reactive 
enamine intermediate. In an attempt to overcome these limitations, the Blanchet group reported 
chiral phosphoric acid-catalyzed syn-selective aldol reactions of glyoxylates and unbranched 
ketones.
[62]
 However, in just one example, 2-methyl tetralone was successfully used as the 
starting material, giving the corresponding quaternary α-carbonyl stereocenter in good yields 
(78%) and moderate dia- and enantioselectivity (syn/anti = 55/45; 78:22 er) (Scheme 2.2). 
 
Scheme 2.2: Chiral phosphoric acid-catalyzed aldol reaction using 2-methyl tetralone. 
 Apart from this example, the functionalization of challenging α-branched ketones via 
Brønsted acid catalysis was not addressed until the List group introduced the concept of enol 
catalysis by reporting enantioselective conjugate additions of α-branched cyclic ketones to 
enones catalyzed by a chiral phosphoric acid (Scheme 2.3).
[63]
 Remarkably, in the presence of a 
chiral phosphoric acid only the higher substituted enol was formed giving access to the α,α-
disubstituted ketones in excellent yields (up to 95%) and enantioselectivites (er from 90.5:9.5 to 
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97.5:2.5). It was suggested, that the Brønsted-acidic P–OH and basic P=O moieties of the chiral 
phosphoric acid not only accelerated the enolization but also activated both reaction partners via 
hydrogen bonding. Shortly after, intramolecular versions of Brønsted acid-catalyzed Michael 
reactions were reported by Lam and Yao groups using unbranched ketones.
[64]
 Furthermore, 
Toste et al. reported on chiral phosphoric acid-catalyzed addition of α-branched ketones to 
allenamides.
[65]
  
 
Scheme 2.3: Phosphoric acid catalyzed addition of α-branched ketones to enones. 
Recently, the List groups achieved the direct allylation of α-branched cyclic ketones via 
enol catalysis (Scheme 2.4).
[66]
 The combination of a palladium catalyst, chiral phosphoric acid 
3b and an atmosphere of CO2 enabled an asymmetric Tsuji-Trost-type allylation using allylic 
alcohols as reagents. This reaction is highly atom-economic, as only one equivalent of water is 
produced as side product. The targeted ketones, bearing a quaternary stereocenter were obtained 
in excellent yields (up to 93%) and enantioselectivities (er from 90.5:9.5 to 95.5:4.5). This 
methodology was applied in a formal total synthesis of (+)-crinane (18).  
The application of this strategy to C–X bond-forming reactions has not been reported 
prior to this thesis. 
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Scheme 2.4: Direct allylation of α-branched ketones by List et al.[66] 
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2.3 Catalytic Asymmetric Robinson Annulations 
 Discovered by Sir Robert Robinson in 1935, the reaction now termed Robinson 
annulation is one of the most powerful transformations for the synthesis of cyclohexanone 
derivatives.
[67]
 Being one of the first reported tandem reactions, it consists of three successive 
steps: (1) Michael-addition of a carbonyl compound to a vinyl ketone (e.g. methyl vinyl ketone), 
(2) intramolecular aldol reaction and (3) irreversible dehydration furnishing a bicyclic enone 
(Scheme 2.5). The reaction can be carried out under basic conditions that favored initial 
formation of the enolate; but also under acidic conditions favoring the final dehydration step.
[68]
 
Interestingly, when unsymmetrically substituted ketones were used as starting materials, 
alkylation usually occured at the more substituted α-carbon.[67c, 68] Since this reaction enables 
simultaneous formation of two C–C bonds producing just one molecule of water as a side 
product, it was applied in numerous total synthesis, e.g. of hispidospermidin,
[69]
 (+)-codein
[70]
 or 
(±)-guanacastepene A.
[71]
 
 
Scheme 2.5: Base-mediated sequence of conjugate addition and aldol condensation initially 
reported by Robinson et al. 
 The discovery, structural elucidation and medical application of testosterone, esterone, 
estradiol and progesterone in the first half of the 20
th
 century increased the demand for steroid-
derived pharmaceuticals. The commercial success of steroid-based contraceptive agents fostered 
the design and development of novel synthetic methods. At this time, Marker degradation was the 
major semi-synthetic method for the synthesis of steroids from diosegenine (19) which can be 
isolated from a Mexcian wild yam (Scheme 2.6).
[72]
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Scheme 2.6: Marker degradation starting from diosegenine (19). 
 Since only Mexico harvested the yams at the industrial magnitude, it rapidly became a 
world center for steroid production.
[73]
 Endiones of type 24a and 25b, which are reminiscent of 
the corresponding AB- or CD-ring systems in steroids, were recognized as an attractive 
alternative intermediates for the totals synthesis. Both can be easily accessed in racemic form via 
stepwise Robinson annulation starting from the corresponding 1,3-diketones catalyzed by 
pyrrolidine.
[74]
 However, enantiopure endiones could only be afforded via resolution or 
microbiological transformation of one antipode.
[75]
 Since these methods limit the yield of the 
targeted products to maximum 50%, an asymmetric synthesis was highly desired.  
 In 1971 Hajos and Parrish at Hoffmann La Roche reported the proline-catalyzed 
intramolecular aldol reaction of triketones 20a and 21a to give aldols 22a and 23a, which upon 
treatment with an acid produced the desired endiones 24a (Hajos–Parrish ketone) and 25a 
(Wieland–Miescher ketone), with good yields and enantioselectivities.[76][77] Independently, Eder, 
Sauer and Wiechert from Schering, reported a similar proline-catalyzed reaction. Employing 
higher catalyst loadings, elevated temperatures and perchloric acid as an additive gave the target 
ketones 24a and 25a in a single step (Scheme 2.7).
[78]
 This proline-catalyzed desymmetrization of 
meso-1,3-diones is nowadays referred to as the Hajos–Parrish–Eder–Sauer–Wiechert (HPESW) 
reaction.
[79]
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Scheme 2.7: Hajos-Parrish-Eder-Sauer-Wiechert reactions. 
 This reaction was a powerful alternative to the total dominance of transition metals 
catalysis in asymmetric synthesis. The mechanism, including the characterization of the transition 
state, was elucidated by Houk and List.
[80]
 For many reasons the synthetic potential of proline-
catalyzed reactions was overlooked for the next approximately 30 years,
[3, 81]
 although the 
HPESW reaction was applied in several total syntheses, such as ent-deoxycholic acid,
[82]
 (+)-
adrenosteron,
[83]
 (+)-cortistatin A
[84]
 and scabronin G
[85]
 to name only a few. 
Although significant efforts were dedicated to extending and improving the scope and 
enantioselectivity of the HPESW reaction, it has not made to a large-scale industrial synthesis. 
Especially the synthesis of Wieland-Miescher ketone (25a), which under proline catalysis was 
only obtained in lower enantioselectivity compared to Hajos-Parrish ketone (24a), was 
particulary challenging since it required several crystallization steps to obtain it in enantiopure 
form.
[86]
 One remarkable application of this catalytic system was the extension of chiral Brønsted 
acid-catalyzed Robinson annulations of β-keto esters,[87] Akiyama et al. reported a chiral 
Brønsted acid-catalyzed version of the HPESW reaction (Scheme 2.8).
[60]
 Using TRIP as the 
catalysts, the targeted tri- and tetracyclic products could be obtained in high yields (up to 94%) 
and enantioselectivities (er from 92:8 to 97:3). However, using 20a and 21a as the starting 
materials afforded the Hajos-Parrish ketone (24a) and the Wieland-Miescher ketone (25a) in 
lower enantioselectivities (85:15 er and 91:9 er, respectively).  
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Scheme 2.8: TRIP-catalyzed HPESW reaction. 
 Although these developments overcame some limitations of the classical HPESW 
approach, such as high catalysts loadings, use of high boiling solvents and moderate to low 
enantioselectivity, the synthesis of triketones 20a and 21a was still required. A more economical 
and practical approach could be the direct Robinson annulation of the corresponding 2-
substituted 1,3-diketones. However only few examples of such Robinson reactions were reported 
(Scheme 2.9): In 1997 Barbas et al. reported an antibody catalyzed synthesis of the Wieland-
Miescher ketone.
[88]
 Despite the high enantioselectivity (er >97.5:2.5) and the antibody efficiently 
catalyzing the cyclodehydration step, only modest catalytic performance was obtained for the 
initial Michael reaction.  
Importantly, L-proline itself is sufficiently potent to catalyze the Robinson annulation 
without erosion of enantioselectivity (49% yield, 88:12 er), as was reported by the same group 
shortly after the discovery of the proline-catalyzed intermolecular aldol reaction.
[89]
 In a more 
recent publication Bonjoch and Nájera described the application of BINAM derived catalysts 29 
in a solvent free Robinson annulation of 27a.
[90]
 Unfortunately, the catalyst was inactive for the 
initial Michael reaction resulting in a two-step one-pot procedure. Luo et al. reported that primary 
amine catalyst 30 enabled the synthesis of various Wieland-Miescher ketones in high yields (up 
to 87%) and excellent enantioselectivities (er from 92:8 to 96:4).
[91]
 Despite longer reaction times 
(typically 3–6 d at 2 mol% catalyst loading) a synthesis at 100 g scale pointed to its practical 
limitation: Although the Wieland-Miescher ketone (25a) could be isolated in excellent yield and 
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enantiomeric excess (90%, 95:5 er) an additional crystallization step was required to obtain the 
product as a single enantiomer (60% overall yield, 99.5:0.5 er). Therefore, increasing the yield 
and enantioselectivity of Hajos–Parrish and Wieland–Miescher ketones via Robinson annulation 
remained a synthetic challenge. 
 
Scheme 2.9: Reported catalytic systems for the Robinson annulation of 1,3-diketones.  
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2.4 Catalytic Asymmetric α-Aminations of Ketones 
 α-Amino ketones and related β-amino alcohols are common structural motifs in natural 
products, pharmaceuticals, ligands or chiral auxiliaries that are often approached by organic 
synthesis (Figure 2.9).
[92]
 For example the synthesis of ketamine
[93]
 has recently attracted 
significant attention because this highly potent anesthetic is now considered for treating clinical 
depression.
[94]
 Because (S)-ketamine is up to four times more potent than its enantiomer its 
efficient asymmetric synthesis is of high relevance for pharmaceutical industry.
[95]
 
Conventional synthetic strategies of β-amino alcohols take advantage of chiral pool 
reagents (e.g. via reduction of amino acids). Alternatively, since these motifs incorporate two 
nucleophilic functional groups, common approaches relied upon opening of aziridines or 
epoxides.
[92d]
 It is therefore not surprising that asymmetric access of these structures is often 
achieved by Sharpless oxyamination
[96]
 and subsequent oxidation.  
 
Figure 2.9: Selected examples of enantiopure α-amino ketones and β-amino alcohols in natural 
products and pharmaceuticals. 
 Although enantioselective electrophilic amination of carbonyl compounds was 
reported,
[97]
 the first catalytic version only appeared in 1997, when Evans et al. showed that 
chiral magnesium complex 34 enables the addition of aryl carboximides 31 to azodicarboxylate 
32a affording the target compounds in up to 97% yield and up to 95:5 er (Scheme 2.10). Later, 
numerous methods utilizing azodicarboxylates, N-hydroxycarbamates or nitrosobenzene as 
electrophilic reagents were reported. However, they usually relied on activated starting materials 
such as vinyl esters and ethers, nitroacetates, oxindoles, α-fluorinated ketones, β-keto or α-cyano 
carbonyl compounds.
[92b, 92c, 98]
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Scheme 2.10: First catalytic asymmetric electrophilic amination of carbonyl compounds by 
Evans et al.
[99]
  
In 2002 List
[100]
 and Jørgensen
[101]
 independently reported the L-Proline catalyzed 
amination of unbranched aldehydes with diazocarboxylates that, upon subsequent reduction, 
produced corresponding protected 1,2-hydrazino alcohols in excellent yield and 
enantioselectivity (Scheme 2.11). Shortly after, Jørgensen confirmed the generality of this 
synthetic approach by extending it to unbranched cyclic and acyclic ketones.
[102]
 Because of 
higher steric hindrance aryl ketones remained challenging substrates. However, Chen and 
coworkers could overcome this limitation by reducing the steric bulk of the catalysts (Scheme 
2.11).
[103]
 Applying 10 mol% of chincona alkaloid derived catalysts 35 the desired products could 
be obtained in good to moderated yields (up to 77%) and excellent enantioselectivies (up to 99:1 
er). Recently, Wasa et al. reported a frustrated Lewis Acid/Brønsted base catalyst enabling the 
direct enantioselective α-amination of unsubstituted aryl ketones.[104] Also, α-diazoesters were 
used as electrophilic amination reagents in a scandium-catalyzed example by Feng.
[50]
 
Already in 2003 Bräse et al. expanded the scope of L-Proline-catalyzed reactions to the 
direct amination of α,α-disubstituted aldehydes.[105] Using diazocarboxylates as an electrophilic 
nitrogen source the targeted products were isolated in good yields (50–87%) and 
enantioselectivities (er from 88:12 to 93:7). Because the formation of the corresponding enamine 
intermediate is strongly sterically hindered higher catalyst loadings (50 mol%) and longer 
reaction times were required. Furthermore, one of the α-substituents should be an aryl group 
since otherwise the enantioselectivity was decreased down to 64:36 er. Because of importance 
produced α-amino aldehydes, significant efforts were directed towards improving the reaction 
performance.
[98i]
 Several systems employing secondary
[106]
 as well as primary amine catalysts
[107]
 
were developed and the corresponding products further applied in the total synthesis of 
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biologically active compounds, such as BIRT-377, (S)-AIDA or (S)-APICA by the Barbas 
group.
[108]
 
 
Scheme 2.11: Direct enantioselective α-amination reactions of unbranched aldehydes and 
ketones. 
 Despite excellent results achieved for α-branched aldehydes, electrophilic aminations of 
α-branched ketones via enamine catalysis suffered from the low reactivity and unfavorable steric 
hindrance. Only very recently alternative approaches enabling the access to corresponding α-
amino ketones in a catalytic and enantioselective fashion were developed. The low acidity of α-
alkyl ketones was circumvented by Terada et al. by employing chiral 
bis(guanidino)iminophosphoranes as organosuperbases.
[53a]
 Upon activation with NaHMDS, 
these compounds could deprotonate 2-alkyltetralones and their analogues and afford the desired 
products in excellent yields (up to >99%) and enantioselectivities (er from 84:16 to 99:1) 
(Scheme 2.12 a). Recently, Trost et al. showed that the Zn-ProPhenol system can promote the 
direct amination of branched and unbranched ketones (Scheme 2.12 b).
[47b]
 Because strongly 
basic conditions were applied, these methods were limited to tetralone-derivatives and their 
analogues since one side of the ketone should be blocked in order to prevent the side reaction via 
the less hindered unsubstituted position. 
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Scheme 2.12: Amination of α-branched aryl ketones using a) organosuperbase 15 and b) Zn-
ProPhenol. 
 This challenge was recently addressed by Zhang et al. in a non-enantioselective copper 
catalyzed direct nitration of α-branched ketones using CAN as the oxidant (Scheme 2.13),[109] 
that suffered from side reactions and moderate to low yields of target compounds. The authors 
suggested that the reaction proceeds via oxidation of in situ formed cerium enolates to form α-
acyl radicals which are then quenched by NO2 resulting from the decomposition of CAN. The 
reaction could also proceed in the absence of copper, however higher yields were obtained in 
presence of 20 mol% of Cu(OAc)2 presumably due to enhanced enolate formation. 
 
Scheme 2.13: Direct α-nitration of α-branched cyclic ketones.   
In summary, despite extensive experimental efforts, direct catalytic and enantioselective 
amination of simple α-branched ketones remains a synthetic challenge.  
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2.5 Direct α-Oxidations of Ketones 
 α-Hydroxy carbonyls are common motifs in natural products and pharmaceuticals and are 
therefore highly appealing synthetic targets (Figure 2.10).
[110]
 The developed direct synthetic 
approaches include the reaction of in situ generated enolates with (chiral) electrophilic oxygen 
sources as oxaziridines
[111]
 or use of the Vedejs reagent (MoOPH)
[112]
 or oxidation of the 
corresponding vinyl ethers (Rubottom oxidation).
[113]
 
 
Figure 2.10: Selected natural products and pharmaceuticals bearing the α-hydroxy ketone 
moiety. 
2.5.1 Direct α-Hydroxylations of Simple α-Branched Ketones 
Hydroxylation of simple α-branched ketones remains challenging, not only because of the 
lower α-C–H acidity, but also because it is necessary to control the branched vs unbranched 
regioselectivity. Only few methods could address this issue (Figure 2.11). Although not catalytic, 
but still remarkable methods were published by Schulz
[114]
 and Zhang,
[115]
 that, presumably rely 
upon carbocationic pathway (for details, see section 2.5.6). They used water as a nucleophilic 
oxygen source together with strong oxidants such as electron deficient quinones or aminoyl 
radical salts. Whereas the scope of latter method was limited to 2-aryl cyclohexanones, the 
former method also allowed the reaction with challenging acyclic ketones. Recently, direct 
catalytic methods employing either Pd
[116]
, Cu
[117]
 or strong bases as Cs2CO3
[118]
 and molecular 
oxygen as the oxidant were developed, although no metal-free methods for the direct 
hydroxylation of unactivated α-branched ketones have been reported.  
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Figure 2.11: Recent methods for the direct hydroxylation of simple α-branched ketones using 2-
substituted cyclohexanone as example: a) stoichiometric/(sub)stochiometric reagents and b) 
catalytic systems employing molecular oxygen. 
2.5.2 Catalytic Asymmetric Aminoxylation Reactions  
In contrast to activated carbonyl compounds, such as β-keto carbonyl derivatives, direct 
asymmetric hydroxylation of simple aldehydes and ketones is an imminent challenge in 
asymmetric catalysis.
[92a, 92b, 119]
 It is not surprising that methods taking advantage of nature’s 
chiral pool,
[120]
 chiral reagents
[111]
 or chiral auxiliaries
[121]
 were commonly employed. Alternative 
approaches utilizing methods initially developed for asymmetric epoxidations/dihydroxylations 
of olefins, e.g. the Sharpless dihydroxylation
[122]
 or the Jacobsen-Katsuki
[123]
 and Shi-
epoxidations,
[124]
 in Rubottom-type reactions of preformed vinyl ethers and esters provided a 
workaround solution.  
Recently, Yamamoto and co-workers reported on Lewis acid catalyzed aminoxylation 
reactions using silyl vinyl ethers or tin enolates with nitrosobenzene as the oxidant. High O/N 
selectivity was observed and the corresponding hydroxy ketones could be obtained in an 
additional step using CuSO4 as catalyst (Scheme 2.14).
[125]
 Interestingly, the O/N selectivity 
changed depending on the employed conditions: in presence of a Lewis acid the reaction 
exclusively proceeded via O-attack, whereas in the absence of Lewis acid N-attack was preferred. 
As nitroso compounds exist in an equilibrium of monomer and dimer forms,
[126]
 the reactions 
selectivity was explained by the Lewis acid shifting this equilibrium towards the formation of the 
dimer. Nevertheless, these indirect methods require 1 to 2 additional synthetic steps including 
prefunctionalization of the starting material. 
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Scheme 2.14: Lewis acid catalyzed reaction of vinyl ethers or esters with nitrosobenzene by 
Yamamoto et al. (LA = Lewis acid). 
 Inspired by these reports, direct and enantioselective aminoxylation reactions of simple 
carbonyl compounds were also employed within the contxt of organocatalysis (Scheme 2.15).
[92c, 
127]
 In 2003, MacMillan,
[128]
 Hayashi
[129]
 and Zhong
[130]
 independently reported the reaction of 
linear aldehydes with nitrosobenzene using L-Proline as the catalyst affording corresponding 
products in excellent yields and enantioselectivies (≥97:3 er). Only O-selective attack of the in 
situ formed enamine onto nitrosobenzene was obtained, however a threefold excess of the 
aldehyde compared to nitrosobenzene was required to avoid self-condensation. Extension of the 
scope towards cyclic ketones,
[102, 131]
 acyclic ketones and α-branched aldehydes was possible 
although their O/N-selectivity was compromised.
[132]
 Furthermore, the selectivity can be inverted 
by reducing the acidity of the catalyst.
[98k, 133]
 Due to the intrinsic limitations of enamine catalysis 
similar reactions with α-branched ketones have not been reported.[131b] 
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Scheme 2:15: Organocatalytic α-aminoxylation of a) aldehydes and b) ketones. 
While exploring the desymmetrization of meso-cyclohexanones via L-Proline catalyzed 
aminoxylation, Barbas et al. discovered the direct formation of corresponding hydroxy ketones in 
the presence of excessive amounts of nitrosobenzene (Scheme 2.16 a).
[134]
 The following 
mechanism assuming a dual role of nitrosobenzene was proposed: Nitrosobenzene was supposed 
to act as an oxidant furnishing the corresponding aminoxylated ketone intermediate; additionally, 
the second nitrosobenzene equivalent reduced the N–O bond affording azoxybenzene (43) as a 
side product. This proved to be a generic mechanism for proline-catalyzed aminoxylation 
reactions also observed in reactions with aldehydes and cyclohexanones.  
More recently Zhong et al. applied this approach to the direct hydroxylation of β-keto 
carbonyl compounds using chiral phosphoric acid 1c as the catalysts (Scheme 2.16 b), that 
afforded the target products in good yields (up to 88%) and good to excellent enantioselectivities 
(er up to >99:1).
[135]
 Acyclic substrates were also tolerated under the reaction conditions, albeit 
the yields and enantioselectivities were compromised.  
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Scheme 2.16: Aminoxylation/N–O reduction sequence catalyzed by a) L-Proline and b) chiral 
Brønsted acid 1c.  
2.5.3 Alternative Approaches 
In the recent years, several alternative approaches for the direct synthesis of α-hydroxy 
carbonyl compounds, such as via phase-transfer catalysis (PTC), have been developed. PTC 
enables enantioselective hydroxylations of ketones using molecular oxygen and an excess of 
reductant (e.g. P(OEt)3).
[136]
 However, the reactions were carried out in strongly basic conditions 
and therefore their scope was limited to α,α’-substituted ketones, e.g. acetophenone-derivatives, 
2-substituted indanones or tetralones. 
 Alternative strategies made use of singlet oxygen, hypervalent iodine reagents, 
oxaziridines or benzoyl peroxide and use chiral secondary amines as catalysts
[92c]
. However, 
these methods were limited to unbranched carbonyl compounds and apart of two publications on 
the reaction of α-branched aldehydes by List[137] and Jacobsen[138] groups, direct hydroxylation of 
branched substrates (especially of simple α-branched ketones) was not reported. 
The majority of reactions discussed here proceed via ionic mechanisms. Alternative 
synthetic methods relying on α-carbonyl radicals generated through formal H-atom abstraction, 
e.g. by the combination of acetone and t-butyl hydro peroxide require rather harsh reaction 
conditions.
[139]
 Therefore, the last part of this section will focus on an exciting alternative method 
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of generating α-carbonyl radicals via single electron oxidation of enols under mild reaction 
conditions. 
2.5.4 Oxidation of Enols 
Surprisingly, the one-electron oxidation chemistry of carbonyl groups is barely 
investigated.
[140]
 Intra-
[141]
 and intermolecular
[142]
 oxidative transformations involving one-
electron oxidation of enolates were applied in total synthesis of (±)-hirsutene,
[143]
 acremoauxin A, 
oxazinin 3
[144]
 and palau’amine.[145] One-electron oxidation of enamines, so-called SOMO 
catalysis, is a well-established methodology for the asymmetric α-functionalization of simple 
aldehydes and ketones.
[146]
 Because of rapid tautomerization into thermodynamically favorable 
ketone forms, mechanistic studies on the oxidation of enols are scarce. It is therefore not 
surprising that their more stable and highly electron rich analogues, such as vinyl ethers,
[147]
 silyl 
vinyl ethers
[148]
 and vinyl esters
[149]
 are much better explored.  
2.5.5 Properties of Enol Cation Radicals 
 Neutral ketones are thermodynamically more stable than their enol-tautomers. However, 
theoretical and experimental studies suggested that, in contrast to one-electron reduction, enol 
cation radicals are more stable than corresponding ketone ions under single electron 
oxidation.
[150]
 One plausible explanation is that bond energies (C=O vs C=C) are higher in enols 
(Figure 2.2). However, significant geometrical changes of enols upon one-electron oxidation 
(elongation of the C–C bond from 1.35 Å to 1.44 Å and shortening of the C–O bond from 1.37 Å 
to 1.30 Å), suggest that the electron is removed from the π-orbital. These structural changes do 
not occur in corresponding ketones, as the electron is presumably removed from the oxygen lone 
pair. Removing an electron from the π-system requires less energy than from an oxygen lone pair 
and leads to inversed stability of ketone and enol radical cations.
[140a, 151]
  
Thermodynamic data acquired for stable β,β-mestiyl enols indicated that similar behavior 
is also observed in solution (Figure 2.12)
[152]
 and suggested two plausible pathways for the 
formation of enol cation radicals: 1) Oxidation of the ketone and subsequent 1,3-hydrogen 
migration or 2) selective oxidation of the enol present in the tautomer equilibrium. However, ab 
initio calculations suggested higher energy barriers for the rearrangement of aldehyde and keto 
radical cations, hence strongly favoring the latter pathway.
[140a]
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R = E1/V E2/V ΔG°1/kcal mol
–1
 ΔG°2/ kcal mol
–1
 
H 1.00 1.98 –3.1 –25.7 
tBu 0.98 1.85 2.6 –17.7 
Figure 2.12: Thermodynamic data on oxidation of the keto/enol tautormeric equilibrium in 
solution. Note: As only irreversible oxidations were obtained, these numbers can be only viewed 
as good estimate.
[152]
 
 Therefore oxidation potential of enols is ~ 1 V lower compared to corresponding ketones, 
which, in turn, suggests that applying only a mild oxidant could ensure a selective oxidation of 
enols present in the tautomeric equilibrium. Furthermore, recent studies demonstrated that 
hydrogen bonding can further decrease the oxidation potential of enols by another 0.5 V.
[153]
 
2.5.6 Reactions of Enol Cation Radicals 
 Despite using activated ketones, pioneering work of Moing, Le Guillanton and Simonet, 
reporting the dimerization of α-cyano ketones under anodic conditions,[154] and Yoshida, 
reporting oxidative [2+3] cycloadditions of 1,3-diketones and olefins,
[155]
 have demonstrated the 
synthetic potential of selective enol oxidation (Scheme 2.17). Both mechanisms assumed the 
formation of α-carbonyl radicals upon oxidation of the enol and subsequent deprotonation; 
however the exact mechanism was not elucidated. Since both tautomers are present in the 
reaction medium an alternative reaction pathway via oxidation of the ketone could not be ruled 
out.  
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Scheme 2.17: Early examples of synthetic application of enol cation radicals. 
 Schmittel et al. could overcome this limitation by investigating strongly sterically 
hindered mesityl-substituted carbonyl compounds of which the kinetically stabilized enol as well 
as the corresponding ketone could be obtained in tautomerically pure form.
[152, 156]
 Oxidizing β- 
and β,β-diemesityl substituted enols with two equivalents of an appropriate outer-sphere one-
electron oxidant, e.g. triarylaminium salts or iron(III) phenantroline (FePhen), lead to 
benzofuranes (44) (Scheme 2.18 a). Same products could be generated by cyclic voltammetry 
under preparative electrooxidation conditions. The studies proposed two plausible mechanisms: 
(1) Upon oxidation, the enol cation radical was deprotonated and produced an α-carbonyl radical, 
which underwent second oxidation, cyclisation and 1,2-methyl migration. Although the 
intramolecular cyclization of the enol cation radical could not be excluded (2), oxidation of less 
hindered enols in the presence of a nucleophile, e.g. methanol or water, produced corresponding 
α-substituted carbonyl compounds (Scheme 2.18 b) and indicated the presence of a carbocationic 
intermediate. This formal Umpolung of ketones, however with simpler substrates, was 
independently discovered by Schulz et al..
[114]
   
Due to the short life-time of enol cation radicals their electrochemical characterization 
deemed impossible. The life-time of a radical resulting from the corresponding enol ether is in 
the order of seconds, which indicates that proton loss creating α-carbonyl radicals could be the 
primary reaction pathway.
[140a]
  
 
2 Background 
 
 
37 
 
 
Scheme 2.18: a) Proposed mechanisms for the oxidative formation of benzofuranes (44) and b) 
α-hydroxylation in presence of water. 
2.5.7 Proton Coupled Electron Transfer 
The observed net reaction leading to the ketone α-radical is a hydrogen atom transfer 
(HAT) from the enol to the oxidant. In these reactions a formal homolytic cleavage of the X–H 
bond of a donor and recombination of the resulting hydrogen atom with the corresponding 
acceptor generates neutral free radicals which undergo subsequent reactions. The thermodynamic 
driving force for HAT reactions is proportional to the difference of the strengths of broken and 
newly formed bonds. The transfer only takes place if the donor and the acceptor are having 
similar bond dissociation free energies (BDFE). Since most synthetically interesting functional 
groups feature bond strengths exceeding 100 kcal mol
-1
 and the reduction generates, due to the 
vicinal position to a radical, X–H bonds with significantly lower BDFEs, the synthetic utility of 
HAT, with some exceptions, is strongly limited (Figure 2.13). The weakest known metal-hydride 
species H–V(CO)4(dppb) has a V–H BDFE of ca. 50 kcal mol
-1
,
[157]
 and it is therefore still too 
strong for reductive activation of common organic π-systems.[158] 
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Figure 2.13: Selected BDFEs of common organic functional groups.
[158]
 
According to Bordwell et al., factors contributing to the BDFE of a given bond can be 
analyzed in a thermodynamic cycle (Figure 2.14).
[159]
 The homolytic bond cleavage can be 
considered as a sum of the hetreolytic bond cleavage (characterized by its pKa) and the energy 
required to reduce/oxidize the formally formed ions to corresponding radical species and the 
hydrogen atom. This ultimately suggests that, in order to weaken the X–H bond of a hydrogen 
atom donor, either pKa or redox potential should be altered. Since within the same molecule these 
parameters are inversely correlated, a rational design of the reagent remains challenging. 
 
Figure 2.14: Thermodynamic cycle for the determination of BDFEs according to Bordwell.
[159]
 
In a HAT mechanism proton and electron result from the same bond, in a multisite proton 
coupled electron transfer (PCET) process they originate from spatially separated independent 
donors: a Brønsted acid and a single electron oxidant. Since products are neutral free radicals, 
PCET is similar to traditional HAT; however it is not affected by its thermodynamic constrains 
and therefore could to enable the activation of previously energetically inaccessible functional 
groups.   
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 Although no bond is homolytically cleaved during PCET process, according to Mayer et 
al. a conceptually similar thermodynamic cycle should still be valid (Figure 2.15).
[160]
 In this case 
the sum of pKa and redox potentials gives an “effective” BDFE which quantifies the ability of 
any acid/reductant to function as a hydrogen atom donor. Furthermore, the pKa and the redox 
potentials are now featured by two independent molecules and can be adjusted according to the 
requirements.  
 
Figure 2.15: Thermodynamic cycle for the determination of BDFEs of multisite PCET according 
to Mayer.
[160]
 
PCET allows tunable access to more powerful HAT reagents; but it also enables highly 
selective and orthogonal bond activation. In contrast to conventional HAT processes, whose 
selectivity is mainly determined by the bond strength, pre-coordination via hydrogen bonding and 
distance of electron- (> 10 Å) and proton-transfer (1–2 Å) are dominant factors for PCET. 
 Besides favorable thermodynamic advantages PCET is also kinetically favored over the 
competing stepwise pathways (Figure 2.16). It circumvents high energy intermediates and 
reactions could be carried out under much milder conditions (in respect to pKa or potentials) than 
required for particular substrates.  
Nevertheless, competition between HAT and PCET might occur, as for example with 
aromatic ketones.
[161]
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Figure 2.16: Reaction coordinate demonstrating kinetic advantages of PCET relative to the 
corresponding stepwise processes.
[158, 162]
 
2.5.8 Recent Applications of PCET in Asymmetric Catalysis 
PCET mechanism is best known for its role in biological energy conversion during 
respiration and photosynthesis.
[163]
 Due to rising interest in photoredox catalysis, PCET has also 
been recognized as method of chemical synthesis.
[158, 162, 164]
 In 2013, Knowles et al. reported a 
reduction of ketones to corresponding ketyl radicals and their subsequent coupling with olefins to 
furnish substituted cyclopentanes (Scheme 2.19).
[165]
 The key factor in the successful reduction of 
BDFE of the ketone to the one of ketyl radicals (~26 kcal mol
-1
) was the combination of a 
ruthenium-based photoredox catalyst and a Brønsted acid.  
Scheme 2.19: Ketyl-olefin coupling reported by Knowles et al.
[165]
 
By following this seminal work, PCET has expanded into new application areas. Notable 
examples are the activation of N–H bond in amides, carbamates and sulfonamides[166], the O–H 
bond in alcohols
[167]
 or the S–H bond in thiols.[168] However, until recently, only few 
enantioselective applications were reported. Knowles and co-workers performed reductive 
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coupling of ketones and hydrazones (Scheme 2.20 a).
[169]
 Similar to their previous report on 
ketyl-olefin couplings, a ketyl radical was generated via PCET using a photoredox catalysts and a 
chiral phosphoric acid. A subsequent C–C bond forming step and quenching of the resulting N-
centered radical with a Hantzsch ester furnished the targeted cyclic amino alcohols in good to 
excellent yields (up to 96%) and enantioselectivities (er from 83.5:16.5 to 98:2). More recently 
the same group reported a photocatalytic method for the synthesis of indole radical cations which 
could be intercepted by TEMPO to furnish alkoxyamine-substituted pyrroloindoles in good yields 
(up to 80%) and enantioselectivities (er from 93.5:6.5 to 96:4).
[170]
 In this case a single-electron 
reduction was the key step and a combination of photoredox catalyst and chiral phosphate 
ensured high levels of reactivity and selectivity. Further derivatization of the obtained products 
using a catalytic single-electron oxidation/mesolytic cleavage sequence in presence of 
nucleophiles was demonstrated. 
 
Scheme 2.20: Enantioselecitive a) coupling of ketones and hydazones and b) synthesis of inole 
radical cations. 
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Meggers group reported a combination of their previously developed chiral-at-rhodium 
Lewis acid and a photocatalyst enabling enantioselective access to β-amino carbonyl-derivatives 
from α,β-unsaturated 2-acyl imidazoles and N-aryl carbamates.[171] According to the proposed 
reaction mechanism an N-centered radical was generated via PCET together with the radical 
resulting from single electron reduction of rhodium-coordinated α,β-unsaturated 2-acyl 
imidazole. Subsequent radical recombination afforded the desired products in excellent yields (up 
to 99%) and enantioselectivites (er from 97:3 to 99:1). The same group reported an asymmetric 
variant of a PCET/1,5-HAT sequence for the remote C–H alkylation of amides initially reported 
by Knowles
[172]
 and Rovis.
[173]
 
. 
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3 Objectives 
The Hajos–Parrish–Eder–Sauer–Wiechert reaction is an iconic transformation in 
organocatalysis and a benchmark for evaluating newly developed amine catalysts. Furthermore, 
the obtained products have been used as starting materials in numerous total syntheses. As 
already mentioned in section 2.3, Akiyama showed that this intramolecular aldol reaction can be 
catalyzed by a chiral phosphoric acid.
[60]
 However, in order to obtain high enantiomeric excess, 
specific activated substrates had to be used. In this context we wondered if we could find a 
solution to this problem and achieve the direct and highly enantioselective synthesis of Hajos–
Parrish and Wieland–Miescher ketones, starting from readily available 2-substituted-1,3-
diketones and methyl vinyl ketone (Figure 3.1).  
 
Scheme 3.1: Envisioned enantioselective Robinson annulation of cyclic 1,3-diketones. 
The direct α-functionalization of α-branched ketones is a major challenge in asymmetric 
catalysis and only few systems for the in situ generation of reactive enolate equivalents have been 
reported. These systems typically operate under basic conditions and typically favor the 
formation of the corresponding kinetic products. Therefore, they are restricted to substrates in 
which one side of the ketone is blocked. In this context we wondered if Brønsted acid-catalyzed 
enolization (enol catalysis) could enable the formation of the more substituted enols, thus giving 
enantioselective access to α,α-disubstituted ketones. In parallel to our studies on the chiral 
phosphoric acid-catalyzed Michael addition of unactivated branched ketones to enones via enol 
catalysis,
[63, 174]
 we also decided to pursue α-heterofunctionalization reactions, which could grant 
us an efficient access to highly valuable synthetic building blocks.  
In particular, direct α-amination appeared as highly attractive approach because it opens a 
straight forward synthetic route towards enantiomerically pure α-amino ketones and β-amino 
alcohols, which are ubiquitous structures in natural products and pharmaceuticals. Despite the 
poor atom-economy, azodicarboxylates were envisioned as suitable electrophilic amination 
reagents, since they are highly reactive and commercially available (Figure 3.1).  
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We further aimed at extending the scope of enol catalysis to C–O bond forming reactions 
(Figure 3.1). As previously described, α-hydroxy ketones are also important and ubiquitous 
motifs that could be obtained by direct hydroxylation of ketones. Beyond controlling the 
enantioselectivity, the major challenge in such transformations is the choice of an appropriate 
electrophilic oxygen source. 
 The α-arylation of aldehydes, β-keto esters, substituted indoles or 2-naphtols via the 
conjugate addition to 1,4-benzoquinones is a well-established methodology in asymmetric 
organocatalysis.
[175]
 As an extension of our previous work on enol catalysis, we further 
considered a phosphoric acid-catalyzed addition of cyclic ketones to benzoquinones (Figure 3.1). 
 
Figure 3.1: Proposed activation mode of enol catalysis and envisioned transformations. 
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4 Results and Discussion 
4.1 Brønsted Acid-Catalyzed Asymmetric Robinson Annulations 
The work presented in this section was done with support by Dr. Desislava Petkova. 
4.1.1 Initial Studies 
In an initial experiment 1,3-diketone 26a was subjected to an excess of methyl vinyl 
ketone (28) and  (S)-TRIP (1a) as the catalyst and the desired product could be obtained in 52% 
NMR-yield and 84.5:15.5 er (Scheme 4.1). Comparing this with Akiyama’s results (86% yield, 
85:15 er starting from the corresponding triketone intermediate)
[60]
 suggested that the one-pot 
Robinson annulation should be possible under Brønsted acidic conditions and the reaction 
proceeds with negligible erosion of enantioselectivity.  
 
Scheme 4.1: Initial experiment on the Brønsted acid-catalyzed asymmetric Robinson annulation. 
Absolute configuration assigned according to Akiyama et al. 
In order to simplify the initial process of screening for optimal reaction conditions, we 
decided to first focus on the enantiodetermining aldol reaction starting from triketone 20a and to 
later apply the optimized conditions to the one-pot sequence described above. In addition to 
phosphoric acids, we evaluated the performance of various IDP catalysts. Out of the tested 
substitution patterns of 3,3'-aryl substituents, ortho-substitution proved to be the most crucial in 
respect to enantioselectivity. Using catalysts 10a, the targeted product was obtained in high 
enantioselectivities, yet in low yields (Table 4.1). Despite several attempts to further optimize the 
conditions through additives and application of temperature programs, the yields could not be 
improved. Furthermore, when these conditions were applied to the envisioned complete Robinson 
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annulation sequence, the product was obtained in only 22% yield and reduced enantioselectivity 
(94:6 er) after prolonged reaction time (5 d).  
 
Entry T/°C time yield
a
 er 
1 80 3 h 35% 85.5:14.5 
2 50 24 h 34% 87:13 
3 rt 48 h 17% 98:2 
Table 4.1: Selected conditions for the Brønsted acid-catalyzed aldol reaction toward the Hajos-
Parrish ketone. 
a
Determined by 
1
H NMR analysis of the crude reaction mixture using Ph3CH as 
internal standard. 
 Especially at low temperatures, the compound 47, resulting from the attack of the enol 
formed at the cyclopentadione onto the methyl ketone, was identified as the main side product of 
this transformation (Scheme 4.2). Since equilibrium constants for the enolization of primary 
ketones (e.g. acetone, pK = 7.20) and cyclopentanone (pK = 7.20) are similar, it is likely that 
both aldol reactions occur at similar rates, but the low solubility of 47 in nonpolar solvents shifts 
the equilibrium towards this undesired aldol product. Furthermore, IDPs furnished higher 
amounts of undesired 47 than phosphoric acids. This could be explained by the catalysts 
structure, where monomeric phosphoric acids provide an open cavity while highly confined 
active site of the IDPs forces the flexible substrate into a more staggered conformation. 
Since the irreversible elimination of the alcohol in 47 is disfavored according to Bredt’s 
rule
[176]
 and aldol reactions are per se reversible, we wondered if the byproduct could be 
converted to the targeted Hajos-Parrish ketone 24a. Indeed, when 47 was subjected to the 
reaction conditions using catalysts 10a at elevated temperatures, diketone 24a could be obtained, 
albeit with reduced enantioselectivity (71.5:28.5 er). Therefore we concluded that the reaction 
should be performed at elevated temperatures. Furthermore, the optimal catalysts should possess 
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a proper confined environment, which does catalyze the desired transformation enantioselectively 
without erosion of chemoselectivity. 
C10
C3 C4
C2
O3
C8
O2
O1
C5C1
H1
C6
C7
C9
 
Scheme 4.2: Preparation, reactivity and X-ray crystal structure of 47. 
4.1.2 Breakthrough and Fine-Tuning of Reaction Conditions 
 A breakthrough was achieved by switching from BINOL-derived TRIP to SPINOL-
derived STRIP, which produced the target compound in up to 95.5:4.5 er and synthetically useful 
yields (Table 4.2).  
 With these promising results in hand, we turned our attention toward our initial goal, the 
full Robinson annulation. Unfortunately, this approach turned out to be rather challenging. 
Despite several attempts, yields of the target material did not exceed 10%, although the 
enantioselectivities were high (Table 4.3, Entries 1, 2 and 4). One possible explanation is that, 
because of their high polarity, 1,3-diketones are poorly soluble in non-polar solvents.. A possible 
solution would be to either add an acidic co-catalysts or phase-transfer catalysts forming soluble 
ion-pairs. This, however, did not improve the yield and enantioselectivity (Entry 3 and 5). 
Interestingly, even though the reaction barely proceeds in water (Entry 6), to our delight, the 
addition of water as a co-solvent strongly improved the yields without erosion of 
enantioselectivity (Entry 7). It is known that the initial Michael reaction proceeds in water under 
acidic conditions, however the solubility of the formed triketone 20a was low. Therefore, we 
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speculated that our phosphoric acid catalyst, besides promoting enolizaiton, also acts as a phase 
transfer catalyst. The addition of dibutylhydroxytoluene (BHT) to prevent the polymerization of 
methyl vinyl ketone at elevated temperatures further improved the yields without deterioration of 
enantioselectivity (Entry 8; 38% NMR-yield, 98:2 er).  
 
Entry solvent T/°C yield
a
 er 
1 PhMe 80 47% 94:6 
2 CyH 80 41% 95:5 
3 n-Hex 80 62% 95.5:4.5 
4 n-Hex 60 7% 97.5:2.5 
Table 4.2: Optimization of reaction conditions using (S)-STRIP as the catalyst. 
a
Determined by 
1
H NMR analysis of the crude reaction mixture using Ph3CH as internal standard. 
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Entry solvent C/M yield
a
 er comment 
1 n-Hex 0.5 2% 98.5:1.5 - 
2 n-Hex 0.25 4% 98.5:1.5 - 
3 n-Hex 0.5 8% 96.5:3.5 10 mol% of BzOH added 
4 n-Hept 0.5 4% 98.5:1.5 - 
5 n-Hept 0.25 7% n.d. 10 mol% of TBAB added 
6 H2O 0.25 3% n.d. - 
7 
n-Hept/H2O 
(2/1) 
0.3 19% 98:2 - 
8 
n-Hept/H2O 
(2/1) 
0.3 38% 98:2 1.5 equiv of BHT added 
Table 4.3: Initial results on the Robinson annulation using (S)-STRIP as the catalysts. The best 
result is highlighted in bold. 
a
Determined by 
1
H NMR analysis of the crude reaction mixture 
using Ph3CH as internal standard. 
  
The yields were further increased by performing the reaction at higher temperatures (100 
°C) and higher ratio of n-Hept/H2O (9/1). The amount of BHT was not critical; however, at least 
1 equivalent had to be used to efficiently suppress polymerization. The optimized reaction 
conditions are presented in Scheme 4.2. 
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Scheme 4.2: Optimized reaction conditions. 
Interestingly, decreasing the catalyst loading from 5 mol% to 2.5 mol% decreased the 
yield, yet slightly enhanced the enantioselectivity. This highlighted a trend which we already 
observed during our optimization studies: lower yields, under otherwise similar or identical 
reaction conditions, coincided with higher enantioselectivities. Although the magnitude of 
changes was rather small, it prompted us to consider a kinetic resolution pathway which favors 
the desired enantiomer in the final dehydration step. Therefore, racemic ketol (±)-22a was 
prepared using DL-Proline (Scheme 4.3). Indeed, when (±)-22a was subjected to the optimized 
reaction conditions an enantioenrichment favoring the obtained major enantiomer was observed. 
However, a possible DKR mechanism cannot be excluded at this point.  
 
Scheme 4.3: Investigations into the kinetic resolution of ketol (±)-22a. 
4.1.3 Preliminary Substrate Scope 
 Although these results were highly promising, a preliminary substrate scope showed that, 
under given conditions, the reaction scope lacked generality (Figure 4.1). Whereas the Hajos-
Parrish ketone (24a) could, as was already shown, be synthesized in good yield and 
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enantioselectivity (79% NMR-yield and 94.5:4.5 er), its benzyl-derivative showed not only lower 
reactivity but also selectivity (64% NMR-yield and 91:9 er). Gratifyingly, when extending the 
ring size of the used 1,3-diketone, the Wieland-Miescher ketone (25a) could be obtained in 83% 
isolated yield and 98:2 er. 
 
Figure 4.1: Preliminary substrate scope.  
With these results in hand, we then decided to investigate the generality of our 
transformation toward various Wieland-Miescher ketone derivatives. The starting materials were 
obtained in a one pot aldol/conjugate reduction sequence of cyclohex-1,3-dione (48) and a 
corresponding aldehyde in presence of Ethidine (49) using DL-Proline as catalysts (Scheme 4.4). 
Phenyl-substituted substrate 27i was synthesized via copper(I)-catalyzed coupling of cyclohex-
1,3-dione (48) and iodobenzene.  
 
Scheme 4.4: General procedures for the synthesis of the starting materials. 
To our delight, under the reaction conditions nearly all tested substrates gave the expected 
products in good to excellent yields (62–99%) and excellent enantioselectivities (>98:2 er) 
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(Scheme 4.5). Current limitations are aryl-substituted substrates, such as 27i, and other vinyl 
ketones, since both lead to in complex reaction mixtures (25i and 25j).  
 
Scheme 4.5: Preliminary substrate scope of Wieland-Miescher ketones. 
4.1.4 Revisiting the Catalyst Structure 
 Having disclosed an efficient system for the synthesis of Wieland-Miescher ketones, we 
turned our attention back to underperforming Hajos-Parrish ketones. From our previous studies 
we concluded that the selectivity issue cannot be solved by further modifying the reaction 
conditions and therefore we decided to further optimize the catalyst structure. We identified three 
starting points for further catalyst development: 1) the active site, 2) the 3,3'-substituents and 3) 
the catalyst backbone. Out of these three possibilities, the first two seemed to us to be the most 
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facile, since we could take advantage of well-established BINOL chemistry and then extend our 
positive experience to the SPINOL-backbone. 
Modification of the Active Site 
As described above, IDP catalysts showed no significant improvement regarding the 
enantioselectivity compared to TRIP. This could be explained by the high confinement and rigid 
structure generated by the two BINOL-backbones. We therefore tested bisphosphorylimide 50 
and N-phosphinyl phosphoramide 51,
[177]
 in which one of the BINOL-moieties is substituted by 
aryl/aryloxy groups. Unfortunately, enantioselectivity was not improved (Entries 1–4, Table 4.4). 
We assume that the active site of these catalysts is stretching too far out of the cavity and 
therefore limiting the required interaction of substrate and substituents in the 3,3'-position of the 
catalysts. 
 
Entry catalyst yield
a
 er comment 
1 50 75% 76:34 - 
2 50 86% 82:18 without H2O 
3 51 73% 75:25 - 
4 51 68% 75.5:24.5 without H2O 
5 TRIP (1a) 74% 78:22 - 
6 TRIP (1a) 51% 83:17 without H2O 
Table 4.4: Evaluation of bisphoshorylimides and N-phosphinyl phosphormaindes as catalysts. 
a
Determined by 
1
H NMR analysis of the crude reaction mixture using Ph3CH as internal standard. 
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Modification of the 3,3’-Substitutents 
As this line of research turned out to be unsuccessful, we further focused on the 
modification of the 3,3'-substitutents. Akiyama recently reported phosphoric acids 1d and 1e 
(Table 4.5), in which the biphenyls, due to the large substituents, approach a torsion angle of 
90°.
[178]
 This has the consequence that one of the ortho-substituents of the second aryl-moiety 
reaches into the active site of the catalysts thus making it more confined. Indeed, promising 
enantioselectivities without significant erosion of yields were obtained (Table 4.5). However, the 
attempted cross-coupling towards the corresponding SPINOL-derived phosphoric acids did not 
lead to the target product.   
 
Entry catalyst yield
a
 er comment 
1 1d 71% 78.5:21.5 - 
2 1d 48% 84:16 without H2O 
3 1e 66% 87:13 - 
4 1e 55% 88.5:11.5 without H2O 
5 TRIP (1a) 74% 78:22 - 
6 TRIP (1a) 51% 83:17 without H2O 
Table 4.5: Evaluation of novel substituents in 3,3'-position of BINOL-derived phosphoric acids.. 
a
Determined by 
1
H NMR analysis of the crude reaction mixture using Ph3CH as internal standard. 
In parallel we attempted to increase the steric bulk of the TRIP-substituent by extending 
the isopropyl to 3-isopentyl groups. The synthesis of bromide 55 was achieved in 4 consecutive 
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steps from commercially available trimethyl benzene-1,3,5-tricarboxylate (52) (Scheme 4.6). 
Addition of ethylmagnesium bromide to 52, followed by sequential acid-catalyzed elimination 
and hydrogenation furnished 1,3,5-tri(pentan-3-yl)benzene (54) in 83% yield.. Selective mono-
bromination was achieved in 95% yield using gold(III)-chloride and freshly recrystallized NBS.  
 
Scheme 4.6: Synthesis of 2-bromo-1,3,5-tri(pentan-3-yl)benzene (55).  
This sequence provided us with sufficient material for subsequent trials toward cross-
coupling to MOM-protected 3,3'-bisiodo BINOL. We chose the Negishi cross-coupling since by 
this method C–H bond activation at the alkyl chains could be minimized. Despite successful 
lithiation and transmetalation to zinc the cross-coupling was unsuccessful. In all cases only 
remaining starting material was detected by 
1
H NMR analysis of crude reaction mixtures. 
Modification of the Catalyst Backbone 
Because previous strategies were not successful, we proceeded with further modifications 
of the catalyst backbone. In 2007 Zhou et al. reported the synthesis of spirobitetraline-derived 
chiral phosphoramidite ligands and their application in asymmetric hydrogenations.
[179]
 
Comparing the crystal structures of spirobiindane-derived diol (SPINOL, 56) and the 
spirobitetraline-derived diol (57), suggested that the additional carbon atoms increased the 
dihedral angles and O–O distances (Figure 4.2 a). This indicated that a potential catalyst, having 
aryl-substituents in the 3,3'-position, would not only have a more twisted structure but also a 
shorter spatial distance of the 3,3’-substituents and therefore a more confined active site. 
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Calculations performed with both corresponding structures having TRIP substitutes in the 3,3’-
position supported this assumption (Figure 4.2 b).  
 
 
Figure 4.2: (a) Comparison of key elements of the crystal structures of spirobiindane-derived 
diol (SPINOL, left, 56) and spirobitetraline-derived diol (right, 57). (b) Calculated structures of 
the corresponding phosphoric acids, bearing the TRIP-substituent in 3,3’-position. Calculations 
were performed at the B3LYP-level of theory in the gasphase. Protons are removed for better 
visibility. 
We therefore attempted the synthesis of diol 66 as described by Zhou et al. (Scheme 4.7). 
Lithium aluminum hydride reduction of 3-methoxy cinnamic acid (58) gave alcohol x in 
quantitative yield. Subsequent treatment with phosphorus tribromide furnished bromide 60, 
which was transformed into the corresponding Grignard reagent and quenched with methyl 
formiate to give alcohol 61 in 49% yield over three steps. Swern oxidation and subsequent 
bromination using sodium bromide and hydrogen peroxide in acetic acid resulted in compound 
63 in 82% yield. The bromines functioned as a protecting group for the subsequent Friedel–
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Crafts-alkylation because they blocked the more reactive para-position. The Friedel–Crafts step 
required additional optimization, as the original conditions resulted in complex mixtures 
containing only trace amounts of the desired product. However, performing the reaction in 
methansulfonic acid at 0 °C produced (±)-64 in 82% yield. Removal of the bromines via 
metalation/protonation and deprotection using sodium ethanethiolate finally gave the target 
racemic diol (±)-66. 
 
Scheme 4.7: Synthesis of (±)-66. 
 Separation of the enantiomers can be achieved by esterification of (±)-66 with (1S)-(+)-
10-camphersulfonyl chloride followed by chromatographic separation of the corresponding 
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diasteromers.
[179]
 However, this process required two additional synthetic steps and separation of 
the diastereoisomers was not straigtforward. Our attempts to separate the enantiomers by 
preparative HPLC were unsuccessful: it was only achieved at the analytical scale. As an 
alternative, we decided to continue the synthesis and separate the final phosphoric acids, because 
for these compounds separation on ion exchange columns looked more promising.  
To install substituents at the 3,3'-positions, we attempted the synthesis of the 
corresponding bromides via directed ortho-lithiation/bromination sequence. Presumably because 
of inefficient coordination by the methoxy groups, the direct deprotonation of (±)-65 using n-
BuLi and TMEDA was unsuccessful. Quenching of the crude reaction mixture with D2O did not 
show deuterium incorporation. Attempts to brominate the unprotected diol (±)-66 with NBS 
resulted in complex mixtures of products containing various amounts of bromine (up to four). A 
promising initial result was obtained by treating the MOM-protected diol (±)-67 with n-BuLi 
followed by 1,2-dibromo-1,1,2,2-tetrachloroethane. In a small-scale experiment an inseparable 
mixture of mono- and di-brominated product was detected (Scheme 4.8). Further optimization of 
this reaction conditions should enable the access in synthetically useful yields. 
 
Scheme 4.8: MOM-protection and initial attempts toward bromination. 
4.1.5 Conclusions 
 We developed a Brønsted acid-catalyzed enantioselective Robinson annulation of cyclic 
1,3-diketones with methyl vinyl ketone. Using STRIP as the catalyst gave access to various 
derivatives of the Wieland-Miescher ketone in good to excellent yields and excellent 
enantioselectivities (≥ 98:2 er). Unfortunately, derivatives of the Hajos-Parrish ketone were 
obtained in lower enantioselectivity. To address this challenge, synthetic efforts towards a 
presumably more confined bis-tetraline-derived phosphoric acid were taken.  
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4.2 Catalytic Asymmetric α-Amination of α-Branched Ketones via Enol 
Catalysis[180] 
The work presented in this section was done with support by Dr. Gabriele Pupo. Towards 
the end of this study, a conceptually similar work with complimentary scope was published by 
Toste et al.
[181]
 
4.2.1 Optimization Studies 
We began our investigation by employing 2-methyl cyclohexanone (68a) and dibenzoyl 
azodicarboxylate (32c) as model substrates. Performing the reaction at 100 °C and using (S)-
TRIP (1a) as catalysts resulted in full conversion of the starting material and the desired product 
69a was obtained in promising 86:14 er (Scheme 4.9).  
Scheme 4.9: Initial result for the asymmetric α-amination of α-branched ketones. 
These promising results prompted us to evaluate the catalytic abilities of other phosphoric 
acids (Scheme 4.10). Having bulky groups in the ortho-position of the 3,3'-substituent turned out 
to be beneficial regarding the enantioselectivity, i.e. out of the tested phosphoric acids, 1f and 1j, 
both not having any ortho-substituent, catalyzed the reaction with the lowest enantioselectivity 
(59:41 er and 48:52 er, respectively). Changing the three i-Pr groups of TRIP (1a) to either 
cyclohexyl- or t-Bu-groups
[182]
 did not improve enantioselectivities (1h, 86:14 er and 1l, 80:20 er, 
respectively). Gratifyingly, 9-anthracenyl substituted phosphoric acid 1m delivered the desired 
product in excellent 93:7 er. Other catalyst motifs resulted either in very low reactivity (IDP) or 
racemic product (DSI).  
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Scheme 4.10: Screening of catalysts. 
Performing the reactions at 100 °C afforded complex reaction mixtures and control 
experiments showed that the azodicarboxylate was decomposing to several unidentified products. 
Lowering the temperature resulted in a cleaner reaction profile and improved the 
enantioselectivity: Reaction at room temperature gave the desired ketone in 64% isolated yield 
and 97:3 er (Table 4.5, Entry 3). Note: For better consistency, the reaction was stopped after 15 h; 
although TLC analysis of the crude reaction mixture indicated the presence of unreacted starting 
material. 
Because of the rotamers, the NMR spectrum of 69a contained extremely broad signals 
and hence yields based on an internal standard could not be accurately determined. Instead, 
conversion of the starting material based on an internal standard was used as an indicator for 
reactivity.  
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Entry T/°C yield
a
 er 
1 100 n.d. 93:7 
2 60 76% 95.5:4.5 
3 rt 64% 97:3 
Table 4.5: Effect of temperature. 
a
Determined by purification of the crude reaction mixture by 
preparative TLC. 
A solvent screening revealed that the choice of solvent mainly affected reactivity, whereas 
enantioselectivity remained the same (Table 4.6). Due to the higher enantioselectivity, 
acetonitrile was chosen as a solvent for further studies. 
 
Entry solvent conversion
a
 er 
1 PhMe 96% 96.5:3.5 
2 CH2Cl2 96% 98:2 
3 EtOAc 68% 97.5:2.5 
4 MTBE 50% 97:3 
5 DMSO 13% n.d. 
6 acetone 28% 98:2 
7 MeCN 74% 98.5:1.5 
Table 4.6: Screening of solvents. 
a
Determined by 
1
H NMR analysis of the crude reaction mixture 
using Ph3CH as internal standard. 
Reactivity was improved by increasing the concentration (Table 4.7, Entry 1 and 2). 
Remarkably, the reaction also proceeded under neat conditions, however with slightly lower 
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enantioselectivity (Entry 3). Catalysts loading could be reduced from 5 mol% to 1 mol%, 
however longer reaction times were required to reach full conversion of the starting material 
(Entry 4). The amount of azodicarboxylate could be reduced to 1.2 equivalents without 
deterioration of selectivity or yield (Entry 5). Under fully optimized conditions, the desired 
product was obtained in 85% yield and 99:1 er (Entry 6). 
 
Entry M mol% 1m equiv. 32a conversion
a
 er 
1 0.5 5 2 74% 98.5.1.5 
2 1.0 5 2 93%. 98.5:1.5 
3 neat 5 2 >95% 95.5:4.5 
4 0.5 1 2 28% 99:1 
5 0.5 5 1.2 68% 98.5:1.5 
6 2 5 1.2 (85%) 99:1 
Table 4.7: Further optimization of reaction parameters. Isolated yields are given in parenthesis. 
a
Determined by 
1
H NMR analysis of the crude reaction mixture using Ph3CH as internal standard. 
4.2.2 Substrate Scope 
Having identified optimal reaction conditions, we focused our attention on the substrate 
scope. In addition to 32c, other azodicarboxylates, e.g. DEAD (Et, 32b) and DIAD (i-Pr, 32d), 
were tested as electrophiles. Gratifyingly, the corresponding α-hydrazino ketones were obtained 
in good yields and excellent enantioselectivities (>98:2 er). Using Boc-protected hydrazine 
(DBAD, 32a) no desired product was observed even at elevated temperatures (Scheme 4.11).  
4 Results and Discussion 
 
 
63 
 
 
 
Scheme 4.11: Scope of azodicarboxylates.  
 A variety of 2-alkyl- and 2-aryl-subsituted ketones were tolerated by the system, 
delivering the desired products in excellent yields and enantioselectivities (Scheme 4.12). 
Furthermore, the method could also be expanded to 2-alkyl substituted cyclopentanones (69k and 
69l). Remarkably, cyclohexanone itself turned out to be a suitable substrate and the 
corresponding mono-aminated product 69d was obtained in 69% yield and 89:11 er. Gratifyingly, 
no racemization was observed, emphasizing the selectivity of this catalytic system. The 
developed method was also scalable: The reaction of 2-phenyl cyclohexanone (76) and DEAD 
(32b) delivered the corresponding product in 77% yield and 97.5:2.5 er at 1 mmol scale. 
However, reduced reactivity and selectivity were obtained using 1-indanone and 1-tetralone 
derived substrates.  
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Scheme 4.12: Scope of ketones. The absolute configuration of products was assigned according 
to 69d. 
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4.2.3 Synthesis of Carbamate-Protected α-Amino Ketones 
Although being very convenient electrophilic amination agents, azodicarboxylates 
produce a disadvantageous N–N bond. Usually, this bond is cleaved under reductive conditions 
(e.g. using Rayne Ni/H2 or SmI2), which is not compatible with the ketone moiety in α-hydrazino 
ketones and all of our attempts using a variety of heterogeneous hydrogenation catalysts led to 
full decomposition. Magnus group recently reported an alternative approach giving carbamate-
protected α-amino ketones via an (i) alkylation and (ii) E1cB elimination sequence.
[183]
 Using this 
reaction conditions α-amino ketone 70 was isolated in 27% yield over two steps (Scheme 4.13). 
 
Scheme 4.13: Initial attempt for N–N bond cleavage of carbamate-protected hydrazine 
derivatives via E1cB mechanism. 
 Although formally being a two-step procedure, the transformation can be performed in 
one-pot without additional work up or purification of the intermediate. Using α-hydrazino ketone 
(±)-69h, we further optimized this cleavage reaction (Table 4.8). Using the standard reaction 
conditions, the target product was obtained in 14% yield (Entry 1). Changing the base from 
Cs2CO3 to KOH marginally improved the yield (Entry 2). Applying higher amounts of base, 
changing the order of addition or modifying the alkylating agent resulted in no improvements 
(Entries 3–5). 
 We reasoned that steric bulk of the two benzoyl carbamates hinders the elimination step 
and therefore leads to decomposition of the corresponding alkylated intermediate. In order to 
overcome this, we decided to switch from dibenzoyl protected α-hydrazino ketone 69h to 
diethoxy protected 69i (Table 4.9). Indeed, similar trends were obtained as before, yet the 
isolated yields were higher. Under standard reaction conditions, the desired product could be 
isolated in 24% yield (Entry 1). In contrast to our previous results, only decomposition of starting 
material was observed when changing the base to KOH (Entry 2). Increasing the temperature to 
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70 °C and changing the ester group from methyl to ethyl turned was beneficial and the 
corresponding ketone was isolated in 39% yield (Entries 3 and 4).  
 
Entry conditions R yield 
1 Cs2CO3 (6 equiv.); 16 h at 50 °C OMe 14% 
2 KOH (6 equiv.); 16 h at 50  C OMe 16% 
3 KOH (30 equiv.); 50 °C OMe 0% 
4 Cs2CO3 (6 equiv.); 72 h at 50 °C then 8 h at 80 °C NMe2 traces 
5 Cs2CO3 (6 equiv.); 72 h at 50 °C OEt 0% 
Table 4.8: Optimization of reaction conditions for the one-pot N–N bond cleavage. Isolated 
yields are presented. 
 
Entry conditions R yield 
1 Cs2CO3 (6 equiv.); 16 h at 50 °C Me 24% 
2 KOH (6 equiv.); 16 h at 50  C Me traces 
3 Cs2CO3 (6 equiv.); 16 h at 70 °C Me 36% 
4 Cs2CO3 (6 equiv.); 16 h at 70 °C Et 39% 
Table 4.9: Optimization of reaction conditions for the one-pot N–N bond cleavage. Isolated 
yields are presented. 
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Finally, the above mentioned conditions were applied to the synthesis of carbamate 
protected α-amino ketone 71, which was isolated in 35% yield and without erosion of 
enantioselectivity (Scheme 4.14). 
 
Scheme 4.14: Cleavage of the N–N bond under redox neutral conditions.  
4.2.4 Conclusions 
 In summary, a direct asymmetric α-amination of α-branched ketones via enol catalysis 
was developed. In the presence of a chiral phosphoric acid, the higher substituted enol was 
exclusively formed and subsequently reacted with azodicarboxylates to produce α-hydrazino 
ketones in excellent yields (40–99%) and enantioselectivities (up to 99:1 er). Preliminary results 
on the cleavage of the disadvantageous N–N bond under redox neutral conditions provided direct 
access to enantiomerically enriched carbamate-protected α-amino ketones. The reaction probably 
proceeds via a transition state (Figure 4.3) in which the phosphoric acid not only promotes 
enolization but also activates the electrophile through protonation.  
 
Figure 4.3: a) Proposed transition states for the α-amination of a) aldehydes via enamine 
catalysis and b) α-branched ketones via enol catalysis. 
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4.3 The Direct α-Hydroxylation of Cyclic α-Branched Ketones via Enol 
Catalysis 
The work presented in this section was done in collaboration with Dr. Gabriele Pupo and 
Stefanie Dehn. The calculations presented here were performed by Dr. Giovanni Bistoni at the 
Max-Planck-Institut für Chemische Energiekonversion (CEC) and the Max-Planck-Institut für 
Kohlenforschung. 
4.3.1 Oxidative Cleavage of α-Branched Ketones 
 While conceiving the project, we were inspired by the work of Cordova et al., who 
reported the direct hydroxylation of simple aldehydes and ketones via enamine catalysis using in 
situ generated singlet oxygen.
[184]
 Although some aspects of this work are under debate, a recent 
study conclusively showed that such transformations are indeed possible using aldehydes as the 
starting materials.
[185]
 We therefore began our investigations by irradiating a solution of 2-methyl 
cyclohexanone (68a), catalytic amounts of DPP and Rose Bengal (72) with visible light under an 
atmosphere of oxygen (Figure 4.4 a). Unfortunately, under various reaction conditions, 
1
H NMR 
analysis of the crude reaction mixture did not reveal desired α-hydroxy ketone even in trace 
amounts. However, a new compound, which we could identify as 6-oxoheptanoic acid (73), was 
detected (Figure 4.4 b).  
Addition of radical scavengers (e.g. BHT) or reducing agents (e.g. triethylphosphite) did 
not have any effect, suggesting that the reaction proceeds via an ionic mechanism with no or very 
short lived peroxide-containing intermediates. We therefore believe that this reaction proceeds 
via a [2+2] cycloaddition of the enol and the generated singlet oxygen to form 74, which is not 
stable under the reaction conditions and opens to give 73a (Scheme 4.15). At first glance, this 
transformation might not appear as synthetically useful; however, when cyclohexanone is used as 
a substrate, this would enable a rather efficient access to adipic acid– an industrial precursor to 
nylon. 
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Figure 4.4: (a) Selected conditions for the initial experiments of the direct α-hydroxylation of α-
branched ketones using singlet oxygen. (b) (blue) Part of the crude 
1
H NMR of the reaction. (red) 
1
H NMR spectra of 2-methyl cyclohexanone (68a). 
  
 
Scheme 4.15: Proposed reaction mechanism for the formation of 73a. 
Unfortunately, only low conversions of 68a (up to 30%) were obtained using our initial 
conditions. Another major issue was the reproducibility: A simple modification of reaction 
conditions such as changing the reaction vial strongly affected the outcome. Reproducibility (but 
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not the yield) was impoved by changing the light source from a normal household light bulb to an 
LED power block, containing six connected 20 W LEDs (Figure 4.5). We therefore decided to 
further optimize the reaction conditions using 2-methyl cyclohexanone (68a) as the starting 
material. 
 
Figure 4.5: Reaction set up using six connected 20 W LEDs. When closed, the temperature 
inside the core could reach 110 °C. 
An initial screening of photosensitizers revealed that using tetraphenylporphyrin (tpp, 75) 
significantly increases the yield (74%, Table 4.9 Entry 2). Other common acids, such as triflic 
acid and methanesulfonic acid or other phosphoric acids also catalyzed the reaction, albeit the 
yields were lower (Entries 5–7).  
 Screening of catalyst loading and the amount of photosensitizer did not show any further 
improvement and therefore we attempted the isolation of the products. This proved to be 
challenging as the visibility of such compounds on TLC is low, thus hindering isolation by flash 
column chromatography. Acid/base extractions of the crude reaction mixture gave inseparable 
mixtures of product and catalyst. We attempted in situ esterification of the carboxylic acid 
moiety. However, the isolated yields of the corresponding esters never exceeded 42%.  
4 Results and Discussion 
 
 
72 
 
 
 
Entry solvent photosensitizer catalyst yield
a
 
1 MeCN Rose Bengal DPP 47% 
2 MeCN tpp DPP 74% 
3 PhMe tpp DPP 40% 
4 DMF tpp DPP <5% 
5 MeCN tpp TfOH 9% 
6 MeCN tpp H3PO4 24% 
7 MeCN tpp MeSO3H 45% 
Table 4.9: Summary of reaction optimization. Best result is highlighted in bold. 
a
Determined by 
1
H NMR analysis of the crude reaction mixture using Ph3CH as internal standard.  
 Finally, we could overcome this drawback by applying over-stochiometric amounts of 
TFA, which, due to its low boiling point, was easily removed under reduced pressure. 73b, the 
oxidation product of 2-phenyl cyclohexanone, was isolated in 72% yield by simple acid/base 
extraction of the crude reaction mixture and subsequent removal of all volatiles under reduced 
pressure (Scheme 4.16). Unfortunately, using cyclohexanone as the starting material did not 
result in any detectable amounts adipic acid.  
 
Scheme 4.16: Optimized reaction conditions and preliminary scope of the oxidative cleavage of 
ketones. 
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4.3.2 Development of a Non-Enantioselective Direct α-Hydroxylation of α-
Branched Cyclic Ketones 
 Since the desired α-hydroxy ketones were not afforded via the reaction with singlet 
oxygen, we shifted our interest towards other electrophilic oxygen reagents. Oxaziridines, such as 
the Davis’ oxaziridine, seemed to be a straight forward approach for C−O bond formation. 
However, since a stoichiometric amount of a N-tosyl imine is produced as side product in course 
of the reaction the corresponding Mannich reaction would affect the yield of desired product.
[181]
 
Furthermore, additional synthesis / purification steps would be required to obtain the labile 
oxaziridines. Nitrosobenzene, on the other hand, is stable, commercially available and has been 
used as an oxidant in organocatalytic aminoxylations of simple aldehydes and ketones. In fact, in 
the presence of a Brønsted acid, second equivalent of nitrosobenzene can  act as a reductant and 
directly afford the desired hydroxyl carbonyl compounds via tandem aminoxylation/N–O bond 
cleavage sequence (Scheme 2.16 a).
[134]
 We also reasoned that  the synthetic advantage of a 
single step procedure outweighs the moderate atom economy and therefore decided to investigate 
the non-enantioselective direct α-hydroxylation of α-branched ketones using nitrosobenzene. 
We started on by using 2-phenyl cyclohexanone (76) as a model. Considering our 
experiences with oxidative cleavage of ketones, a selection of common acids in stoichiometric 
and catalytic amounts were tested (Table 4.10). Over-stochiometric amount of a strong acid is 
required for the reaction:, no reaction took place in acetic acid and low conversions were 
observed using its more acidic mono- and di-chlorinated derivatives (Entries 1–3). Optimal 
results were obtained when using 3 equiv. of trichloroacetic acid (TCA), affording the target 
hydroxyl ketone in 60% isolated yield. Although full conversion of the starting material was 
observed using TFA or pTsOH, lower yields of 77a were observed (Entries 5 and 6). Reduced 
amounts of TCA resulted in lower conversion rates (Entries 7 and 8). On the other hand, higher 
amount of TCA, lead to no improvement (Entries 9 and 10). Since clean reaction profiles were 
observed in all cases, we suspected that moderate yields could be explained by the formation of 
some polymer.  
.   
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Entry acid equiv acid conversion
a
 yield
a
 
1 AcOH 3 n.r. - 
2 ClCH2CO2H 3 <10% traces 
3 Cl2CHCO2H 3 76% 28% 
4 TCA 3 >95% (60%) 
5 TFA 3 >95% (37%) 
6 pTsOH 3 >95% 37% 
7 TCA 0.5 65% 41% 
8 TCA 2 77% 53% 
9 TCA 4 >95% (60%) 
10 TCA 5 >95% (56%) 
Table 4.10: Optimization of reaction conditions for the non-enantioselective direct α-
hydroxylation of α-branched ketones. Isolated yields in parentheses. Best result highlighted in 
bold. 
a
Determined by 
1
H NMR analysis of the crude reaction mixture using Ph3CH as internal 
standard.  
Next, we set out to explore the scope of this transformation. To our delight, the reaction 
proved to be rather general: a variety of cyclic α-aryl and α-alkyl ketones readily reacted under 
these reaction conditions, giving the desired products in moderate to good yields (Scheme 4.12). 
Regarding the substitution on the α-aryl moiety, no significant electronic effect was observed 
(e.g. (±)-77f vs (±)-77g, 56% vs 54% yield). ortho-Substituted α-aryl cyclohexanones, which 
were difficult substrates in our previous studies, could be transformed to their corresponding 
hydroxy ketones in good yields ((±)-77b and (±)-77p). 2-Methyl indanone and tetralone were 
also well tolerated and produced the desired products in 64% and 61% yield, respectively ((±)-
77s and (±)-77t). Furthermore, challenging α-alkyl cyclohexanones readily reacted under the 
optimized reaction conditions ((±)-77u–(±)-77w). While using α-phenyl cycloheptanone as the 
starting material gave the desired product (±)-77r in 57% yield, the corresponding 
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cyclopentanone resulted in a complex mixture of products; also acyclic ketones did not react.
 
Scheme 4.12: Scope of the non-enantioselective α-hydroxylation of α-branched ketones. 
The robustness of our method was demonstrated by scale-up experiments with the model 
substrate. Gratifyingly, (±)-77a could be obtained at a maximum tested scale of 10 mmol without 
deterioration of yield (Scheme 4.18). To demonstrate the practical utility of obtained compounds, 
product (±)-77a was further derivatized to a variety of synthetically useful functionalities. 
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Namely, amino alcohol (±)-78 was obtained via reductive amination. Reduction of (±)-77a using 
K-Selectride
®
 gave diol (±)-79 in excellent yield and diastereoselectivity. Notably, using NaBH4 
as the reductant resulted in similar yields, yet lower selectivity of the product (4:1 dr by 
1
H NMR 
analysis of the purified product). Treatment of (±)-77a with methyl magnesium chloride resulted 
in diol (±)-80 as single diastereomer. Unfortunately, the product was contaminated with trace 
amounts of unreacted starting material, presumably due to enolate formation. Elimination under 
acidic conditions gave enone 81 in 54% yield alongside with 16% of its regioisomer 82, which 
presumably was formed via a Favorfskii-rearrangement-type reaction (a proposed reaction 
mechanism is shown in Scheme 4.18). Finally, treatment with the Bestmann-ylide
[186] 
afforded 
lactone (±)-83, providing an efficient access to dihydroactinidolide-type structures(Scheme 
4.19).
[187] 
 
Scheme 4.18: Proposed reaction mechanism for the formation of 82. 
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Scheme 4.19: Scale-up experiment and derivatizations of (±)-77a. 
a
Isolated as an inseparable 
mixture with unreacted starting material (
1
H NMR ratio: (±)-80/(±)-77a = 5.6/1). 
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4.3.3 Development of a Direct Enantioselective α-Hydroxylation of α-Branched 
Cyclic Ketones 
 The experimental work described in this section was done in collaboration with Dr. 
Gabriele Pupo. Full optimization studies can be found in his PhD thesis and are therefore only 
briefly summarized here.
[174]
 
4.3.3.1 Optimization of Reaction Conditions 
Having established a protocol for the non-enantioselective direct α-hydroxylation of α-
branched cyclic ketones, we proceeded towards the development of an enantioselective variant. 
Initial experiments towards a catalytic version using 2-phenyl cyclohexanone (76) as the starting 
material showed that addition of catalytic amounts of DPP to the reaction mixture containing 
acetic acid enabled the hydroxylation of 76 in promising 50% yield (Scheme 4.20). Note: No 
background reaction using acetic acid was observed. 
 
Scheme 4.20: Initial experiment on the development of a catalytic direct α-hydroxylation. 
 Already preliminary optimization studies showed that the addition of acetic acid and use 
of aromatic solvents was beneficial for both, yield and enantioselectivity.
[174]
 Other 
nitrosobenzene-derivatives neither improved the yield nor selectivity.
[174]
 Furthermore, in contrast 
to meta- or para-substituted aryl groups, ortho-substituted aryl groups in the 3,3'-position of the 
catalyst reduced the yield and enantioselectivity. For example, using (S)-TRIP as the catalyst, 
(±)-77a could only be obtained in 14% yield and 58.5:41.5 er. Interestingly, electron-
withdrawing aryl groups in the 3,3'-position was beneficial, i.e. catalyst 1f afforded (±)-77a  in 
44% yield and 82.5:17.5 er. A further increase in the yield and enantioselectivity was obtained 
when catalyst 1p, bearing a perfluorinated naphthyl-substitutent, was used, giving the desired 
product in 55% yield and 89:11 er. Following this lead, a series of catalysts with perfluorinated 
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aryl groups was prepared and tested, resulting in optimal catalyst 1q, which gave the hydroxy 
ketone (±)-77a in 43% yield and 92.5:7.5 er. 
 
Scheme 4.21: Screening of BINOL-derived phosphoric acids for the direct α-hydroxylation of α-
branched cyclic ketones. NMR yields, determined by analysis of the 
1
H NMR of the crude 
reaction mixture using Ph3CH as internal standard are presented. 
 Due to its more ridgid and confined structure we envisioned that the corresponding 
SPINOL-derived catalysts would further improve the enantiomeric excess of the desired product. 
Similar to the preparation of 1q, (R)-SPINOL (84) was first MOM-protected (Scheme 4.22). 
Directed lithiation with n-BuLi and, subsequent quenching with 87 at –78 °C followed by MOM-
deprotection using HCl in methanol afforded 86 in overall 50% yield. The 
lithiation/SNAr/deprotection sequence was challenging and required additional optimization. 
Despite several attempts, this step could not be performed with more than 200 mg of 85. The 
synthesis was completed upon reaction with phosphoryl chloride and subsequent hydrolysis.  
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Scheme 4.22: Synthesis of SPINOL-derived phosphoric acid 6b. 
 The exclusive selectivity of the SNAr reaction was confirmed by comparing shifts and 
multiplets observed in the 
19
F NMR with published spectra obtained in a simpler systems.
[188]
 6b 
was isolated as crude mixture of rotamers, as was also confirmed by HPLC analysis. 
Interconversion and equilibration in solution was observed by 
31
P NMR in CDCl3 (Figure 4.5). 
However, using DMSO-D6 as the solvent hindered this process, thus allowing full 
characterization and quantification of all three rotamers by 
1
H,
19
F-HOESY experiments (Figure 
4.6). 
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Figure 4.5: Time-dependent 
31
P NMR study of 6b.  
 
 
Name Position of Substituents Relative Intensity Sets of Signals 
AA F11 next to H8 0.5 1 
BB F19 next to H8 1 1 
AB/BA F11 and F19 next to H8 1.5 (0.75 + 0.75) 2 
Figure 4.6: Obtained results of the 
1
H,
19
F-HOESY experiments in DMSO-D6. 
  
0 h 
17 h 
48 h 
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When catalyst 6b was used under our optimized reaction conditions, the hydroxy ketone 
77a was obtained in 56% isolated yield and 98:2 er (Scheme 4.22). Despite the moderate yield, 
the starting material was fully converted (as assessed by 
1
H NMR analysis of the crude reaction 
mixture). Interestingly, in the absence of acetic acid the 77a was obtained with the same level of 
enantioselectivity, yet significantly lowers yields.   
 
Scheme 4.22: Application of SPINOL-derived phosphoric acid 6b in the enantioselective α-
hydroxylation of cyclic α-branched ketones. 
 Next we set to revise the reaction conditions and adjust them to optimal catalyst (Table 
4.11). Higher catalysts loadings and increased concentration improved the yields (Entries 1–4). 
Decreasing the amount of nitrosobenzene from 3 to 2.2 equivalents resulted in no erosion of yield 
or selectivity (Entry 5). 
Through careful analysis of the 
1
H NMR of the crude reaction mixtures, we identified 6-
oxo-6-phenylhexanoic acid (73b) as a major side product together with expected azoxybenzene 
(43) and trace amounts of azobenzene (84). A plausible mechanism is shown in Scheme 4.23. 
The aminoxylated ketone 37 formed under the reaction conditions reacted with a second 
equivalent of nitrosobenzene forming intermediate A. In the desired pathway (red), A underwent 
N–O bond cleavage forming the targeted product and azoxybenzene. A can also form ketal 
intermediate B (blue), which, following C–C bond cleavage, gives acid 73b and azobenzene (84).  
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Entry cat. loading concentration conversion
a
 yield
a
 er 
1 5 mol% 0.1 M 72% 41% 98:2 
2 5 mol% 0.2 M 78% 40% 98:2 
3 10 mol% 0.5 M 91% 56% 97:3 
4 10 mol% 1.0 M 92% 57% 97.5:2.5 
5
b
 10 mol% 0.5 M 83% 55% 97.5:2.5 
Table 4.11: Final optimization of reaction parameters. 
a
Determined by 
1
H NMR analysis of the 
crude reaction mixture using Ph3CH as internal standard. 
b
2.2 equiv of PhNO used. 
 
 
Scheme 4.23: Plausible reaction mechanism including the formation of 73b. 
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Extensive studies showed that the formation of 73b can be avoided by slow addition of 
nitrosobenzene to the reaction solution, however without improving the target product yield 
(≤56%). After evaluating various methods, we concluded that the speed of addition, via either a 
syringe pump or portion-wise, did not have any significant influence yield and we therefore 
decided to use the latter protocol for practical reasons.  
4.3.3.2 Substrate Scope and Application 
We further examined the scope of this transformation (Scheme 4.24). Various 
cyclohexanones bearing electron-rich and electron-poor aromatic substituents in the 2-position 
readily reacted producing the corresponding hydroxy ketones in moderate yields and excellent 
enantioselectivities. Regarding electronic effects, electron-rich substrates resulted in similar 
yields as the model ketone 77a. A ketone with an electron-withdrawing substituent gave the 
corresponding product in reduced yield, yet higher enantioselectivity (77f, 29% yield, 98.5:1.5 
er). While no reaction was observed when employing a ketone with an ortho-substituted α-aryl 
group, substituents in the meta- or para-position were well tolerated. Despite its strong steric 
hindrance, 2-(1-naphtyl) cyclohexanone was also compatible with the protocol (77b, 38% yield, 
91:9 er). Ketones with different ring sizes afforded the targeted products in lower yields and 
enantioselectivities (77r, 29% yield, 95.5:4.5 er and 77u, 14% yield, 91.5:8.5 er). Due to partial 
hydrolysis of the ethylene glycol protecting group, hydroxy ketone 77v could only be isolated in 
25% yield but excellent enantioselectivity (>98:2 er). Whereas using 2-methyl indanone resulted 
in racemic product, no reaction was observed using 2-methyl tetralone (not shown). 
4 Results and Discussion 
 
 
85 
 
 
 
Scheme 4.24: Substrate scope of α-aryl cyclic ketones. The absolute configuration was 
confirmed by X-ray analysis of the crystal structure of 77a and assigned by analogy for the other 
substrates. 
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 2-alkyl cyclohexanones delivered the desired products in lower yields and 
enantioselectivities (Scheme 4.25). Interestingly, in the tested series, a branched alkyl group 
performed best (77u).  
 
Scheme 4.25: Scope of α-alkyl cyclohexanones. 
 The robustness of our method was shown in a scale up experiment. On a maximum tested 
scale of 2.5 mmol, 77a was isolated without erosion of the yield or enantioselectivity using a 
decreased catalysts loading (Scheme 4.25). In analogy with the results shown in Scheme 4.18, 
hydroxy ketone 77a was transformed to diols 79 and 80 and to unsaturated ester 83 in good yields 
and without deterioration of enantioselectivity.   
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Scheme 4.25: Scale up experiment and derivatizations of 77a. 
a
Isolated as an inseparable mixture 
with remaining starting material (
1
H NMR ratio: 80/77a = 5.8:1) 
4.3.3.3 Preliminary Mechanistic Studies 
 The discrepancy between the conversion of starting material and observed yields 
prompted further mechanistic studies. Catalyst degradation was excluded by 
19
F and 
31
P NMR 
analysis of the crude reaction mixture. Furthermore, reactions using stoichiometric amounts of 
catalyst resulted in the same yield as the catalytic ones (52% NMR-yield). We further discovered 
that background formation of azoxybenzene adds to the inaccurate mass balance. Issues regarding 
the mass balance were insofar surprising to us, as the 
1
H NMR spectra of the crude reaction 
mixtures usually indicated a clean reaction profile.   
 NMR-studies showed that the products were stable under the reaction conditions. 
However, when DPP was used as the catalyst, slow degradation to an unknown compound 
occured. A parallel reaction between the starting material and azoxybenzene (43) was excluded, 
although slow conversion towards 73b was observed in combination with azobenzene (84).  
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 Following the reaction by 
1
H NMR, we noticed its rate changed after 50–60% conversion 
of the starting material, suggesting a possible kinetic resolution. Indeed, when the reaction was 
stopped after 5 h, the unreacted starting material (76) was reisolated in 23% yield and 90:10 er 
(Figure 4.7 a). Kinetic experiments using DPP as the catalysts showed that the rate was 
independent of nitrosobenzene concentration (Figure 4.7 b). Together, this suggested that the 
rate-determining step of this reaction is the enolization.  
  
 
Figure 4.7: a) Test for kinetic resolution and kinetic measurements using different concentrations 
of nitrosobenzene regarding b) the conversion of the starting material (in %).  
 We continued our mechanistic investigation by probing the N–O bond cleaving step. The 
synthesis of the proposed intermediate 43 proved to be challenging; however, was finally 
accomplished by a silver-mediated addition of silyl vinyl ether 85 reported by Yamamoto et al 
(Scheme 4.27).
[125c]
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Scheme 4.27: Synthesis of aminoxylated ketone 37. 
 The transformation into hydroxy ketone 77a was investigated by subjecting 37 to the 
reaction conditions and analyzing the resulting mixture by 
1
H NMR (Table 4.11). Although we 
never detected 37 by NMR, we proved that it is a possible intermediate in the reaction sequence. 
A rapid reaction of 37 to 77a was obtained when stoichiometric amounts of nitrosobenzene were 
used (Entries 1 and 2). Employing smaller amounts (0.5 equiv.) resulted in a slower reaction, yet 
higher yields during the initial phase (Entry 3). A longer reaction time led to full consumption of 
starting material (Entry 4). In all cases, no enantioenrichment of hydroxy ketone 77a was 
observed, suggesting that the initial nitroso aldol reaction is enantiodetermining. Interestingly, the 
formation of 2-phenyl cyclohexanone (76) was observed in absence of nitrosobenzene, 
suggesting that the initial aminoxylation reaction is reversible (Entries 5 and 6). Surprisingly, 
enrichment of the opposite enantiomer, suggesting that the complex of catalyst and desired 
enantiomer of 37 is thermodynamically less stable and therefore more prone to undergo retro-
aminoxylation reaction, was observed. The slower reaction rates obtained in the absence of 
catalyst suggested that the phosphoric acid is involved in the N–O bond cleaving step (Entry 7). 
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Entry X time 37
a
 77a
a
 76
a
 er of 77a 
1 1.0 3 h traces 64% - - 
2 1.0 24 h traces 68% - 50:50 
3 0.5 3 h 18% 78% - - 
4 0.5 24 h traces 64% - 50:50 
5 0 3 h 58% 14% 7% - 
6 0 24 h 27% 41% 10% 45:55 
7
b
 0.5 3 h 50% 36% 2% - 
Table 4.11: Preliminary investigations on the N–O bond cleavage reaction. aDetermined by 
1
H NMR analysis of the crude reaction mixture using Ph3CH as internal standard. 
b
No catalyst 
used. 
4.3.3.4 Computational Study 
 To gain further insight into the reaction mechanism, computational studies at the DLPNO-
CCSD(T)/def2-TZVPPD + SMD(benzene)//PBE-D3 (BJ)/def2-svp level of theory were 
performed using 2-phenyl cyclohexanone (76) and catalysts (R)-6b as substrates. The lowest 
energy pathway is depicted in Figure 4.7. As the addition of acetic acid had no influence on 
enantioselectivity, it was not considered the presented calculations. 
 At the outset, we focused on the mechanism and the regioselectivity (less vs more 
substituted enol) of the phosphoric acid catalyzed enolization step. Our calculations suggest 
initial protonation of the ketone to form complex RC which then undergoes a double hydrogen 
transfer mechanism via TS1 or TS1' to form the corresponding enol-catalyst complexes C or C'. 
The formation of the desired more substituted enol (C) is not only kinetically (TS1 is 
3.6 kcal/mol lower than TS1'), but also thermodynamically favored (C is 6.2 kcal/mol lower in 
energy than C'). The kinetic preference can be explained by the Hammond-postulate, suggesting 
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a late transition state which is therefore geometrically similar to the product. As the calculated 
energy difference between RC and TS1 is the largest, enolization is rate limiting, which is in 
good agreement with our kinetic experiments. 
 
Figure 4.7: ∆G profile for the direct asymmetric α-hydroxylation of 76. The reference energy 
corresponds to the dissociated species at infinite separation 
 Starting from C, the transformation towards aminoxylated ketone 37 was attempted. This 
step is challenging for theory as it potentially involves charged intermediates and the coexistence 
of catalyst rotamers have to be taken into account. Nevertheless, our studies show that this step 
proceeds via initial protonation of the nitrogen of the nitrosobenzene (nitrogen protonation was 
found to be thermodynamically favored by 4.2 kcal/mol compared to oxygen) and subsequent 
attack of the enol-catalyst complex onto the oxygen. The transition state of the (S)-enantiomer, 
the same one obtained in our synthetic studies, is favored by 5.6 kcal/mol (TS2a vs TS2b), which 
is in a good agreement with the experimentally determined 98:2 er. Interestingly, the energy 
barrier leading to the obtained (S)-enantiomer is only 2.3 kcal/mol, whereas the one leading to the 
opposite enantiomer is 7.9 kcal/mol. Considering the aminoxylated ketone 37, the obtained (S)-
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enantiomer is thermodynamically less stable than the opposite (1 kcal/mol), explaining the 
enrichment of the opposite enantiomer in our synthetic studies starting from (±)-37. 
 By employing the recently developed Local Energy Decomposition (LED), electrostatic 
interactions between the catalyst and the reactants are believed to stabilize TS2a over TS2b and 
steric repulsion is presumably responsible for the enantioselectivity. A representation of both 
transition states is depicted in Figure 4.8. 
 
Figure 4.8: Representation of the enantiodetermining transition states TS2a and TS2b. 
 As observed synthetically, the final steps towards the targeted hydroxy ketone are rapid. 
Interaction of complex Db with an additional molecule of nitrosobenzene eventually leads to 
complex F which gives, after a rearrangement involving a hydrogen bond shift (G), the final 
product (H) with a very small energy barrier (TS3).  
4.3.4 Conclusions 
In summary, we have investigated and developed systems for direct oxidations of cyclic 
α-branched ketones under acidic conditions. Depending on the oxidant used, the reaction 
outcome varied. When using singlet oxygen, an oxidative cleavage forming a compound bearing 
a carboxylic acid and a ketone moiety occurred. In contrast, in excess of nitrosobenzene the 
corresponding hydroxy ketones were formed via a aminoxylation /N–O bond cleavage sequence. 
Further modifications of reaction conditions allowed us to use a chiral phosphoric acid as the 
catalyst, affording the desired products in moderate yields and excellent enantioselectivities. 
Derivatization of the obtained products supported the synthetic utility of our presented method. 
Kinetic and mechanistic experiments complemented with high-end computational studies 
provided insight into the mechanism of the proposed reaction sequence.   
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4.4 α-Oxidation of Cyclic Ketones with 1,4-Benzoquinones via Enol 
Catalysis[189] 
The work presented in this section was done in collaboration with Barry Oppelaar. 
We envisioned the direct arylation of ketones via enol catalysis using 1,4-benzoquinones 
as the reactions partners. Surprisingly, the reaction between 2-phenyl cyclohexanone (76) and 
1,4-benzoquinone (86) using DPP as the catalyst yielded only trace amounts of the expected 1,4-
addition products (87a or 87b) and exclusively produced formal 1,6-addition product ((±)-88a) 
(Figure 4.9). 
 
Figure 4.9: Discovery of the phosphoric acid-catalyzed 1,6-addition of branched ketones to 1,4-
benzoquinone. 
 Related structures have been observed in the oxidation of silyl vinyl ethers to enones 
using 2,3-dichloro-5,6-1,4-benzoquinone (DDQ) as the oxidant (Figure 4.10).
[190]
 In this case, the 
desired enone is formed spontaneously via elimination from the intermediate derived from the 
1,4-addition of the silyl vinyl ether to DDQ. However, if the silyl vinyl ether is sterically 
demanding, lower yields of the targeted enone are obtained and the product of the 1,6-addition 
(O-product) is instead observed. Extensive kinetic experiments by the Mayr group explained this 
observation by the reduced rate of the C-attack and the hindered elimination from the 
corresponding intermediate.
[190c]
 Proceeding via an ionic mechanism, the 1,4-addition is 
reversible and therefore the irreversible formation of the thermodynamically favorite O-product is 
preferred, thus inhibiting the formation of the enone. Measured rate constants and a negative 
result in a radical clock experiment suggest that the formation of the O-product proceeds via a 
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single electron transfer (SET)/inner sphere electron transfer (ISET) mechanism. This is supported 
by studies of the Renaud group, who investigated the O- vs C-selectivity of radical addition to 
1,4-benzoquinone.
[191]
 
time C-attack O-attack elimination
1 min 94% 6% -
1 h 82% 16% 2%
72 h 4% 72% 24%
 
Figure 4.10: Mechanism of the oxidation of silyl vinyl ethers with DDQ.
[190c]
 
Nevertheless, these reactions have been considered merely as curiosities, since they 
require preformed enol equivalents, strong oxidants and have not been approached in a catalytic 
or an enanatioselective fashion. In light of its uniqueness and potential utility, we decided to 
explore this unusual transformation. 
4.4.1 Exploration of the Reactivity 
We began our investigations by exploring the non-asymmetric transformation in more 
detail. At first, we evaluated the catalytic potential of other commonly used organic acids using 
2-phenyl cyclohexanone (76) and 1,4-benzoquinone (86) as the starting materials (Table 4.12). 
Using a high excess of 86, DPP, the least acidic acid among the tested ones, performed best in 
terms of yield and chemoselectivity. Namely, when using DPP as catalyst, the targeted 
aryloxylated ketone could be isolated as the single product in 60% yield; whereas using pTsOH 
resulted in a mixture of 1,6/1,4-addition products (combined yield of 37% yield, 1,6/1,4 = 16:1). 
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Entry acid equiv. yield
a
 
1 TFA 0.5 traces 
2 TFA 1.0 8% 
3 TCA 0.5 traces 
4 TCA 1.0 14% 
5 pTsOH 0.5 38% (46%) 
6 pTsOH 1.0 37% 
7 DPP 0.5 (60%) 
Table 4.12: Evaluation of conventional acids as catalysts for the 1,6-addition of 2-phenyl 
cyclohexanone (76) to 1,4-benzoquinone (86). 
a
Determined by 
1
H NMR analysis of the crude 
reaction mixture using Ph3CH as internal standard. Isolated yields in parentheses. 
Using the above mentioned conditions, we then switched our attention towards the 
generality of the transformation, initially focusing on the ketone scope (Scheme 4.28). While α-
aryl ketones readily reacted ((±)-88a–(±)-88d), α-alkyl ketones resulted only in trace amounts of 
the desired products, even at prolonged reaction times and higher temperatures. Regarding 
substitution on the α-aryl group, meta- and para-substituents were well accepted and the resulting 
products could be obtained in similar yields ((±)-88b and (±)-88d). In contrast, substituents in the 
ortho-position yielded only trace amounts of the targeted products. Regarding electronic effects, 
an electron-withdrawing substituent lead to diminished yields and selectivity, i.e. ketone (±)-88c 
was isolated as an inseparable mixture of the corresponding 1,6- and 1,4-addition products. The 
reaction turned out to be limited to cyclohexanones, as only trace amounts of either the 1,6- or the 
1,4-addition products were obtained using ketones with different ring sizes. The same results 
were obtained using either indanone or tetralon-derived ketones. Using an indanone-derived β-
keto ester as starting material resulted in the exclusive formation of the oxidized product from 
1,4-addtion (89), which could only be isolated as inseparable mixture with hydroquinone, 
presumably due to partial formation of a charge-transfer complex.  
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Scheme 4.28: Ketone scope of the non-asymmetric 1,6-addition reaction. 
a
Isolated as an 
inseparable mixture with hydroquinone. 
Regarding different benzoquinones, sterics as well as electronics have a crucial influence 
on the outcome of the reaction (Scheme 4.29). While electron-poor quinones, e.g. 2,5- and 2,6-
dichloro benzoquinone readily reacted to form the corresponding products in good yields ((±)-88f 
and (±)-88g), electron-rich quinones, such as 1,4-naphtaquinone or 2,6-dimethyl quinone, 
resulted in no conversion of the starting material. This is presumably due to the increased steric 
hindrance, as the same result was obtained using chloranil, a strong oxidizing agent.
[192]
 When 
DDQ was used, full conversion of the ketone was obtained, however no detectable amounts of 
the desired product were formed. As confirmed by the 
13
C NMR shifts, the O-alkylated product 
could be exclusively obtained using the 4-amino phenol-derived quinone (±)-88e.  
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Scheme 4.29: Benzoquinone scope of the non-asymmetric 1,6-addition reaction. 
4.4.2 Exploration of the Asymmetric Transformation 
 With these results in hand we attempted the development of an asymmetric variant of this 
transformation using 2-phenyl cyclohexanone (76) and 1,4-benzoquinone (86) as the starting 
materials. In an initial round of catalyst screening, we wanted to demonstrate that 
enantioinduction by a chiral phosphoric acid is possible (Scheme 4.30). Considering substitution 
patterns of the aryl-moiety in 3,3'-position of the BINOL backbone, meta-substituents did not had 
any beneficial effect on selectivity (compare catalysts 1o and 1f). A substituent in the para-
position gave a slight increase in enantioselectivity; however, the corresponding reaction had to 
be performed at a higher temperature due to the low reactivity (catalyst 1s). Substitution in the 
ortho-position had the highest impact on the outcome of the reaction. Namely, 1-naphtyl- and 
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ortho,ortho-dimethyl-substituted catalysts 1i and 1g delivered the corresponding aryloxylated 
product in already promising enantioselectivities (83.5:16.5 er and 87:13 er, respectively). 
Similar enantiomeric excess was obtained with TRIP, albeit with only trace amounts of product 
(1a, 85:15 er).   
 
Scheme 4.30: Initial catalyst screening. 
a
Performed at 40 °C. 
 Using ortho,ortho-dimethyl substituted catalyst 1g, further parameters were briefly 
screened (Table 4.13). No reaction was observed when the concentration was diluted to 0.1 M. 
Increasing the amount of 1,4-benzoquinone from 1.1 to 3.0 equivalents did not improve the yield, 
however an erosion in enantioselectivity was obtained (Entries 2–4). While maintaining the level 
of enantioselectivity, the yield was improved using toluene as the solvent (Entry 10). The 
addition of acetic acid inhibited the reaction (Entry 11) and no improvement was obtained by 
increasing the reaction temperature from room temperature to 50 °C.  
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entry solvent A yield
a
 er comment 
1 CH2Cl2 1.1 traces - 0.1 M 
2 CH2Cl2 1.1 22% 87:13  
3 CH2Cl2 2 23% 79:21  
4 CH2Cl2 3 21% 78:22  
5 DCE 1.1 16% 82:18  
6 MeCN 1.1 n.r. -  
7 CHCl3 1.1 21% 78.5:21.5  
8 Et2O 1.1 n.d. 81:19  
9 CyH 1.1 n.d. 86:14  
10 PhMe 1.1 42% 85.5:14.5  
11 CH2Cl2 1.1 traces n.d. 3.5 equiv AcOH 
added 
12 CH2Cl2 1.1 28% 86:14 At 50 °C 
Table 4.13: Initial screening of conditions. Best result in highlighted in bold. 
a
Determined by 
1
H NMR analysis of the crude reaction mixture using Ph3CH as internal standard.  
These initial results prompted us to reinvestigate the structure of the catalyst. As 1-
naphtyl substitution proved to be promising, we focused our attention in the second round of 
catalysts optimization on related structural motifs (Scheme 4.31). To our delight, 2-methyl-1-
naphtyl substituted catalyst 1u delivered the targeted product in 28% yield and 95:5 er. Notably, 
1u was used as a mixture of rotamers. The separation via semi-prep HPLC is reported, however 
was not successful in our hands.
[193]
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Scheme 4.31: Screening of 1-naphtyl-derived substituted phosphoric acids. Yields determined by 
1
H NMR analysis of the crude reaction mixture using Ph3CH as internal standard.  
With the optimized catalyst in hands, we attempted to refine the reaction conditions in 
order to improve the yield. The results of these efforts are summarized in Table 4.14. A 
significant improvement was obtained by changing the solvent from toluene to benzene (Entries 1 
and 2). 6-oxo-6-phenylhexanoic acid (73b), the product of over-oxidation, was identified as one 
major side product. Performing the reaction at 0 °C inhibited its formation and slightly increased 
the yield of the target ketone (Entry 3). The mechanism for the formation of 73b is unclear; 
however, traces of it can be observed when some of the obtained products (88) were stored over a 
long period of time under air and at room temperature. As previously shown, increasing the 
concentration was beneficial regarding the yield and the desired product was isolated in 50% 
yield and 96:4 er (Entry 4). Finally, increasing the amount of 1,4-benzoquinone to 3 equivalents 
provided 88a in 67% isolated yield and 96:4 er (Entries 5 and 6)  
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entry solvent T M X yield
a
 er 
1 PhMe rt 0.25 1.1 28% 95:5 
2 PhH rt 0.25 1.1 38% 95:5 
3 PhH 0 °C 0.25 1.1 42% 95:5 
4 PhH 0 °C 0.5 1.1 (50%) 96:4 
5 PhH 0 °C 0.5 3 (67%) 96:4 
6 PhH 0 °C 0.5 5 (59%) 96:4 
Table 4.14: Refinement of reaction conditions. Best result highlighted in bold. 
a
Determined by 
1
H NMR analysis of the crude reaction mixture using Ph3CH as internal standard. Isolated yield 
in parentheses. 
Having found what seemed to be optimal reaction conditions, we turned our attention 
towards the scope of this asymmetric transformation (Scheme 4.32). Similar to the non-
enantioselective variant, this method is limited to α-aryl ketones. Despite several attempts to 
overcome this drawback by rescreening more acidic catalysts or varying the reaction conditions, 
no reaction using cyclic α-alkyl ketones or cyclohexanone was observed. Nevertheless, para-
substituents on the α-aryl group were well tolerated under the optimized reaction conditions and 
the corresponding products were isolated in similar yields and enantioselectivities as the model 
substrate (88a–88j). While substituents in the meta-position gave the targeted products in lower 
yield yet increased enantioselectivities (88k–88n), ortho-substituted α-aryl ketones did not show 
any reactivity. An electron-withdrawing substituent led to decreased chemoselectivity, i.e. ketone 
88c could only be isolated as an inseparable mixture of the 1,4- and 1,6-addition products with 
diminished enantioselectivity. Gratifyingly, 2-naphtyl cyclohexanone readily reacted under the 
optimized reaction conditions giving 88o in 72% yield and 93.5:6.5 er. Besides 2,5-dichloro-1,4-
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benzoquinone (88g, 33%, 67.5:32.5 er), the use of other 1,4-benzoquinone derivatives or ketones 
with different ring sizes resulted in either no reaction or complex mixtures.   
 
Scheme 4.32: Scope of the phosphoric acid-catalyzed 1,6-addtion of α-branched ketones (76) to 
benzoquinones (86). Isolated yields presented. 
a
Using (S)-1u, 3 d reaction time. 
b
Using (S)-1u, 4 
d reaction time at room temperature.  
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 A surprising observation was made when para-methoxy substituted 2-phenyl 
cyclohexanone was used as the starting material. Formation of the desired product 88p was 
observed; however it was not stable under the reaction conditions and reacted further to form 
dimer 90 as an equimolar mixture of diastereoisomers (Scheme 4.33).  
 
Scheme 4.33: Reaction using a para-methoxy substituted 2-aryl ketone as the starting material.  
 Despite several attempts, the crystallization of the enantioenriched substrates could not be 
achieved. Therefore the absolute configuration of the products was determined in analogy to 
literature known α-hydroxy ketone 77a (vide infra).  
A scale up experiment using 500 mg of 2-phenyl cyclohexanone (76) proceeded smoothly 
and gave 88a without deterioration of yield or enantioselectivity (Scheme 4.34). Gratifyingly, the 
introduced hydroquinone moiety was converted to a synthetically-useful hydroxy group under 
oxidative conditions similar to those applied for the removal of PMP protecting groups.
[194]
 
Alcohol 91 was obtained as single diastereomer after reduction of 88a with K-Selectride. 
Interestingly, in presence of an excess of TFA, the hydroquinone moiety was transformed into the 
corresponding TFA protected hydroxy ketone 92 with complete loss of chiral information. 
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Scheme 4.34: Scale up and derivatization experiments. 
4.4.3 Study of the Reaction Mechanism 
When considering the mechanism of this reaction, several aspects have to been taken into 
account. (1) No reaction was observed in the absence of a phosphoric acid catalyst. (2) The scope 
was limited to α-aryl ketones; i.e. low reactivity was observed when α-alkyl ketones were used as 
starting materials. (3) Reactivity was only obtained when electron-neutral or –poor 
benzoquinones were used as reaction partners. On the other hand, some strongly activated 
benzoquinones, such as chloranil, were not reacting presumably due to steric reasons. (4) The 
reaction selectively produced the C–O bond and the 1,4-addition products were only obtained in 
trace amounts. Finally, (5) the reisolated starting material was racemic, suggesting that, in 
contrast to our direct hydroxylation, phosphoric acid-catalyzed enolization was not rate 
determining (Scheme 4.35).  
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Scheme 4.35: Results of the test for kinetic resolution. 
To gain further insight into the reaction mechanism, we attempted a different-excess-
experiment. Accordingly, the protocol for the non-enantioselective variant of this reaction was 
performed using different amounts of 1,4-benzoquinone (86) and the progress was followed over 
time by analyzing aliquots taken from the crude reaction mixture with 
1
H NMR. Catalyst loading 
of 25 mol% was applied in order to slow down the reaction rate, as full consumption of the 
starting material within 3 h was obtained when 50 mol% of DPP were used. The plot visualizing 
product formation over time is depicted in Figure 4.11. The visible change in the kinetic profile 
suggested, that the rate limiting step involved benzoquinone and therefore the enolization, as it 
only incorporates ketone and catalyst, was not rate limiting. Note: Due to the low solubility of 
1,4-benzoquinone in benzene, the reaction mixtures obtained using 2 and 3 equivalents of 1,4-
benzoquinone were saturated throughout the duration of the measurement, thus leading to similar 
slopes.  
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Figure 4.11: Effect of 1,4-benzoquinone molar excess. 
 In contrast to the conversion of starting material, product formation could be 
approximated as linear within the initial 300 min of reaction time. We therefore envisioned that a 
Hammett plot might give us further information on the electronic nature of the rate determining 
transition step. Thus, a series of competition experiments, comparing the initial rates of para-X 
substituted α-aryl ketones to 2-phenyl cyclohexanone (76, X = H) was conducted. The 
experiments were performed by subjecting the corresponding substrate alongside 2-phenyl 
cyclohexanone using the standard protocol (25 mol% catalysts loading) and analyzing aliquots, 
taken every 60 min by 
1
H NMR using an internal standard. The corresponding plots are depicted 
in Figure 4.12. Note: except X = Me every experiment was conducted twice, hence the larger data 
set.  
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Figure 4.12: Relative kinetic data of para-substituted α-aryl cyclohexanones compared to 2-
phenyl cyclohexanone (76). Note: Non-normalized ratios determined by 
1
H NMR analysis of the 
crude reaction mixture compared to Ph3CH as internal standard are presented on the y-axis. 
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The slope for each relative kinetic profile was determined using EXCEL. From this data, 
the log(kX/kH) could be calculated and plotted against the corresponding Hammett parameters (σ, 
σ+, σ-) taken from the literature (Figure 4.13).[195] 
 
X σ σ+ σ– log(kX/kH) 
H 0 0 0 0 
CF3 0,54 0,61 0,65 –0,66 
Me –0,19 –0,31 –0,17 0,18 
Cl 0,23 0,11 0,19 –0,24 
F 0,06 –0,07 –0,03 –0,01 
 
 
 
Figure 4.13: Hammett analysis. a) Determined log(kX/kH) values and the corresponding Hammett 
parameters. b) Plot using σ. c) Plot using σ+. d) Plot using σ–. 
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The decrease rate of product formation using electron-withdrawing substituents leads to 
negative ρ-values (slopes) in all three Hammett plots. This indicates a reduction of negative 
charge/buildup of positive charge in the rate determining transition state. As all three Hammett 
plots showed similar R
2
-values, indicating the quality of the estimated trend line, no significant 
influence of mesomeric or inductive effects was evident.  
The conclusion of the obtained results leads to the proposed reaction mechanism depicted 
in Scheme 4.35. Phosphoric acid catalyzed enolization of the ketone followed by coordination of 
the benzoquinone derivative forms complex A. This complex undergoes a proton coupled 
electron transfer (PCET) to form diradical complex B. In this scenario the employed phosphoric 
acid simultaneously acts as acid, protonating the benzoquinone, and as base, deprotonating the 
enol. This oxidation step is in good agreement with the obtained negative ρ-values in the 
Hammett plots and the extensive kinetic studies by Mayr et al. suggesting that related products 
are formed via a SET/ISET mechanism.
[190c]
 Subsequent radical-radical recombination furnishes 
the targeted product and releases the catalyst.  
 
Scheme 4.35: Proposed reaction mechanism. 
At this point, we cannot exclude the possibility that the oxidation step from A to B occurs 
via an electron transfer and subsequent proton transfer (or vice versa). However, this is less likely 
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as the difference in the BDFEs of the O–H groups of phenols (as an extreme case of an enol, 
88.3 kcal mol
-1
/DMSO) and of the semiquinone radical (65.2 kcal mol
-1
/DMSO) is too high to 
allow a HAT-type mechanism.
[160]
 The existence of radical intermediates could synthetically not 
be verified as experiments in the presence of radical quenchers, such as BHT or TEMPO, only 
reduced the rate of product formation but did not inhibited the reaction itself. Such experiments 
can only be positive if diffusion of both radicals is faster than the recombination, suggesting that, 
in our case, the radical recombination, due to the tight complex B, occurs very rapidly. This is in 
line with the ISET mechanism suggested by Mayr et al.
[190c]
 According to oxidation potentials of 
enol cation radicals using stable enols obtained via cyclovoltametry, the oxidation of α-keto 
radicals, similar to the one proposed in complex B, is even more facile than the initial radical 
formation. In these cases, the formed carbocation could be intercepted by nucleophiles such as 
methanol.
[140e]
 However in our case only reduced rates, presumably due to interrupted hydrogen 
bonding, and no further side products could be obtained in the presence of an excess amount of 
methanol.  
4.4.4 Conclusions 
 In summary, we report the first direct, catalytic and asymmetric α-aryloxylation of 
ketones via enol catalysis. Using 1,4-benzoquinones as the reaction partners, various α-branched 
cyclic ketones underwent selective formal 1,6-addition, forming exclusively the C–O bond in 
good to moderate yields (up to 73%) and enantioselectivities (up to 96.5:3.5 er). Preliminary 
mechanistic studies are in line with a phosphoric acid promoted proton coupled electron transfer. 
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5 Summary 
 
Figure 5.1: Proposed activation mode of enol catalysis (E = electrophile). 
Despite of being a rather obvious approach, Brønsted acid-catalyzed enolizations have so 
far barely found application in asymmetric catalysis. Although a few systems for enantioselective 
α-functionalization of unactivated α-branched ketones have been reported, they usually rely on 
tetralone analogs and, hence, omitting the challenge of the regioselectivity. Over the last years, 
others and our groups independently demonstrated that enol catalysis can overcome these 
limitations.
[62-63, 65-66, 181]
 Indeed, the more substituted enol is exclusively formed under 
phosphoric acid catalysis giving enantioselective access to synthetically promising α,α-
disubstituted ketones (Figure 5.1). We demonstrated the generality of this methodology by 
applying it to a variety of enantioselective C–C, C–N and C–O bond forming reactions using 
simple α-branched and unbranched ketones as substrates. 
 
Scheme 5.1: Enantioselective synthesis of Wieland–Miescher ketones via Brønsted acid-
catalyzed Robinson annulation. 
Inspired by the results from Akiyama group, we developed a highly enantioselective 
Robinson annulation of 1,3-diketones giving derivatives of the synthetically valuable Wieland–
Miescher ketone (25) in good to excellent yields (up to 99%) and enantioselectivities (≥ 98:2 er) 
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(Scheme 5.1).
[60]
 Our approach has two key features: First, we used a biphasic water-containing 
solvent system that assits the initial Michael reaction. Second, we employed the confined 
spirocyclic biindane-derived phosphoric acid STRIP (6a). In contrast to previously reported 
catalytic systems, our method delivers the targeted products in shorter reaction times (~24 h) 
even at low catalysts loadings (down to 1 mol% tested) without significant erosion of 
enantioselectivity or yield. Promising results in the synthesis of the corresponding Hajos-Parrish 
ketones prompted us to attempt the synthesis of a novel bitetralane-derived backbone, whose 
catalytic properties are currently being investigated. 
Next, we disclosed the direct amination of α-branched cyclic ketones via enol catalysis 
employing diazocarboxylates as electrophilic aminating agents (Scheme 5.2). Using catalytic 
amounts of a chiral phosphoric acid, the target products could be obtained in excellent yields (up 
to 99%) and enantioselectivites (up to 99:1 er). Remarkably, cyclohexanone proved to be a 
suitable substrate and the corresponding product showed no racemization under the optimized 
reaction conditions emphasizing the selectivity of our method. The obtained products could be 
further transformed to N-carbamate protected α-amino ketones without affecting of 
enantioselectivity.  
 
Scheme 5.2: Direct α-amination of α-branched ketones via enol catalysis. 
Then, we turned our attention towards the direct hydroxylation of cyclic α-branched 
ketones. Initial attempts employing singlet oxygen as an electrophilic oxygenating agent failed: 
we only observed the oxidative cleavage of the in situ formed enols. The products bearing a 
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carboxylic acid and ketone moiety, were presumably formed via an unstable 1,2-dioxetane 
intermediate, formed by either stepwise or concerted [2+2] cycloaddition. 
 The targeted direct hydroxylation was achieved by using nitrosobenzene as an oxidant. In 
initial experiments we developed a non-enantioselective variant using trichloroacetic acid (TCA) 
as a promoter (Scheme 5.3). A variety of cyclic α-branched ketones readily reacted under the 
optimized reaction conditions giving the target α-hydroxy ketones in good yields (up to 66%). 
The developed system is scalable, as was demonstrated by preliminary experiments at a 10 mmol 
scale, and also enabled the reaction of challenging α-alkyl ketones. 
 
Scheme 5.3: Direct α-hydroxylation of α-branched ketones under acidic conditions. 
Employing the novel SPINOL-derived phosphoric acid 6b as a catalysts enabled the first 
enantioselective direct α-hydroxylation of α-branched cyclic ketones via enol catalysis, giving 
the corresponding products in moderate yields (up to 56%) yet excellent enantioselectivities (up 
to 98.5:1.5 er) (Scheme 5.3). Initial mechanistic experiments together with computational studies 
supported the proposed aminoxylation/N–O bond cleavage sequence and gave first insights into 
the mechanism of phosphoric acid-catalyzed enolizations. Our findings support a mechanism, in 
which acidic P–OH and basic P=O are involved in the enolization step.  
5 Summary 
 
 
114 
 
 
Furthermore, enol catalysis enabled an unprecedented direct α-aryloxylation of α-
branched cyclic ketones using 1,4-benzoquinones as reaction partners (Scheme 5.4). This 
transformation was discovered by serendipity and we further developed its asymmetric variant 
furnishing the corresponding products in good yields (up to 73%) and excellent 
enantioselectivites (up to 96.5:3.5 er). Initial mechanistic studies suggested, that this 
transformation proceeds via a proton coupled electron transfer (PCET) mechanism. 
 
Scheme 5.4: Direct α-aryloxylation of α-branched ketones via enol catalysis. 
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6 Outlook 
Although enol catalysis proved to be an efficient method for the direct asymmetric α-
functionalization of α-branched cyclic ketones several limitations and challenges require further 
development of the method: 
(1) The scope is limited to addition reactions and the feasibility of substitution reactions 
has yet to be explored. Because of their high synthetic value, direct α-methylation/benzylations 
and α-trifluoromethylations of carbonyl compounds are highly appealing challenges and catalytic 
asymmetric variants are scarce.
[196]
 Additionally, deracemization strategies, either through 
selective deuteration or in combination with enzymes (e.g. lipases) can also be envisioned. 
(2) The scope of nucleophiles is currently limited to cyclic ketones and expansion towards 
linear ketones is highly desired. A major challenge regarding these substrates would be the 
control of E/Z-geometry of the enol, as these diastereomers may lead to opposite enantiomers. In 
a more distant future, the scope should be expanded towards other carbonyl compounds, such as 
aldehydes, lactones or cyclic anhydrides. Although the functionalization of α-branched aldehydes 
using chiral primary amines as catalysts is well-established, a complementary method promises 
many unexpected transformations. Vinylogous reactions, starting either from enones or allylic 
ketones, might allow the remote control of distal stereocenters. 
(3) We have demonstrated that the combination of chiral phosphoric acids and appropriate 
oxidants enables the formation of α-carbonyl radicals via single-electron oxidation of in situ 
formed enols. Future studies should broaden the scope of such transformations by investigating 
other reaction partners, such as alkenes or nitriles, and other oxidants. For example, the direct and 
selective oxidation of ketones to enones would be a particularly important goal since it promises 
to circumvent the drawbacks of commonly used Saegusa-Ito oxidations. Alternatively, using of 
electrochemical methods would be an appealing alternative to stoichiometric oxidants. 
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Figure 6.1: Envisioned further transformations using enol catalysis. 
In order to address some of these challenges, we already preformed a few initial 
experiments on the Brønsted-acid catalyzed Robinson annulation of α-branched aldehydes (93) 
and methyl vinyl ketone (28) (Figure 6.2). This is a challenging reaction for enamine catalysis as 
a selective reaction of two competing carbonyl groups is involved, although systems utilizing 
bifunctional catalysts were reported recently.
[197]
 To our delight, 5 mol% of a chiral phosphoric 
acid delivered the targeted cyclohexanones (94) in good yields and promising enantioselectivities 
(up to 92:8 er). 2-Aryl substituted aldehydes were preferred substrates, presumably due to the 
higher E/Z-ratio of the formed enol. Unfortunately, cyclohexanone 94e, which is a key 
intermediate in the total synthesis of retigeranic acid.
[198]
 could only be obtained in low yield and 
compromised selectivity. Nevertheless, these studies suggest that, in principle, it should be 
possible to extend the scope of enol catalysis towards linear carbonyl groups. Further 
optimization studies are currently ongoing.  
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Figure 6.2: Preliminary results on the Brønsted acid-catalyzed Robinson annulation of α-
substituted aldehydes. Yields determined by 
1
H NMR analysis of the crude reaction mixture 
using Ph3CH as internal standard. 
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7 Experimental Section 
7.1 General Experimental Conditions 
Chemicals 
Chemicals (Abcr, Acros, Aldrich, Gelest, Fluka, Fluorochem, Strem, TCI) were purchased as 
reagent grade and used without further purification unless indicated otherwise. Nitrosobenzene 
was purified by recrystallization (‒20 °C, ethanol). 1,4-Benzoquinone was recrystallized from 
boiling hexanes. All ketones were purified by flash column chromatography (hexanes/EtOAc) 
prior to use. 
Solvents 
Solvents (CH2Cl2, CHCl3, Et2O, THF, toluene) were dried by distillation from an appropriate 
drying agent in the technical department of the Max-Planck-Institut für Kohlenforschung and 
received in Schlenk flasks under argon. The other solvents (acetone, benzene, cyclohexane, 
chlorobenzene, 1,4-dioxane, DME, DMF, DMSO, EtOAc, EtOH, MeCN, MeOH, MTBE, NMP, 
n-Bu2O, n-hexane, n-octane, n-pentane, pyridine, α,α,α-trifluorotoluene, xylenes) were purchased 
from commercial suppliers and dried over molecular sieves. 
Inert Gas 
Dry argon was purchased from Air Liquide with >99.5% purity. 
Glassware 
All non-aqueous reactions were performed in oven-dried (85 °C) or flame-dried glassware under 
Argon. Solvents were removed under reduced pressure at 40 °C using a rotary evaporator and 
drying under high vacuum (10
−3
 mbar). 
Thin Layer Chromatography 
Thin-layer chromatography (TLC) was performed using silica gel pre-coated plastic sheets 
(Polygram SIL G/UV254, 0.2 mm, with fluorescent indicator; Macherey-Nagel), which were 
visualized with a UV lamp (254 or 366 nm) and phosphomolybdic acid (PMA). PMA stain: PMA 
(20 g) in EtOH (200 mL). Preparative thin-layer chromatography was performed on silica gel 
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pre-coated glass plates SIL G-25 UV254 and SIL G-100 UV254 with 0.25 mm and 1.0 mm SiO2 
layers (Macherey-Nagel). 
Flash Column Chromatography 
Flash column chromatography (FCC) was carried out using Merck silica gel (60 Å, 230−400 
mesh, particle size 0.040−0.063 mm) using technical grade solvents. Elution was accelerated 
using compressed air. All reported yields, unless otherwise specified, refer to spectroscopically 
and chromatographically pure compounds. 
Nomenclature 
Nomenclature follows the suggestions proposed by the computer program ChemBioDraw 
(15.0.0.106) of CBD/Cambridgesoft. 
Nuclear Magnetic Resonance Spectroscopy 
1
H, 
13
C, 
19
F, 
31
P nuclear magnetic resonance (NMR) spectra were recorded on a Bruker AV-500, 
AV-400 or DPX-300 spectrometer in a suitable deuterated solvent. The solvent employed and 
respective measuring frequencies are indicated for each experiment. Chemical shifts are reported 
with tetramethylsilane (TMS) serving as a universal reference of all nuclides and with two or one 
digits after the comma. The resonance multiplicity is described as s (singlet), d (doublet), 
t (triplet), q (quadruplet), p (pentet), hept (heptet), m (multiplet), and br (broad). All spectra were 
recorded at 298 K unless otherwise noted, processed with Bruker TOPSPIN 2.1 or MestReNova 
11.0.2 suite of programs, and coupling constants are reported as observed. The residual 
deuterated solvent signal relative to tetramethylsilane was used as the internal reference in 
1
H 
NMR spectra (e.g. CDCl3 = 7.26 ppm), and are reported as follows: chemical shift δ in ppm 
(multiplicity, coupling constant J in Hz, number of protons). 
13
C, 
19
F, 
31
P NMR spectra were 
referenced according to Ξ- values (IUPAC recommendations 2008) relative to the internal 
references set in 
1
H NMR spectra (e.g. 
13
C: Me4Si, 
19
F: CCl3F, 
31
P: H3PO4 each 0.00 ppm). All 
spectra are broadband decoupled unless otherwise noted. 
Mass Spectrometry 
Electron impact (EI) mass spectrometry (MS) was performed on a Finnigan MAT 8200 (70 eV) 
or MAT 8400 (70 eV) spectrometer. Electrospray ionization (ESI) mass spectrometry was 
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conducted on a Bruker ESQ 3000 spectrometer. High resolution mass spectrometry (HRMS) was 
performed on a Finnigan MAT 95 (EI) or Bruker APEX III FTMS (7T magnet, ESI). The 
ionization method and mode of detection employed is indicated for the respective experiment and 
all masses are reported in atomic units per elementary charge (m/z) with an intensity normalized 
to the most intense peak. 
Specific Rotations 
Specific rotations were measured with a Rudolph RA Autopol IV Automatic Polarimeter at the 
indicated temperature with a sodium lamp (sodium D line, λ = 589 nm). Measurements were 
performed in an acid resistant 1 mL cell (50 mm length) with concentrations (g/(100 mL)) 
reported in the corresponding solvent.  
High Performacne Liquid Chromatography 
High performance liquid chromatography (HPLC) was performed on Shimadzu LC-20AD liquid 
chromatograph (SIL-20AC auto sampler, CMB-20A communication bus module, DGU-20A5 
degasser, CTO-20AC column oven, SPD-M20A diode array detector), Shimadzu LC-20AB 
liquid chromatograph (SIL-20ACHT auto sampler, DGU-20A5 degasser, CTO-20AC column 
oven, SPD-M20A diode array detector), or Shimadzu LC-20AB liquid chromatograph (reverse 
phase, SIL-20ACHT auto sampler, CTO-20AC column oven, SPD-M20A diode array detector) 
using Daicel columns with a chiral stationary phase. All solvents used were HPLC-grade solvents 
purchased from Sigma-Aldrich. The column employed and respective solvent mixtures are 
indicated for each experiment.  
Preparative High Performance Liquid Chromatography 
Preparative high performance liquid chromatography (Prep-HPLC) was performed on a 
Shimadzu LC-8A/10A liquid chromatograph (FRC-10A fraction collector, SPD-10-AVP diode 
array detector). All solvents used were HPLC-grade solvents purchased from Sigma-Aldrich. The 
column employed and respective solvent mixtures are indicated for each experiment.  
Gas Chromatography 
Gas chromatography (GC) analyses on a chiral stationary phase were performed on HP 6890 and 
5890 series instruments (split-mode capillary injection system, flame ionization detector (FID), 
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hydrogen carrier gas). All the analyses were conducted in the GC department of the Max-Planck-
Institut für Kohlenforschung. The conditions employed are described in detail in the individual 
experiments. 
Gas Chromatography Mass Spectroscopy 
Gas chromatography-mass spectrometry (GC-MS) analyses were recorded on an Agilent 
Technologies 6890N Network GC System equipped with a 5973 Mass Selective Detector, Gerstel 
Multi-Purpose Sampler MPS2, and a Macherey-Nagel Optima 5 column (30 m length, 0.25 mm i. 
D.) and an Agilent Technologies 7890A GC System equipped with a 5975C VL MSD mass 
selective detector, Gerstel Multi-Purpose Sampler MPS2, and a Macherey-Nagel Optima 5 
column (30 m length, 0.25 mm i.D.).  
Liquid Chromatography Mass Spectrometry 
Liquid chromatography-mass spectrometry (LC-MS) was performed on a Shimadzu LC-MS 
2020 liquid chromatograph. All solvents used were HPLC-grade solvents purchased from Sigma-
Aldrich. The column employed, the respective solvent mixture, and the MS parameters are 
indicated for each experiment. Elemental Analysis Elemental analysis (EA) was performed on a 
Vario Elementar EL (CHN) and an Ionchromatograph Metrohm IC 883 (SP). 
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7.2 General Procedures for Synthesis of 2-Aryl Ketones 
Commercially unavailable 2-substituted aryl ketones were synthesized according to the following 
unoptimized procedures. 
Procedure 1: Under an atmosphere of dry argon, an oven-dried Schlenk flask was charged with 
Cs2CO3 (2.2 equiv.), Pd2(dba)3 (0.5 mol%) and Xantphos (1.2 mol%). After evacuating and 
backfilling the flask with argon three times, dry dioxane (1 M), the corresponding aryl 
bromide/iodide (1 eq) and cyclohexanone (2 equiv.) were added and the mixture was stirred at 
80 °C for 24 h. After cooling down to room temperature, the reaction mixture was diluted with 
Et2O and washed with water. The aqueous layer was extracted with Et2O (3x), the combined 
organic layers were dried over Na2SO4 and the solvent was removed under reduced pressure. The 
crude product was purified by flash column chromatography (SiO2, hexanes/EtOAc = 100/0 then 
10/1). If required, an additional purification with toluene as eluent was performed.   
 
Procedure 2: At ‒78 °C, n-BuLi (2 equiv., 2.5 M in n-hexane) was added to a solution of the 
corresponding aryl bromide (2 equiv.) in THF (0.25 M) and the resulting solution was stirred for 
1 h at this temperature. Then cyclohexene oxide (1 equiv.) and BF3
.
Et2O (1.5 equiv.) were added 
and the resulting solution stirred for additional 3 h at ‒78 °C. The reaction mixture was quenched 
by addition of sat. aq. NaHCO3 solution, warmed to room temperature and diluted with ethyl 
acetate. The layers were separated and the organic layer was washed with 2 N NaOH solution and 
brine. The combined organic layers were dried over Na2SO4 and the solvent removed under 
reduced pressure. The crude product was purified by flash column chromatography (SiO2, 
hexanes/EtOAc = 100/0 then 10/1). Under an atmosphere of dry argon the obtained product was 
dissolved in dry DMSO (0.25 M). Dry triethylamine (10 equiv.) and sulfur trioxide-pyridine 
complex (3 equiv.) were then added and the resulting mixture was stirred overnight at room 
temperature. The reaction was quenched with water and extracted with CH2Cl2. The combined 
organic layers were dried over Na2SO4 and the solvent was removed under reduced pressure. The 
crude product was purified by flash column chromatography (SiO2, hexanes/EtOAc = 100/0 then 
10/1). 
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7.3 Brønsted Acid-Catalyzed Asymmetric Robinson Annulations 
7.3.1 Characterization of Intermediates 
2-Methyl-2-(3-oxobutyl)cyclopentane-1,3-dione (20a)
[199]
 
 
Procedure: To a solution of 2-methyl-cyclopentane-1,3-dione (1.12 g, 10.0 mmol, 1.0 equiv.) in 
MeCN (15 mL) NEt3 (5.0 ml, 35.9 mmol, 3.6 equiv.) and Methylvinylketone (0.97 mL, 
12.0 mmol, 1.2 equiv.) were added and the resulting mixture was stirred over night at room 
temperature. The solvents were removed under reduced pressure and the crude product was 
purified by column chromatography (SiO2, hexanes/EtOAc = 1/1) to give 20a as a colorless oil 
(1.26 g, 69%). 
1
H NMR (500 MHz, CDCl3): δ = 2.87–2.71 (m, 4H), 2.44 (t, J = 7.2 Hz, 2H), 2.09 (s, 3H), 1.88 
(t, J = 7.2 Hz, 2H), 1.09 (s, 3H). 
13
C NMR (125 MHz, CDCl3): δ = 216.0, 208.1, 55.2, 37.5, 34.8, 30.2, 27.9, 19.2. 
HRMS (ESIpos): m/z calculated for C10H14NaO3 [M+Na]
+
: 205.0835, found 205.0835. 
 
2-methyl-2-(3-oxobutyl)cyclohexane-1,3-dione (21a)
[199]
 
 
Procedure: To a solution of (1.26 g, 10.0 mmol, 1.0 equiv.) in MeCN (15 mL) NEt3 (5.0 ml, 
35.9 mmol, 3.6 equiv) and Methylvinylketone (0.97 mL, 12.0 mmol, 1.2 equiv) were added and 
the resulting mixture was stirred over night at room temperature. The solvents were removed 
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under reduced pressure and the crude product was purified by column chromatography (SiO2, 
hexane/EtOAc = 1/1) to give 21a as a colorless oil (1.91 g, 97%).  
1
H NMR (500 MHz, CDCl3): δ = 2.74–2.59 (m, 4H), 2.33 (t, J = 7.6 Hz, 2H), 2.10 (s, 3H), 2.07–
1.96 (m, 3H), 1.94–1.85 (m, 1H), 1.23 (s, 3H). 
13
C NMR (125 MHz, CDCl3): δ = 210.2, 207.7, 64.5, 38.5, 37.9, 30.1, 29.7, 20.2, 17.7. 
HRMS (ESIpos): m/z calculated for C11H16NaO3 [M+Na]
+
: 219.0992, found 219.0991. 
 
(1S,2R,5S)-2-hydroxy-2,5-dimethylbicyclo[3.2.1]octane-6,8-dione (47a) 
 
Procedure: A solution of 20a (200 mg, 1.10 mmol, 1.0 equiv.) and DPP (27.5 mg, 10 mol%) in 
anhydrous toluene (1 mL) was stirred at room temperature overnight. Filtration of the crude 
reaction mixture yielded the targeted product as white solid (159 mg, 80%). 
1
H NMR (500 MHz, CDCl3): δ = 2.78 (d, J = 7.4 Hz, 1H), 2.63 (dd, J = 19.3, 7.4 Hz, 1H), 2.55 
(dd, J = 19.3 Hz, 0.9 Hz, 1H), 2.13 (ddd, J = 12.8, 12.8, 6.7 Hz, 1 H), 1.92 (s, 1H), 1.84 (ddd, 
J = 12.8, 5.4, 1.9 Hz, 1H), 1.78–1.65 (m, 2H), 1.40 (s, 3H), 1.07 (s, 3H). 
13
C NMR (125 MHz, CDCl3): δ = 214.0, 211.2, 80.7, 58.3, 57.5, 42.7, 38.5, 32.3, 28.6, 11.9. 
HRMS (ESIpos): m/z calculated for C10H14NaO3 [M+Na]
+
: 205.0835, found 205.0837. 
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X-Ray data for 47a: 
 
 
Table 1.  Crystal data and structure refinement. 
Identification code  9339 
Empirical formula  C10 H14 O3 
Color  colorless 
Formula weight  182.21  g · mol-1  
Temperature  100 K 
Wavelength  1.54178 Å 
Crystal system  ORTHORHOMBIC 
Space group  Pna21,  (no. 33)  
Unit cell dimensions a = 11.9662(5) Å = 90°. 
 b = 10.6428(4) Å = 90°. 
 c = 7.0712(3) Å  = 90°. 
Volume 900.54(6) Å3 
Z 4 
C10
C3 C4
C2
O3
C8
O2
O1
C5C1
H1
C6
C7
C9
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Density (calculated) 1.344  Mg · m-3 
Absorption coefficient 0.808 mm-1 
F(000) 392 e 
Crystal size 0.16 x 0.15 x 0.05 mm3 
 range for data collection 5.563 to 67.474°. 
Index ranges -14  h  14, -12 k  12, -8  l  7 
Reflections collected 19694 
Independent reflections 1551 [Rint = 0.0393] 
Reflections with I>2(I) 1497 
Completeness to  = 67.474° 99.8 %  
Absorption correction Gaussian 
Max. and min. transmission 0.96 and 0.89 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1551 / 1 / 125 
Goodness-of-fit on F2 1.090 
Final R indices [I>2(I)] R1 = 0.0296 wR
2 = 0.0711 
R indices (all data) R1 = 0.0310 wR
2 = 0.0720 
Absolute structure parameter -0.12(9) 
Extinction coefficient 0.0069(10) 
Largest diff. peak and hole 0.170 and -0.139 e · Å-3 
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Table 2.   Bond lengths [Å] and angles [°]. 
______________________________________________________________________  
O(2)-C(5) 1.218(3)  O(3)-C(8) 1.223(3) 
O(1)-C(1) 1.442(3)  C(8)-C(4) 1.516(3) 
C(8)-C(7) 1.511(3)  C(10)-C(4) 1.510(3) 
C(6)-C(7) 1.538(3)  C(6)-C(5) 1.507(3) 
C(6)-C(1) 1.567(3)  C(2)-C(1) 1.526(3) 
C(2)-C(3) 1.528(3)  C(4)-C(5) 1.515(3) 
C(4)-C(3) 1.569(3)  C(1)-C(9) 1.516(3)  
 
O(3)-C(8)-C(4) 124.7(2)  O(3)-C(8)-C(7) 125.3(2) 
C(7)-C(8)-C(4) 109.99(18)  C(7)-C(6)-C(1) 112.76(17) 
C(5)-C(6)-C(7) 102.02(17)  C(5)-C(6)-C(1) 105.67(17) 
C(1)-C(2)-C(3) 113.71(17)  C(8)-C(4)-C(3) 105.63(17) 
C(10)-C(4)-C(8) 115.93(19)  C(10)-C(4)-C(5) 117.10(19) 
C(10)-C(4)-C(3) 112.6(2)  C(5)-C(4)-C(8) 101.18(18) 
C(5)-C(4)-C(3) 102.75(17)  C(8)-C(7)-C(6) 104.27(18) 
O(2)-C(5)-C(6) 127.5(2)  O(2)-C(5)-C(4) 126.2(2) 
C(6)-C(5)-C(4) 106.20(18)  O(1)-C(1)-C(6) 108.68(16) 
O(1)-C(1)-C(2) 105.88(18)  O(1)-C(1)-C(9) 109.81(18) 
C(2)-C(1)-C(6) 108.77(18)  C(9)-C(1)-C(6) 111.36(18) 
C(9)-C(1)-C(2) 112.14(18)  C(2)-C(3)-C(4) 113.08(19)  
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(1S,5S,6R)-6-hydroxy-1,6-dimethylbicyclo[3.3.1]nonane-2,9-dione (47b) 
 
Procedure: The product was obtained as a side product. 
1
H NMR (500 MHz, CDCl3): δ = 2.70–2.64 (m, 1H), 2.61–2.52 (m, 1H), 2.45–2.35 (m, 1H), 
2.13–2.00 (m, 3H), 1.93–1.72 (m, 3H), 1.69–1.61 (m, 1H), 1.38 (s, 3H), 1.17 (s, 3H). 
13
C NMR (125 MHz, CDCl3): δ = 211.7, 211.4, 79.0, 62.6, 57.1, 38.3, 37.1, 32.6, 28.1, 19.4, 
16.6. 
 
(±)-(3aS,7aS)-3a-hydroxy-7a-methylhexahydro-1H-indene-1,5(4H)-dione (22a) 
[199]
 
Procedure: To a stirred solution of 20a (200 mg, 1.09 mmol, 1.0 equiv.) in DMF (1 mL) DL-
proline (6.3 mg, 5 mol%) was added and the resulting solution was stirred overnight at room 
temperature. The reaction was quenched by addition of brine and extracted with EtOAc (3x). The 
combined organic layers were washed with brine, dried over Na2SO4, the solvent was removed 
under reduced pressure and the crude product was purified by column chromatography (SiO2, 
hexane/EtOAc = 1/1) to give 22a as a colorless oil (120 mg, 60%). 
1
H NMR (500 MHz, CDCl3): δ = 2.63 (d, J = 0.8 Hz, 2H), 2.61–2.52 (m, 1H), 2.48–2.40 (m, 
2H), 2.33 (dtt, J = 14.5, 4.9, 0.8 Hz, 1H), 2.08–1.97 (m, 2H), 1.79 (ddd, J = 14.3, 11.6, 5.1 Hz, 
1H), 1.75–1.67 (m, 2H), 1.27 (s, 3H). 
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7.3.2 Synthesis of 2-Substituted 1,3-Diketones 
General procedure: To a solution of the aldehyde (3 equiv.), HEH (1 equiv.) and 1,3-
cyclohexandione/1,3-cyclopentandione (1 equiv) in CH2Cl2 (2 mL/mmol) was added DL-Proline 
(0.2 equiv.). The resulting mixture was stirred over night at room temperature and subsequently 
directlypurified by column chromatography (SiO2, hexanes/EtOAc = 3/1  1/1). 
 
2-benzylcyclopentane-1,3-dione (26b) 
 
The general procedure was performed on a 2 mmols scale, giving 26b as a colorless solid; 206 
mg (54%). 
1
H NMR (300 MHz, MeOH-D4): δ = 7.22–7.14 (m, 4H), 7.13–7.07 (m, 1H), 4.91 (s, 1H), 3.42 
(s, 2H), 2.51 (s, 4H). 
13
C NMR (125 MHz, CDCl3): δ = 141.5, 129.4, 129.1, 126.7, 118.1, 31.4, 27.6. 
HRMS (APPIpos): m/z calculated for C12H13O2 [M+H]
+
: 189.0910, found 189.0911. 
 
2-ethylcyclohexane-1,3-dione (27b) 
 
The general procedure was performed on a 5 mmols scale, giving 27b as a colorless solid; 260 
mg (37%). 
1
H NMR (300 MHz, MeOH-D4): δ = 4.58 (sbr, 1H), 2.39 (t, J = 6.3 Hz, 4H), 2.25 (q, J = 7.4 Hz, 
2H), 1.93 (p, J = 6.4 Hz, 2H), 0.90 (t, J = 7.4 Hz, 3H). 
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HRMS (ESIpos): m/z calculated for C8H13O2 [M+H]
+
: 141.0910, found 141.0910. 
 
2-pentylcyclohexane-1,3-dione (27c) 
 
The general procedure was performed on a 3 mmols scale, giving 27c as a colorless solid; 418 
mg (76%). 
1
H NMR (500 MHz, DMSO-D6) δ = 10.20 (s, 1H), 2.29 (s, 4H), 2.11 (t, J = 7.2 Hz, 2H), 1.81 (p, 
J = 6.4 Hz, 2H), 1.36–1.14 (m, 6H), 0.84 (t, J = 7.1 Hz, 3H). 
13
C NMR (126 MHz, DMSO) δ = 114.8, 31.4, 28.0, 22.1, 21.4, 20.6, 14.0. (Carbonyls are not 
visible due to rapid tautomerization) 
 
2-isobutylcyclohexane-1,3-dione (27d) 
 
The general procedure was performed on a 3 mmols scale, giving 27d as a colorless solid; 129 
mg (38%). 
1
H NMR (500 MHz, DMSO-D6) δ = 10.16 (s, 1H), 2.47–2.12 (m, 4H), 2.03 (d, J = 7.3 Hz, 2H), 
1.82 (p, J = 6.4 Hz, 2H), 1.66 (dp, J = 13.6, 6.8 Hz, 1H), 0.78 (d, J = 6.7 Hz, 6H). 
13
C NMR (126 MHz, DMSO) δ = 114.3, 30.8, 27.6, 22.9, 21.1. (Carbonyls are not visible due to 
rapid tautomerization) 
HRMS (ESIpos): m/z calculated for C10H16O2Na [M+Na]
+
: 191.1042, found 191.1042. 
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2-benzylcyclohexane-1,3-dione (27e) 
 
The general procedure was performed on a 3 mmols scale, giving 27e as a colorless solid; 347 
mg (57%). 
1
H NMR (500 MHz, DMSO-D6) δ = 10.56 (s, 1H), 7.30–7.02 (m, 5H), 3.47 (s, 2H), 2.36 (s, 4H), 
1.85 (p, J = 6.4 Hz, 2H). 
HRMS (ESIpos): m/z calculated for C13H14O2Na [M+Na]
+
: 225.0886, found 225.0884. 
 
2-(3-phenylpropyl)cyclohexane-1,3-dione (27f) 
 
The general procedure was performed on a 3 mmols scale, giving 27f as a coulurless solid; 556 
mg (80%). 
1
H NMR (500 MHz, DMSO-D6) δ = 10.28 (s, 1H), 7.34–7.08 (m, 5H), 2.56–2.49 (m, 2H), 2.43 
(m, 2H), 2.19 (q, J = 9.2, 8.4 Hz, 4H), 1.81 (p, J = 6.5 Hz, 2H), 1.58–1.50 (m, 2H). 
13
C NMR (126 MHz, DMSO) δ = 143.0, 128.6, 128.6, 125.9, 115.0, 35.9, 30.7, 22.0, 21.1. 
(Carbonyls are not visible due to rapid tautomerization) 
 
2-(cyclohexylmethyl)cyclohexane-1,3-dione (27g) 
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The general procedure was performed on a 5 mmols scale, giving 27g as a colorless solid; 517 
mg (50%). 
1
H NMR (300 MHz, MeOH-D4) δ = 4.58 (s, 1H), 2.40 (t, J = 6.4 Hz, 4H), 2.13 (d, J = 7.2 Hz, 
2H), 2.03–1.87 (m, 2H), 1.75–1.53 (m, 2H), 1.39 (ddp, J = 10.9, 7.0, 3.5 Hz, 1H), 1.25–1.08 (m, 
3H), 0.91 (dt, J = 15.3, 11.0 Hz, 2H). 
HRMS (ESIpos): m/z calculated for C13H21O2 [M+H]
+
: 209.1536, found 209.1537. 
 
2-phenylcyclohexane-1,3-dione (28) 
 
To a solution of CuI (61.3 mg, 0.32 mmol, 10 mol%), L-proline (78.2 mg, 0.68 mg, 20 mol%), 
K2CO3 (1.97 g, 14.3 mmol, 4.0 equiv.) and 1,3-cyclohexandione (1.20 g, 10.7 mmol, 3.0 equiv) 
in DMSO (17 mL) was added iodobenzene (0.40 mL, 3.57 mmol, 1.0 equiv). The resulting 
reaction mixture was heated to 90 °C for 48 h. After cooling down to room temperature the 
mixture was poured into aq. HCl (1 M). The phases were separated, and the organic layer was 
extracted with EtOAc (3 × 20 mL). The combined organic extracts were washed with brine and 
dried over Na2SO4, filtered and the solvent was removed in vacuo. Purification by FCC (SiO2, 
hexanes/EtOAc) afforded 28 as a yellow solid (344 mg, 51%) 
1
H NMR (300 MHz, CDCl3) δ = 7.54–7.41 (m, 2H), 7.40–7.32 (m, 1H), 7.23–7.16 (m, qH), 2.63 
(t, J = 6.3 Hz, 2H), 2.51 (dd, J = 7.4, 6.0 Hz, 2H), 2.17–2.03 (m, 2H). 
 
7.3.3 Characterization of Products 
General procedure: 1,3-Diketone (0.2 mmol, 1.0 equiv.), BHT (66.1 mg, 0.3 mmol, 1.5 equiv.) 
and STRIP 6a (7.2 mg, 5 mol%) were placed in a headspace vial and n-heptane (1.8 mL), H2O 
(0.2 mL) and methylvinyl ketone (49 µL, 0.6 mmol, 3.0 equiv) were added. The vial was closed 
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and the resulting mixture was stirred at 100 °C for 24 h at 1000 rpm. After cooling down to room 
temperature the crude mixture was directly purified by FCC (hexanes/EtOAc = 2/1).  
 
7a-methyl-2,3,7,7a-tetrahydro-1H-indene-1,5(6H)-dione (24a) 
 
1
H NMR (500 MHz, CDCl3): δ = 6.00–5.95 (m, 1H), 2.96 (dddd, J = 17.0, 11.1, 10.0, 2.5 Hz, 
1H), 2.84–2.71 (m, 2H), 2.59–2.38 (m, 3H), 2.11 (ddd, J = 13.5, 5.2, 2.2 Hz, 1H), 1.86 (td, J = 
13.8, 5.4 Hz, 1H), 1.32 (s, 3H). 
HRMS (ESIpos): m/z calculated for C10H12NaO2 [M+Na]
+
: 187.0729, found 187.0729. 
HPLC (Chiralcel OD-3, n-heptane/iPrOH = 95/5, flowrate: 1.0 ml/min, λ = 240 nm): tmajor = 
15.67 min, tminor = 16.99 min. 
 
(R)-7a-benzyl-2,3,7,7a-tetrahydro-1H-indene-1,5(6H)-dione (24b) 
 
1
H NMR (500 MHz, CDCl3): δ = 7.31–7.24 (m, 3H), 7.12–7.05 (m, 2H), 6.06 (d, J = 2.4 Hz, 
1H), 3.11–3.01 (m, 2H), 2.60–2.39 (m, 3H), 2.34–2.18 (m, 3H), 2.09–1.98 (m, 1H), 1.84 (td, J = 
13.8, 5.7 Hz, 1H). 
13
C NMR (125 MHz, CDCl3): δ = 217.8, 198.2, 169.4, 135.7, 129.7, 128.8, 128.5, 127.7, 125.3, 
54.3, 42.5, 37.1, 33.0, 29.4, 28.3. 
HPLC (Chiralcel OD-3, n-heptane/iPrOH = 95/5, flowrate: 1.0 ml/min, λ = 240 nm): tminor = 8.58 
min, tmajor = 8.59 min. 
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(S)-8a-methyl-3,4,8,8a-tetrahydronaphthalene-1,6(2H,7H) (25a) 
 
Appearance: yellowish sold; 31.1 mg (87%); 98:2 er. 
1
H NMR (500 MHz, CDCl3): δ = 5.86 (d, J = 1.8 Hz, 1H), 2.77–2.67 (m, 2H), 2.54–2.42 (m, 
4H), 2.19–2.09 (m, 3H), 1.71 (tq, J = 13.3, 4.3 Hz, 1H), 1.45 (s, 3H). 
13
C NMR (125 MHz, CDCl3): δ = 211.2, 198.4, 165.9, 126.9, 50.8, 37.8, 33.8, 31.9, 29.8, 23.4, 
23.1. 
HPLC (Chiralcel OD-3, n-heptane/iPrOH = 95/5, flowrate: 1.0 ml/min, λ = 240 nm): tminor = 11.6 
min, tmajor = 12.9 min. 
 
(S)-8a-ethyl-3,4,8,8a-tetrahydronaphthalene-1,6(2H,7H)-dione (25b) 
 
Appearance: yellowish sold; 31.6 mg (82%); 98.5:1.5 er. 
1
H NMR (500 MHz, CDCl3): δ = 5.86 (d, J = 1.2 Hz, 1H), 2.84-2.74 (m, 1H), 2.65 (dt, J = 15.0, 
6.2 Hz, 1H), 2.52-2.30 (m, 4H), 2.27-2.20 (m, 1H), 2.19-2.11 (m, 1H), 2.06-1.96 (m, 2H), 1.88-
1.78 (m, 1H), 1.75-1.63 (m, 1H), 0.85 (t, J = 7.3 Hz, 3H). 
HRMS (ESIpos): m/z calculated for C12H16NaO2 [M+Na]
+
: 215.1042, found 215.1043. 
HPLC (Chiralpak AD-3, n-heptane/iPrOH = 95/5, flowrate: 1.0 ml/min, λ = 240 nm): tmajor = 7.6 
min, tminor = 8.4 min. 
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(S)-8a-pentyl-3,4,8,8a-tetrahydronaphthalene-1,6(2H,7H)-dione (25c) 
 
Appearance: yellowish sold; 37.2 mg (79%); 99:1 er. 
1
H NMR (500 MHz, CDCl3): δ = 5.86 (d, J = 1.8 Hz, 1H), 2.80 (dddd, J = 15.3, 13.6, 5.2, 2.0 
Hz, 1H), 2.65 (td, J = 14.5, 6.1 Hz, 1H), 2.52–2.30 (m, 4H), 2.23 (ddd, J = 14.5, 4.9, 4.0 Hz, 1H), 
2.19–2.10 (m, 1H), 2.04 (dddd, J = 14.6, 13.2, 5.4, 1.1 Hz, 1H), 1.96–1.85 (m, 1H), 1.81–1.63 
(m, 1H), 1.37–1.18 (m, 5H), 1.06 (dddd, J = 13.9, 12.5, 6.4, 3.5 Hz, 1H), 0.87 (t, J = 7.0 Hz, 3H). 
13
C NMR (125 MHz, CDCl3): δ = 210.3, 198.5, 166.3, 126.2, 55.1, 38.5, 35.6, 33.7, 32.1, 32.1, 
25.7, 24.2, 23.7, 22.5, 14.1. 
HPLC (Chiralpak AD-3, n-heptane/iPrOH = 95/5, flowrate: 1.0 ml/min, λ = 240 nm): tmajor = 
6.17 min, tminor = 7.14 min.  
 
(R)-8a-isobutyl-3,4,8,8a-tetrahydronaphthalene-1,6(2H,7H)-dione (25d) 
 
Appearance: yellowish sold; 27.2 mg (62%); 98.5:1.5 er. 
1
H NMR (500 MHz, CDCl3): δ = 5.77 (d, J = 1.8 Hz, 1H), 2.80–2.67 (m, 2H), 2.47–2.36 (m, 
3H), 2.34–2.20 (m, 2H), 2.13–1.98 (m, 2H), 1.85 (ddd, J = 14.6, 6.5, 1.3 Hz, 1H), 1.72–1.56 (m, 
3H), 0.88 (d, J = 6.6 Hz, 3H), 0.79 (d, J = 6.6 Hz, 3H). 
13
C NMR (125 MHz, CDCl3): δ = 211.1, 198.4, 166.9, 126.2, 55.4, 44.5, 38.9, 33.8, 32.1, 26.0, 
25.0, 24.9, 24.2, 23.9. 
HPLC (Chiralcel OD-3, n-heptane/iPrOH = 95/5, flowrate: 1.0 ml/min, λ = 240 nm): tmajor = 6.7 
min, tminor = 8.5 min.  
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(R)-8a-benzyl-3,4,8,8a-tetrahydronaphthalene-1,6(2H,7H)-dione (25e) 
 
Appearance: yellowish sold; 50.6 mg (99%); 98.5:1.5 er. 
1
H NMR (500 MHz, CDCl3): δ = 7.32–7.23 (m, 3H), 7.09–7.03 (m, 2H), 6.03–5.85 (m, 1H), 
3.18 (q, J = 13.7 Hz, 2H), 2.75–2.61 (m, 2H), 2.60–2.48 (m, 2H), 2.43–2.23 (m, 2H), 2.22–1.96 
(m, 3H), 1.71 (qt, J = 13.2, 4.4 Hz, 1H). 
13
C NMR (125 MHz, CDCl3): δ = 210.1, 198.3, 165.1, 135.7, 129.7, 128.8, 127.7, 127.2, 56.0, 
42.9, 39.3, 33.7, 32.8, 27.7, 23.2. 
HPLC (Chiralpak AD-3, n-heptane/iPrOH = 95/5, flowrate: 1.0 ml/min, λ = 240 nm): tmajor = 9.3 
min, tminor = 10.4 min.  
 
(S)-8a-(3-phenylpropyl)-3,4,8,8a-tetrahydronaphthalene-1,6(2H,7H)-dione (25f) 
 
Appearance: orange oil; 37.7 mg (67%); 98.5:1.5 er. 
1
H NMR (500 MHz, CDCl3): δ = 7.31–7.25 (m, 3H), 7.22–7.17 (m, 1H), 7.15–7.10 (m, 2H), 
5.83 (d, J = 1.8 Hz, 1H), 2.69 (dddd, J = 15.4, 13.6, 5.3, 1.9 Hz, 1H), 2.61 (td, J = 7.2, 2.4 Hz, 
2H), 2.53–2.33 (m, 4H), 2.30–2.16 (m, 2H), 2.13–1.99 (m, 2H), 1.90 (dddd, J = 13.8, 12.3, 4.5, 
1.1 Hz, 1H), 1.77 (ddd, J = 14.2, 12.5, 4.6 Hz, 1H), 1.71–1.59 (m, 2H), 1.46–1.36 (m, 1H). 
13
C NMR (125 MHz, CDCl3): δ = 210.2, 198.4, 166.0, 141.1, 128.6, 128.5, 126.4, 126.3, 54.9, 
38.4, 35.7, 34.4, 33.6, 32.0, 25.9, 25.7, 23.6. 
HPLC (Chiralpak AD-3, n-heptane/iPrOH = 95/5, flowrate: 1.0 ml/min, λ = 240 nm): tmajor = 
17.12 min, tminor = 21.22 min.  
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(R)-8a-(cyclohexylmethyl)-3,4,8,8a-tetrahydronaphthalene-1,6(2H,7H)-dione (25g) 
 
Appearance: orange oil; 45.8 mg (88%); 98:2 er. 
1
H NMR (500 MHz, CDCl3): δ = 5.83 (d, J = 1.7 Hz, 1H), 2.80 (tdd, J = 14.3, 12.0, 5.7 Hz, 2H), 
2.55–2.41 (m, 3H), 2.39–2.34 (m, 1H), 2.33–2.25 (m, 1H), 2.16 (dtq, J = 13.8, 5.4, 2.5 Hz, 1H), 
2.10–2.01 (m, 1H), 1.89 (ddd, J = 14.9, 6.2, 1.4 Hz, 1H), 1.77–1.48 (m, 7H), 1.37–0.82 (m, 6H). 
HRMS (ESIpos): m/z calculated for C17H24O2Na [M+Na]
+
: 283.1668; found 283.1670. 
HPLC (Chiralcel OD-3, n-heptane/iPrOH = 95/5, flowrate: 1.0 ml/min, λ = 240 nm): tmajor = 5.97 
min, tminor = 7.66 min.  
 
(R)-8a-allyl-3,4,8,8a-tetrahydronaphthalene-1,6(2H,7H)-dione (25h) 
 
Appearance: orange oil; 25.0 mg (74%); 99:1 er. 
1
H NMR (500 MHz, CDCl3): δ = 5.89 (d, J = 1.9 Hz, 1H), 5.59 (ddt, J = 16.1, 10.8, 7.4 Hz, 1H), 
5.18–5.06 (m, 2H), 2.83–2.72 (m, 1H), 2.70–2.61 (m, 2H), 2.58–2.47 (m, 3H), 2.44–2.39 (m, 
2H), 2.28–2.12 (m, 2H), 2.06 (dddd, J = 14.4, 10.3, 8.7, 1.2 Hz, 1H), 1.71 (qt, J = 13.6, 4.3 Hz, 
1H). 
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7.3.4 Modifications and Synthesis of Novel Backbones: 
3,3',3''-(benzene-1,3,5-triyl)tris(pentan-3-ol) (53) 
 
Procedure: A solution of trimethyl-1,3,5-benzotricarboxylat (1.50 g, 5.94 mmol, 1.0 equiv.) in 
diethylether (5 mL) was cooled to 0 °C and ethylmagnesium bromide (60 mL, 1 m in Et2O, 60 
mmol, 10.0 equiv) was added dropwise. The reaction was allowed to warm up overnight, 
quenched with aq. NH4Cl solution and the layers were separated. The aqueous layer was 
extracted with Et2O, dried over Na2SO4 and the solvent removed under reduced pressure. 
Recrystallization in hexanes gave the target product as colorless solid (1.50 g, 75%). 
1
H NMR (500 MHz, CDCl3): δ = 1.96–1.71 (m, 12H), 1.64 (s, 3H), 0.73 (t, J = 7.4 Hz, 18H). 
HRMS (ESIpos): m/z calculated for C21H36O3Na [M+Na]
+
: 359.2557; found 359.2559. 
 
1,3,5-tri(pentan-3-yl)benzene (54) 
 
Procedure: A solution of 53 (790 mg, 2.35 mmol, 1.0 equiv) and p-toluenesulfonic acid 
monohydrate (223 mg, 1.17 mmol, 0.5 equiv) in anhydrous toluene (20 mL) was stirred for 2 h at 
80 °C. After cooling down to room temperature the crude reaction mixture was filtered through a 
pad of silica (hexanes as eluent) and the solvent was removed under reduced pressure. The 
obtained clear oil was dissolved in MeOH (24 mL), Pd/C (250 mg, 10%) was added and the 
resulting mixture was put under an atmosphere of hydrogen. After stirring stirred at room 
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temperature for 2 h the reaction mixture was filtered through a pad of celite, the solvent was 
removed giving 54 as clear oil (535 mg, 79%). 
1
H NMR (500 MHz, CDCl3): δ = 6.66 (s, 3H), 2.24 (tt, J = 9.0, 5.4 Hz, 3H), 1.66 (dqd, J = 12.8, 
7.4, 5.4 Hz, 6H), 1.57–1.46 (m, 6H), 0.74 (t, J = 7.3 Hz, 18H). 
13
C NMR (125 MHz, CDCl3): δ = 145.0, 124.9, 49.8, 29.5, 12.3. 
HRMS (EI): m/z calculated for C21H36 [M]
+
: 288.2817; found 288.2817. 
 
1,3,5-tri(pentan-3-yl)benzene (55) 
 
Procedure: Under an atmosphere of dry argon a solution of 54 (740 mg, 2.56 mmol, 1.0 equiv.), 
AuCl3 (8 mg, 1 mol%) and freshly recrystallized NBS (461 mg, 2.59 mmol, 1.0 equiv.) in 
anhydrous DCE (13 mL) was stirred at 80 °C for 16 h. After cooling down to room temperature 
the crude reaction mixture was filtered through a pad of silica (hexanes as eluent) giving 55 as 
clear oil (897 mg, 95%). 
1
H NMR (500 MHz, CDCl3): δ = 6.72 (s, 2H), 3.29–3.17 (m, 2H), 2.24 (td, J = 9.3, 4.8 Hz, 2H), 
1.74–1.60 (m, 6H), 1.60–1.44 (m, 6H), 0.76 (dt, J = 25.0, 7.4 Hz, 18H). 
 
3-(3-methoxyphenyl)propan-1-ol (59) 
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Procedure: To 3-methoxycinnamic acid (5.00 g, 28.1 mmol, 1.0 equiv) in THF (20 mL) lithium 
aluminum hydride (57.0 mL, 1 M in THF, 57.0 mmol, 2.0 equiv) was added at 0 °C. After 
completion the resulting solution was refluxed overnight. After cooling down to 0 °C sat. aq. 
NH4Cl solution was added until the no hydrogen formation was visible, additional Et2O was 
added if necessary. After addition of an excess of MgSO4 the resulting heterogeneous mixture 
was filtered, excessively washed with Et2O and the solvent removed under reduced pressure to 
give 59 (4.60 g, 98%) as colorless oil. 
1
H NMR (500 MHz, CDCl3): δ = 7.23–7.17 (m, 1H), 6.84–6.70 (m, 3H), 3.80 (s, 3H), 3.68 (t, J = 
6.4 Hz, 2H), 2.73–2.64 (m, 2H), 1.95–1.85 (m, 2H), 1.32 (s, 1H). 
13
C NMR (125 MHz, CDCl3): δ = 159.8, 143.6, 129.6, 129.5, 121.0, 114.4, 111.3, 62.5, 55.3, 
34.3, 32.3. 
HRMS (ESIpos): m/z calculated for C10H14O2Na [M+Na]
+
: 189.0886; found 189.0886. 
 
1-(3-bromopropyl)-3-methoxybenzene (60) 
 
Procedure: To a stirred solution of 59 (4.60 g, 27.7 mmol, 1.0 equiv) in Et2O (30 mL) was added 
PBr3 (1.04 mL, 11.1 mmol, 0.4 equiv.) at 0 °C. The mixture was heated to reflux for 3 h and then 
quenched with water and partitioned between Et2O and aqueous NaHCO3. The organic extract 
was dried over Na2SO4 and concentrated. The residue was purified by FCC (SiO2, 
pentane/MTBE = 3/1) to give 60 (4.20 g, 66% yield) as colorless oil. 
1
H NMR (500 MHz, CDCl3): δ = 7.24–7.18 (m, 1H), 6.83–6.73 (m, 3H), 3.81 (s, 3H), 3.40 (t, J = 
6.6 Hz, 2H), 2.76 (t, J = 7.3 Hz, 2H), 2.21–2.12 (m, 2H). 
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1,7-bis(3-methoxyphenyl)heptan-4-ol (61)
[179]
 
 
Procedure: A solution of ethyl formate (1.67 mL, 20.8 mmol, 1.0 equiv.) was added slowly to a 
stirred solution of 3-(3-methoxyphenyl)-propylmagnesium bromide in THF (120 mL), which was 
prepared from 60 (10.0 g, 43.6 mmol, 2.1 equiv.) and magnesium (1.26 g, 52.0 mmol, 2.5 equiv.), 
at 0 °C. Upon completion the reaction mixture was stirred at room temperature overnight. The 
reaction mixture was cooled to 0°C by and sat. aq. NH4Cl solution was added. The organic layer 
was extracted with ethyl acetate (3x100 mL) and dried over Na2SO4. The solvent was removed 
under reduced pressure, and the residue was purified by FCC (SiO2, hexanes/EtOAc = 3/1) to 
afford 61 (5.05 g, 74%) as colorless oil. 
1
H NMR (500 MHz, CDCl3): δ = 7.22–7.15 (m, 2H), 6.82–6.68 (m, 6H), 3.80 (d, J = 0.7 Hz, 
6H), 3.68–3.59 (m, 2H), 2.69–2.52 (m, 4H), 1.85–1.70 (m, 2H), 1.70–1.58 (m, 2H), 1.56–1.39 
(m, 4H), 1.30–1.23 (m, 1H). 
13
C NMR (125 MHz, CDCl3): δ = 159.8, 144.2, 129.4, 121.0, 114.3, 111.1, 71.8, 55.3, 37.2, 
36.1, 27.5. 
HRMS (ESIpos): m/z calculated for C21H28O3Na [M+Na]
+
: 351.1931; found 351.1930. 
 
1,7-bis(3-methoxyphenyl)heptan-4-one (62) 
[179]
 
 
Procedure: Dimethyl sulfoxide (1.5 mL, 21.1 mmol, 1.3 equiv.) was added dropwise to a stirred 
solution of oxalyl chloride (1.6 mL, 18.6 mmol, 1.1 equiv.) in CH2Cl2 (60 mL) at–78°C. The 
mixture was stirred for 15 min, and a solution of 61 (5.5 g, 16.7 mmol, 1.0 equiv) in CH2Cl2 (15 
mL) was added dropwise. The resulting mixture was stirred for an additional 30 min at –78 °C, 
triethylamine (9.3 mL, 66.7 mmol, 4.0 equiv.) was added dropwise. After stirring at –78 °C for 
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additional 15 min and at room temperature for 2 h, water was added, the organic layer was 
separated and the aqueous layer was extracted with CH2Cl2. The combined organic layers were 
washed successively with aq. HCl (1 M), saturated Na2CO3 and dried over Na2SO4. After removal 
of the solvent, the residue was purified by FCC (SiO2, hexanes/EtOAc = 10/1) affording 62 (5.26 
g, 96%) as colorless oil. 
1
H NMR (500 MHz, CDCl3): δ = 7.19 (t, J = 7.8 Hz, 2H), 6.78–6.69 (m, 6H), 3.79 (s, 6H), 2.58 
(t, J = 7.5 Hz, 4H), 2.38 (t, J = 7.4 Hz, 4H), 1.93–1.85 (m, 4H). 
 
1,7-bis(2-bromo-5-methoxyphenyl)heptan-4-one (63) 
[179]
 
 
Procedure: A solution of H2O2 (aq., 35%, 2.15 mL, 22.2 mmol, 5.2 equiv.) in acetic acid (10 
mL) was added dropwise to a stirred solution of 62 (1.38 g, 4.22 mmol, 1.0 equiv.) and NaBr 
(0.91 g, 8.88 mmol, 2.1 equiv.) in acetic acid (20 mL). The mixture was stirred at room 
temperature overnight. The solvent was removed under reduced pressure and the residue was 
dissolved in CH2Cl2, washed with water and dried over Na2SO4. The solvent was removed under 
reduced pressure and the crude product was purified by FCC (SiO2, hexanes/EtOAc = 10/1) 
affording 63 (1.95 g, 95%) as a white solid. 
1
H NMR (500 MHz, CDCl3): δ = 7.40 (d, J = 8.7 Hz, 2H), 6.76 (d, J = 3.0 Hz, 2H), 6.63 (dd, J = 
8.7, 3.1 Hz, 2H), 3.77 (s, 6H), 2.73–2.66 (m, 2H), 2.47 (t, J = 7.3 Hz, 2H), 1.95–1.86 (m, 2H). 
13
C NMR (125 MHz, CDCl3): δ = 210.3, 159.1, 142.1, 133.4, 116.2, 115.0, 113.5, 55.6, 42.0, 
35.6, 24.0. 
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5,5'-dibromo-8,8'-dimethoxy-3,3',4,4'-tetrahydro-2H,2'H-1,1'-spirobi[naphthalene] ((±)-
64)
[179]
 
 
Procedure: 63 (1.9 g, 3.92 mmol, 1.0 equiv.) was added to MsOH (15 mL) at 0 °C. The reaction 
was allowed to warm up overnight. After, the crude reaction mixture was poured onto ice and 
extracted with CH2Cl2. The combined organic layers were dried of Na2SO4 and the solvent was 
removed under reduced pressure. The crude product was purified by FCC (hexanes/CH2Cl2 = 
9/1) giving (±)-64 (1.50 g, 82%) as a white solid. 
1
H NMR (500 MHz, CDCl3): δ = 7.28 (d, J = 8.7 Hz, 2H), 6.47 (dd, J = 8.8, 0.8 Hz, 2H), 3.17 (s, 
6H), 3.07 (ddt, J = 16.9, 4.3, 2.0 Hz, 1H), 2.60 (dddd, J = 16.8, 12.8, 5.5, 0.9 Hz, 2H), 2.10–2.02 
(m, 2H), 1.96 (dtd, J = 13.2, 3.4, 1.8 Hz, 2H), 1.90–1.72 (m, 4H). 
13
C NMR (125 MHz, CDCl3): δ = 156.3, 138.6, 138.3, 129.3, 116.6, 112.2, 55.6, 40.38, 33.8, 
31.6, 19.9. 
 
8,8'-dimethoxy-3,3',4,4'-tetrahydro-2H,2'H-1,1'-spirobi[naphthalene] ((±)-65)
[179]
 
 
Procedure: To a stirred solution of (±)-64 (1.49 g, 3.20 mmol 1.0 equiv.) in anhydrous Et2O (25 
mL) was slowly added n-BuLi (2.3 M in hexane, 7 mL, 16.1 mmol, 5 equiv.) at –78 °C. After 
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stirring the reaction at 0 °C for 2 h it was further warmed to room temperature and stirred for 
further 2 h. Afterwards the reaction mixture was quenched by slow addition of H2O (5 mL) at 0 
°C. The solvent was removed under reduced pressure and the residue was extracted with CH2Cl2. 
The combined organic layers were washed with water and dried over Na2SO4. After removal of 
the solvent, the residue was purified by FCC (SiO2, CH2Cl2/hexanes = 9/1) affording (±)-65 
(900 mg, 91%) as a white solid. 
1
H NMR (500 MHz, CDCl3): δ = 6.98 (t, J = 7.8 Hz, 2H), 6.72 (dq, J = 7.6, 1.0 Hz, 2H), 6.58 
(dt, J = 8.0, 1.1 Hz, 2H), 3.20 (s, 6H), 2.92–2.74 (m, 4H), 2.13–2.05 (m, 2H), 1.98 (dtd, J = 13.3, 
3.3, 2.0 Hz, 2H), 1.80 (tq, J = 11.2, 3.2 Hz, 4H). 
 
3,3',4,4'-tetrahydro-2H,2'H-1,1'-spirobi[naphthalene]-8,8'-diol ((±)-66) 
[179]
 
 
Procedure: To a suspension of NaH (467 mg, 11.7 mmol, 12.0 equiv.) in DMF (8 mL), EtSH 
(0.5 mL, 6.81 mmol, 7.0 equiv.) was added slowly while cooling by an ice bath. (±)-65 (300 mg, 
0.97 mmol, 1.0 equiv.) was added in one portion, and the mixture was stirred at 160 °C for 12 h. 
The reaction was quenched by adding aq. HCl (1 M) at 0 °C, extracted with EtOAc and dried over 
Na2SO4. After removal of the solvent, the residue was purified by FCC (hexanes/CH2Cl2 = 9/1) 
giving (±)-66 (213 mg, 78%) as a white solid. 
1
H NMR (500 MHz, CDCl3): δ = 7.02 (t, J = 7.8 Hz, 2H), 6.71 (dq, J = 7.5, 1.0 Hz, 2H), 6.58 
(dd, J = 8.0, 1.3 Hz, 2H), 4.75 (s, 2H), 2.87–2.81 (m, 4H), 2.13–2.07 (m, 2H), 2.00–1.91 (m, 2H), 
1.81 (ttd, J = 13.8, 5.9, 2.7 Hz, 4H). 
HRMS (ESIpos): m/z calculated for C19H20O2Na [M+Na]
+
: 303.1355; found 303.1353. 
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8,8'-bis(methoxymethoxy)-3,3',4,4'-tetrahydro-2H,2'H-1,1'-spirobi[naphthalene] ((±)-67) 
 
Procedure: To a suspension of NaH (86 mg, 2.15 mmol, 3.0 equiv.) in THF (1.4 mL), (±)-66 
(200 mg, 0.71 mmol, 1.0 equiv.) in THF (0.6 mL) was added at 0 °C. The reaction was stirred at 
0 °C for another 6 h, then chloro(methoxy)methane (0.15 mL, 1.88 mmol, 2.6 equiv.) was added. 
After stirring at room temperature overnight, the reaction was quenched by addition of water and 
diluted with EtOAc. The layers were separated and the aqueous layer was extracted with EtOAc. 
The combined organic layers were dried over Na2SO4, the solvent removed under reduced 
pressure and the crude product was purified by FCC (hexanes/CH2Cl2 = 9/1) to give (±)-67 (221 
mg, 84%) as a white solid. 
1
H NMR (500 MHz, CDCl3): δ = 6.94 (t, J = 7.8 Hz, 2H), 6.79–6.74 (m, 4H), 4.58 (d, J = 6.8 
Hz, 2H), 4.46 (d, J = 6.8 Hz, 2H), 2.95 (s, 6H), 2.90–2.76 (m, 4H), 2.21–2.11 (m, 2H), 2.07–1.98 
(m, 2H), 1.88–1.77 (m, 4H). 
13
C NMR (125 MHz, CDCl3): δ = 154.8, 139.6, 136.1, 125.5, 122.3, 112.8, 94.1, 55.3, 39.5, 
35.1, 31.3, 20.4. 
HRMS (EI): m/z calculated for C23H28O4 [M]
+
: 368.1988; found 368.1986.  
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7.4 Catalytic Asymmetric α-Amination of α-Branched Ketones via Enol 
Catalysis 
7.4.1 Synthesis of Starting Materials 
General procedure for the α-alkylation of cyclic ketones: At –78 °C a solution of the ketone in 
dry THF (30 mL) was added dropwise within 15 min to a stirred solution of LiHMDS (1.0 M in 
THF). The resulting mixture was stirred at –78 °C for 30 min, then MeI (1.3 equiv.) was added 
and stirring was continued for a further 30 min. The reaction mixture was allowed to warm to 
room temperature overnight and quenched by dropwise addition of sat. aq. NH4Cl. The aqueous 
layer was extracted with Et2O; the combined organic extracts were dried over Na2SO4 and 
concentrated under reduced pressure. Purification of the resulting residue by FCC (SiO2, 
pentante/Et2O) affords the targeted α-alkyl ketones. 
 
2-methylcycloheptan-1-one  
 
The general procedure was performed using cyclohepatnone (950 µL, 8.00 mmol) giving the 
desired product (613 mg, 61%) as clear oil. 
1
H NMR (500 MHz, CDCl3): δ = 2.64–2.54 (m, 1H), 2.52–2.43 (m, 2H), 1.91–1.75 (m, 3H), 
1.68–1.55 (m, 1H), 1.48–1.30 (m, 3H), 1.06 (dd, J = 7.0, 1.1 Hz, 3H). 
 
2-methylcyclooctan-1-one  
 
The general procedure was performed using cyclooctanone (1.00 g, 7.92 mmol) giving the 
desired product (426 mg, 38%) as clear oil. 
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1
H NMR (500 MHz, CDCl3): δ = 2.60 (dqd, J = 10.2, 6.8, 3.4 Hz, 1H), 2.47–2.35 (m, 2H), 1.98–
1.84 (m, 2H), 1.78 (ddtd, J = 10.3, 8.6, 6.5, 4.3 Hz, 1H), 1.72–1.36 (m, 6H), 1.27–1.15 (m, 1H), 
1.05 (d, J = 6.8 Hz, 3H). 
 
7.4.2 Characterization of Products 
General Procedure for the direct amination: To a solution of the catalyst 1m (5 mol%) and the 
ketone 68 (0.2 mmol) in acetonitrile (0.1 mL) azodicarboxylate 32c (74.6 mg, 0.24 mmol) was 
added and the resulting mixture was stirred at r.t. for 24h. The crude reaction mixture was 
directly purified by silica-gel column chromatography (CH2Cl2/MTBE = 0%  5%).. 
Dibenzyl (S)-1-(1-methyl-2-oxocyclohexyl)hydrazine-1,2-dicarboxylate (69a) 
 
[α]D
25
: +5.6 (c 1.0, CH2Cl2, 99:1 er.). 
1
H NMR (500 MHz, CDCl3): δ = 7.42–7.01 (m, 10H), 6.82–6.44 (m, 1H), 5.19–4.79 (m, 4H), 
2.74–1.08 (m, 11 H). 
13
C NMR (125 MHz, CDCl3): δ = 209.1, 156.7, 155.8, 135.6, 135.5, 128.6, 128.5, 128.4, 128.3, 
128.1, 70.7, 69.7, 68.6, 68.3, 68.0, 67.8, 39.6, 39.0, 38.3, 29.7, 29.2, 26.5, 21.8, 21.8, 21.0, 19.8. 
HRMS (ESIpos): m/z calculated for C23H26N2NaO5 [M+Na]
+
: 433.1734; found 433.1732. 
HPLC (Chiralcel OJ-3R, MeCN/H2O = 50:50, flowrate: 1.0 ml/min, λ = 220 nm): 
tr(major) = 15.2 min, tr(minor) = 12.2 min. 
 
Diethyl (S)-1-(1-methyl-2-oxocyclohexyl)hydrazine-1,2-dicarboxylate (69b) 
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[α]D
25
: +15.2 (c 1.0, CH2Cl2, 99:1 er). 
1
H NMR (500 MHz, CDCl3): δ = 6.64–6.31 (m, 1H), 4.27–4.08 (m, 4H), 2.85–2.26 (m, 3H), 
2.0–1.13 (m, 14H). 
13
C NMR (125 MHz, CDCl3): δ = 209.4, 156.9, 156.0, 69.5, 62.9, 62.3, 62.2, 39.7, 38.9, 38.3, 
29.7, 29.3, 26.6, 21.9, 21.7, 21.0, 19.8, 14.5, 14.3. 
HRMS (ESIpos): m/z calculated for C13H22N2NaO5 [M+Na]
+
: 309.1421, found 309.1422. 
GC (Hydrodex-γ-TBDAc; G/624, 150°C iso, 0.5 bar H2): tr(major) = 103.3 min, 
tr(minor) = 106.3 min. 
 
Diisopropyl (S)-1-(1-methyl-2-oxocyclohexyl)hydrazine-1,2-dicarboxylate (69c) 
 
[α]D
25
: +21.2 (c 1.0, CH2Cl2, 98:2 er). 
1
H NMR (500 MHz, CDCl3): δ = 6.58–6.17 (m, 1H), 5.07–4.77 (m, 2H), 2.96–2.34 (m, 3H), 
2.08–1.39 (m, 5H), 1.38–1.12 (m, 15H). 
13
C NMR (125 MHz, CDCl3): δ = 209.7, 156.6, 155.5, 70.1, 69.9, 39.8, 38.9, 38.4, 22.0, 21.9, 
21.8, 20.8, 19.8. 
HRMS (ESIpos): m/z calculated for C15H26N2NaO5 [M+Na]
+
: 337.1734, found 337.1734. 
HPLC (Chiralcel OJ-3R, MeCN/H2O = 30:70, flowrate: 0.8 mL/min, λ = 210 nm): tr(major) = 10.3 
min, tr(minor) = 8.9 min. 
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Dibenzyl (S)-1-(2-oxocyclohexyl)hydrazine-1,2-dicarboxylate (69d)
[200]
 
 
[α]D
25
: +18.8 (c 1.0, CH2Cl2, 89:11 er). 
1
H NMR (500 MHz, CDCl3): δ = 7.40–7.20 (m, 10H), 6.95–6.55 (m, 1H), 5.25–5.00 (m, 4H), 
4.98–4.61 (m, 1H), 2.55–2.15 (m, 3H), 2.13–1.47 (m, 5H). 
13
C NMR (125 MHz, CDCl3): δ = 207.7, 156.7, 156.2, 135.8, 135.7, 128.6, 128.5, 128.4, 128.1, 
127.7, 127.5, 68.6, 68.3, 67.7, 67.6, 66.9, 65.8, 65.4, 41.3, 41.1, 30.9, 30.7, 30.5, 29.7, 26.7, 26.6, 
24.3. 
HRMS (ESIpos): m/z calculated for C22H24N2NaO5 [M+Na]
+
: 419.1577, found: 419.1576. 
HPLC (Chiralcel OD-H, nHept/iPrOH = 90/10, flowrate: 1.0 mL/min, λ = 220 nm): 
tr(major) = 16.9 min, tr(minor) = 26.8 min. 
 
Dibenzyl (S)-1-(1-ethyl-2-oxocyclohexyl)hydrazine-1,2-dicarboxylate (69e) 
 
[α]D
25
: +0.4 (c 1.0, CH2Cl2, 98:2 er). 
1
H NMR (500 MHz, CDCl3): δ = 7.39–7.21 (m, 10H), 6.59–6.20 (m, 1H), 5.25–4.95 (m, 4H), 
2.92–2.13 (m, 3H), 2.07–1.32 (m, 7H), 1.09–0.70 (m, 3H). 
13
C NMR (125 MHz, CDCl3): δ = 208.1, 156.9, 156.3, 135.6, 128.8, 128.7, 128.5, 128.4, 72.6, 
68.7, 68.1, 40.4, 39.6, 37.6, 29.2, 27.8, 27.3, 22.1, 21.7, 8.8. 
HRMS (ESIpos): m/z calculated for C24H28N2NaO5 [M+Na]
+
: 447.1890, found: 447.1889. 
HPLC (Chiralcel OJ-3R, MeCN/H2O = 50:50, flowrate: 1.0 mL/min, λ = 220 nm): 
tr(major) = 17.5 min, tr(minor) = 15.7 min. 
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Dibenzyl (S)-1-(2-oxo-1-propylcyclohexyl)hydrazine-1,2-dicarboxylate (69f) 
 
[α]D
25
: +2.8 (c 1.0, CH2Cl2, 98:2 er). 
1
H NMR (500 MHz, CDCl3): δ = 7.41–7.20 (m, 10H), 6.59–6.15 (m, 1H), 5.26–4.97 (m, 4H), 
2.95–2.13 (m, 3H), 2.06–1.35 (m, 8H), 1.21–0.76 (m, 4H). 
13
C NMR (125 MHz, CDCl3): δ = 208.1, 156.7, 156.1, 135.5, 128.6, 128.6, 128.5, 128.4, 128.2, 
73.5, 72.3, 68.5, 67.9, 39.8, 39.3, 37.7, 37.0, 36.5, 29.0, 27.7, 21.9, 21.5, 17.3, 17.1, 14.7, 14.5. 
HRMS (ESIpos): m/z calcd for C25H30N2NaO5 [M+Na]
+
: 461.2047, found: 461.2046. 
HPLC (Chiralpak ID-3, nHept/iPrOH = 90:10, flowrate: 1.0 mL/min, λ = 220 nm): 
tr(major) = 18.1 min, tr(minor) = 31.5 min. 
 
Dibenzyl (R)-1-(1-benzyl-2-oxocyclohexyl)hydrazine-1,2-dicarboxylate (69g) 
 
[α]D
25
: +114.8 (c 1.0, CH2Cl2, 99:1 er). 
1
H NMR (500 MHz, CDCl3): δ = 7.54–6.67 (m, 15H), 5.25–4.69 (m, 5H), 3.46–1.11 (m, 10H). 
13
C NMR (125 MHz, CDCl3): δ = 209.6, 156.0, 137.0, 136.7, 135.6, 130.1, 129.1, 128.9, 128.8, 
128.6, 128.5, 128.2, 128.1, 127.6, 127.3, 127.1, 127.0, 126.8, 72.1, 68.6, 68.3, 67.7, 39.0, 38.5, 
38.1, 38.0, 37.7, 36.9, 30.0, 29.7, 20.3, 20.0. 
HRMS (ESIpos): m/z calculated for C29H30N2NaO5 [M+Na]
+
: 509.2047, found: 509.2045. 
HPLC (Chiralcel OJ-3R, MeCN/H2O = 60:40, flowrate: 1.0 mL/min, λ = 220 nm): 
tr(major) = 8.3 min, tr(minor) = 9.8 min. 
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Dibenzyl (R)-1-(2-oxo-1-phenylcyclohexyl)hydrazine-1,2-dicarboxylate (69h) 
 
[α]D
25
: –44.0 (c 1.0, CH2Cl2, 97:3 er). 
1
H NMR (500 MHz, CDCl3): δ = 7.53–7.06 (m, 15H), 6.24–5.87 (m, 1H), 5.23–4.89 (m, 4H), 
3.10–2.46 (m, 3H), 2.38–2.20 (m, 1H), 2.11–1.41 (m, 4H). 
13
C NMR (125 MHz, CDCl3): δ = 205.6, 156.1, 155.7, 135.6, 135.1, 128.8, 128.7, 128.6, 128.5, 
128.3, 128.2, 128.1, 127.9, 76.4, 68.4, 67.4, 40.7, 27.9, 27.0, 26.5, 22.3. 
HRMS (ESIpos): m/z calculated for C28H28N2NaO5 [M+Na]
+
: 495.1890, found: 495.1892. 
HPLC (Chiralpak IC-3R, MeOH/H2O = 80:20, flowrate: 1.0 mL/min, λ = 220 nm): 
tr(major) = 10.2 min, tr(minor) = 8.4 min. 
 
Diethyl (R)-1-(2-oxo-1-phenylcyclohexyl)hydrazine-1,2-dicarboxylate (69i) 
 
[α]D
25
: –36.4 (c 1.0, CH2Cl2, 97.5:2.5 er). 
1
H NMR (500 MHz, CDCl3): δ = 7.45–7.05 (m, 5H), 6.16–5.84 (m, 1H), 4.30–3.81 (m, 4H), 
2.97–2.37 (m, 3H), 2.33–2.18 (m, 1H), 2.05–1.47 (m, 4H), 1.30–0.90 (m, 6H). 
13
C NMR (125 MHz, CDCl3): δ = 205.8, 205.5, 156.6, 156.3, 155.9, 135.5, 135.1, 128.7, 128.4, 
128.0, 127.8, 76.1, 62.9, 62.4, 62.1, 62.0, 61.8, 40.9, 40.6, 35.2, 34.8, 29.7, 28.0, 26.7, 22.2, 21.8, 
14.4, 14.3, 14.1. 
HRMS (ESIpos): m/z calculated for C18H24N2NaO5 [M+Na]
+
: 371.1577, found: 371.1578. 
HPLC (Chiralcel OD-3, nHept/iPrOH = 95:5, flowrate: 1.0 mL/min, λ = 220 nm): 
tr(major) = 9.1 min, tr(minor) = 7.3 min. 
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Dibenzyl (R)-1-(2-oxo-[1,1'-bi(cyclohexan)]-1-yl)hydrazine-1,2-dicarboxylate (69j) 
 
[α]D
25
: +23.2 (c 1.0, CH2Cl2, 99:1 er). 
1
H NMR (500 MHz, CDCl3): δ = 7.50–7.11 (m, 10H), 6.66–6.18 (m, 1H), 5.29–4.94 (m, 4H), 
3.17–2.44 (m, 1H), 2.42–1.87 (m, 4H), 1.83–0.98 (m, 12H), 0.96–0.78 (m, 2H); 
13
C NMR (125 MHz, CDCl3): δ = 208.1, 156.4, 135.4, 128.7, 128.6, 128.5, 128.4, 128.3, 74.3, 
69.6, 68.8, 68.4, 68.0, 65.3, 43.7, 42.6, 42.2, 40.6, 40.0, 39.4, 34.6, 33.9, 29.6, 29.1, 29.0, 28.2, 
27.2, 26.8, 26.7, 26.4, 26.3, 20.5, 20.3. 
HRMS (ESIpos): m/z calculated for C28H34N2NaO5 [M+Na]
+
: 501.2360, found: 501.2357; 
HPLC (Chiralcel OJ-3R, MeCN/H2O = 60:40, flowrate: 1.0 mL/min, λ = 220 nm): 
tr(major) = 9.7 min, tr(minor) = 8.8 min. 
 
Dibenzyl (S)-1-(1-methyl-2-oxocyclopentyl)hydrazine-1,2-dicarboxylate (69k) 
 
[α]D
25
: +31.6 (c 1.0, CH2Cl2, 95.5:4.5 er). 
1
H NMR (500 MHz, CDCl3): δ = 7.40–7.19 (m, 10H), 6.83–6.45 (m, 1H), 5.24–4.93 (m, 4H), 
2.79–1.52 (m, 6H), 1.30–1.13 (m, 3H). 
13
C NMR (125 MHz, CDCl3): δ = 216.1, 215.6, 156.5, 156.3, 154.8, 154.5, 135.7, 135.6, 128.6, 
128.5, 128.4, 128.3, 128.2, 128.1, 127.8, 68.1, 68.0, 67.8, 34.8, 20.2, 19.9, 18.3. 
HRMS (ESIpos): m/z calculated for C22H24N2NaO5 [M+Na]
+
: 419.1577, found: 419.1575. 
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HPLC (Chiralcel OD-3, nHept/iPrOH = 95:5, flowrate: 1.0 mL/min, λ = 220 nm): 
tr(major) = 17.7 min, tr(minor) = 9.4 min. 
 
Dibenzyl (S)-1-(1-heptyl-2-oxocyclopentyl)hydrazine-1,2-dicarboxylate (69l) 
 
[α]D
25
: –4.4 (c, CH2Cl2, 97:3 er). 
1
H NMR (500 MHz, CDCl3): δ = 7.43–7.08 (m, 10H), 5.28–4.91 (m, 4H), 2.73–1.50 (m, 8H), 
1.40–1.05 (m, 10H), 0.92–0.79 (m, 3H). 
13
C NMR (125 MHz, CDCl3): δ = 215.2, 214.8, 156.7, 156.5, 155.2, 154.9, 135.5, 135.4, 128.6, 
128.5, 128.4, 128.3, 128.3, 128.2, 128.0, 127.9, 70.6, 68.3, 68.1, 67.9, 35.5, 35.3, 34.1, 33.7, 
31.8, 31.6, 30.1, 30.0, 29.7, 29.0, 23.4, 22.6, 18.2, 14.1. 
HRMS (ESIpos): m/z calculated for C28H36N2NaO5 [M+Na]
+
: 503.2516, found: 503.2515. 
HPLC (Chiralpak ID-3, nHept/iPrOH = 80:20, flowrate: 1.0 ml/min, λ = 220 nm): 
tr(major) = 6.1 min, tr(minor) = 8.4 min. 
 
Dibenzyl (S)-1-(1-methyl-2-oxocycloheptyl)hydrazine-1,2-dicarboxylate (69m) 
 
[α]D
25
: +7.2 (c 1.0, CH2Cl2, 77:23 er). 
1
H NMR (500 MHz, CDCl3): δ = 7.42–7.14 (m, 10H), 6.88–6.59 (m, 1H), 5.25–4.93 (m, 4H), 
3.20–0.78 (m, 13). 
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13
C NMR (125 MHz, CDCl3): δ = 210.3, 156.8, 156.5, 155.4, 135.5, 128.6, 128.6, 128.5, 128.5, 
128.3, 128.3, 128.1, 128.1, 72.3, 71.2, 68.3, 67.9, 53.5, 40.4, 38.0, 37.1, 35.7, 30.3, 28.3, 24.7, 
24.0, 23.9, 23.6, 21.6, 21.2. 
HRMS (ESIpos): m/z calculated for C24H28N2NaO5 [M+Na]
+
: 447.1890, found: 447.1888. 
HPLC (Chiralcel OD-3, MeCN-H2O = 50:50, flowrate: 0.9 mL/min, λ = 220 nm): 
tr(major) = 15.1 min, tr(minor) = 12.6 min. 
 
Dibenzyl (S)-1-(1-methyl-2-oxocyclooctyl)hydrazine-1,2-dicarboxylate (69n) 
 
[α]D
25
: +5.4 (c 1.0, CH2Cl2, 60:40 er). 
1
H NMR (500 MHz, CDCl3): δ = 7.54–7.06 (m, 10H), 7.02–6.598(m, 1H), 5.29–4.89 (m, 4H), 
3.62–2.62 (m, 1H), 2.43–0.83 (m, 14). 
13
C NMR (125 MHz, CDCl3): δ = 212.0, 211.6, 211.3, 157.1, 156.7, 155.8, 135.7, 135.7, 135.6, 
128.8, 128.7, 128.7, 128.7, 128.6, 128.5, 128.4, 128.3, 128.2, 71.8, 71.1, 69.7, 68.5, 68.2, 68.0, 
36.5, 35.9, 35.8, 35.6, 35.2, 27.4, 27.1, 26.5, 25.8, 25.5, 22.6, 21.3, 21.1, 20.3, 18.5. 
HRMS (ESIpos): m/z calculated for C25H30N2NaO5 [M+Na]
+
: 461.2047, found: 461.2045. 
HPLC (Chiralcel OD-H, nHept/iPrOH = 90:10, flowrate: 1.0 mL/min, λ = 220 nm): 
tr(major) = 19.6 min, tr(minor) = 15.4 min. 
 
Dibenzyl (S)-1-(2-methyl-1-oxo-2,3-dihydro-1H-inden-2-yl)hydrazine-1,2-dicarboxylate 
(69o) 
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[α]D
25
: +2.8 (c 1.0, CH2Cl2, 60:40 er). 
1
H NMR (500 MHz, CDCl3): δ = 7.91–7.06 (m, 14H), 6.98–6.64 (m, 1H), 5.26–4.88 (m, 4H), 
3.92–3.31 (m, 1H), 3.23–2.76 (m, 1H), 1.38–1.20 (m, 3H). 
13
C NMR (125 MHz, CDCl3): δ = 208.3, 156.8, 154.9, 150.7, 150.2, 135.6, 135.2, 133.4, 128.7, 
128.6, 128.5, 128.4, 128.3, 128.1, 128.0, 127.8, 127.6, 127.3, 126.5, 124.8, 68.3, 67.9, 41.5, 22.6. 
HRMS (ESIpos): m/z calculated for C26H24N2NaO5 [M+Na]
+
: 467.1577, found: 467.1576. 
HPLC (Chiralcel OD-3, nHept/iPrOH = 90:10, flowrate: 1.0 ml/min, λ = 220 nm): 
tr(major) = 7.8 min, tr(minor) = 5.6 min. 
 
Dibenzyl (S)-1-(2-methyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)hydrazine-1,2-
dicarboxylate (69p) 
 
[α]D
25
: +4.4 (c 1.0, CH2Cl2, 66.5:33.5 er). 
1
H NMR (500 MHz, CDCl3): δ = 8.20–6.43 (m, 15H), 5.24–4.93 (m, 4H), 3.21–0.62 (m, 7H). 
13
C NMR (125 MHz, CDCl3): δ = 196.3, 157.0, 156.5, 154.9, 142.4, 135.7, 135.5, 133.7, 131.2, 
128.7, 128.6, 128.5, 128.4, 128.3, 128.1, 128.0, 127.7, 126.9, 68.1, 67.9, 67.8, 67.2, 33.2, 29.7, 
26.8, 20.1. 
HRMS (ESIpos): m/z calculated for C28H34N2NaO5 [M+Na]
+
: 481.1734, found: 481.1736; 
HPLC (Chiralcel OD-3, nHept/iPrOH = 95:5, flowrate: 1.0 mL/min, λ = 220 nm): 
tr(major) = 13.1 min, tr(minor) = 15.9 min. 
 
 
 
7 Experimental Section 
 
 
157 
 
 
Ethyl (R)-(2-oxo-1-phenylcyclohexyl)carbamate (71) 
 
A mixture of 69r (66.5 mg, 0.19 mmol, 1.0 equiv) and Cs2CO3 (373.1 mg, 1.15 mmol, 6.0 equiv) 
in a flame dried Schlenk-flask was evacuated for 30 min and subsequently put under an 
atmosphere of argon. MeCN (1.9 mL) and Ethylbromacetate (63.5µL, 0.57 mmol, 3.0 equiv) 
were added and the resulting mixture was stirred for 22h at 70°C. The reaction was quenched 
with sat. aq. NH4Cl and extracted with EtOAc (3 x 10 mL). The combined organic layers were 
dried over Na2SO4 and concentrated in vacuo. The crude product was purified by silica-gel 
column chromatography (Hex/EtOAc = 10/1) to give 71 (17.8 mg, 35%) as a clear oil. 
1
H NMR (500 MHz, CDCl3): δ = 7.46–7-20 (m, 5H), 6.69–6.48 (sbr, 1H), 4.04–3.83 (m, 2H), 
3.76–3.39 (m, 1H), 2.43–2.22 (m, 2H), 2.06–1.67 (m, 5H), 1.20–0.90 (m, 3H). 
13
C NMR (125 MHz, CDCl3): δ = 208.1, 154.4, 137.6, 128.9, 128.1, 127.6, 66.5, 60.4, 38.7, 
36.0, 28.4, 22.6, 14.6. 
HRMS (ESIpos): m/z calculated for C15H19N1NaO3 [M+Na]
+
: 284.1257, found: 284.1255. 
HPLC (Chiralcel OD-3, nHept/iPrOH = 98:2, flowrate: 1.0 mL/min, λ = 220 nm): 
tr(major) = 7.4 min, tr(minor) = 8.6 min. 
 
Benzyl (2-oxo-1-phenylcyclohexyl)carbamate (70) 
 
1
H NMR (500 MHz, CDCl3): 7.48–7.18 (m, 10H), 6.74 (s, 1H), 5.02 (d, J = 12.3 Hz, 1H), 4.87 
(d, J = 12.4 Hz, 1H), 3.75 (dq, J = 14.3, 3.6 Hz, 1H), 2.51–2.26 (m, 2H), 2.02 (ddq, J = 12.0, 5.6, 
2.7 Hz, 1H), 1.97–1.82 (m, 3H), 1.75 (ddd, J = 17.7, 10.8, 6.6 Hz, 1H). 
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7.4 The Direct α-Hydroxylation of Cyclic α-Branched Ketones via Enol 
Catalysis 
7.4.1 General Procedures 
General procedure (A) for oxidative cleavage of α-branched ketones: In a headspace GC-vial 
ketone (0.25 mmol, 1.0 equiv.) and TPP (1.5 mg, 1 mol%) were dissolved in MeCN (0.5 mL). 
TFA (58 µL, 0.75 mmol, 3.0 equiv.) was added and the dark green mixture was purged with O2 
for 30 sec. The headspace vial was closed and a balloon of O2 was connected. After irradiating in 
the setup depicted Figure 4.2 for 16 h the crude reaction mixture was diluted with CH2Cl2 and 
extracted with sat. Na2CO3. Aq. HCl (1 M) was carefully added to the aqueous layer until pH = 1 
was reached and then extracted with CH2Cl2 (3x). The organic layers were combined and all 
volatiles were removed under reduced pressure giving the targeted products as clear oils. 
 
General procedure (B) for the direct non-enantioselective hydroxylation of α-branched 
ketones: In a GC vial the ketone (0.25 mmol, 1.0 equiv.) was dissolved in a solution of 
trichloroacetic acid (0.75 mmol, 3.0 equiv.) in dry PhMe (2.5 mL) and nitrosobenzene (0.625 
mmol, 2.5 equiv.) was added. The vial was closed and the resulting mixture was stirred at room 
temperature for 16‒24h. The crude reaction mixture was directly purified by flash column 
chromatography (SiO2, hexanes/EtOAc = 100/0 then 10/1). 
Note: Scale up experiments showed, that the removal of trichloracetic acid required additional 
work up after purification by column chromatography: A solution of the substrate in CH2Cl2 was 
washed with sat. aq. NaHCO3 solution, dried over Na2SO4 and the solvent removed under 
reduced pressure. However in reactions on 0.25 mmol scale this was not necessary.  
Note: In some cases traces of azoxybenzene, which turned out to be difficult to remove by 
column chromatography, can be visible in the NMR-spectra.  
 
General procedure (C) for the direct enantioselective hydroxylation of α-branched ketones: 
6b (16.4 mg, 0.02 mmol, 10 mol%) and the corresponding ketone (0.2 mmol, 1.0 equiv.) were 
placed in a plastic GC vial. After the addition of benzene (0.8 mL) and acetic acid (40 µL, 0.7 
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mmol, 3.5 equiv.), nitrosobenzene (21.4 mg, 0.2 mmol, 1.0 equiv.) was added in one portion and 
the reaction mixture was stirred for 2 h. Then, additional nitrosobenzene (32.1 mg, 0.3 mmol, 1.5 
equiv.) was added and stirring was continued for additional 22 h or 46 h. The crude reaction 
mixture was directly purified by flash column chromatography (hexanes/EtOAc gradient 100/0 to 
10/1). 
7.4.2 Characterization of Products  
(6R,6'S)-6,6'-bis(perfluoronaphthalen-2-yl)-2,2',3,3'-tetrahydro-1,1'-spirobi[indene]-7,7'-
diol (86) 
 
General Procedure: In a flame-dried Schlenk, MOM protected SPINOL (1 equiv.) was 
dissolved in dry THF (0.15 M) and the mixture was cooled down to ‒78 °C. n-BuLi (2.5 M in 
hexanes, 4.0 equiv.) was added dropwise and the reaction mixture was stirred at 0 °C for 4 h. 
After cooling to ‒78 °C, the appropriate fluorinated arene (6 equiv) in THF (0.3 M) was added 
dropwise. After 2 h of stirring at ‒78 °C, the initally milky brown solution turned red/purple and 
was stirred overnight at r.t.. After quenching with sat. aq. NH4Cl solution, additional CH2Cl2 was 
added, the phases were separated and the aqueous layer was extracted with CH2Cl2 three times. 
The combined organic layers were then washed with brine and dried over Na2SO4. After 
filtration, the solvents were evaporated under reduced pressure and the resulting crude product 
was directly redissolved in a 0.1 M solution of a 1:1 mixture of THF/methanolic HCl (1.25 M, 10 
eq). In case of solubility issues, more THF was added until a homogeneous solution was 
observed. The reaction mixture was then refluxed for 2‒12 h until TLC analysis showed full 
conversion of the starting material. The solvents were removed under reduced pressure and the 
crude product was purified by FCC (hexanes/Et2O or hexanes/CH2Cl2). 
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The title compound was prepared according to the general procedure on 200 mg (0.58 mmol) of 
(R)-MOM-protected 2,2',3,3'-tetrahydro-1,1'-spirobi[indene]-7,7'-diol (MOM-SPINOL) and 
960 mg (3.5 mmol) of octafluoronapthalene. Purification by FCC (hexanes/EtOAc as eluent). 
Despite extensive attempts, scaling-up of this reaction (>200mg scale) afforded strongly 
diminished yields. 
Appearance: yellowish solid; 224 mg (50%). 
The NMR spectra are complicated by the presence of three rotamers.  
1
H NMR (500 MHz, CDCl3): δ = 7.28‒7.22 (m, 2H), 7.05 (d, J = 7.7 Hz, 2H), 4.88‒4.83 (m, 
2H), 3.24‒3.06 (m, 4H), 2.55‒2.44 (m, 2H), 2.38‒2.27 (m, 2H).  
13
C NMR ({
1
H}, {
19
F}, 125 MHz, CDCl3): δ = 151.0, 149.8, 149.8, 148.2, 148.2, 148.2, 148.1, 
146.1, 146.0, 141.8, 141.7, 141.3, 140.7, 139.8, 139.7, 138.7, 138.7, 132.8, 132.8, 130.5, 130.5, 
130.4, 130.4, 118.2, 118.2, 116.0, 115.9, 115.8, 115.7, 113.5, 113.5, 111.3, 111.2, 108.1, 108.1, 
108.0, 77.4, 77.4, 77.2, 76.9, 58.1, 58.1, 37.7, 37.7, 37.7, 31.5. 
19
F NMR (283 MHz, CDCl3): δ = ‒117.2 - ‒117.7 (m), ‒118.2 - ‒118.8 (m), ‒133.9 - ‒134.2 
(m), ‒134.72 - ‒134.9 (m), ‒143.6 - ‒144.1 (m), ‒144.1 - ‒144.4 (m), ‒146.0 - ‒146.7 (m), ‒
148.9 - ‒149.9 (m), ‒153.7 - ‒154.1 (m), ‒155.9 - ‒156.4 (m). 
HRMS (ESIneg) m/z calculated for C37H13O2F14 [M‒H]
‒
: 755.0698, found: 755.0700. 
 
(1R,5aR,10S)-12-hydroxy-1,10-bis(perfluoronaphthalen-2-yl)-4,5,6,7-
tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocine 12-oxide (6b) 
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General Procedure: In a flame-dried Schlenk, the appropriate 3,3’-substituted SPINOL (1 
equiv) was dissolved in dry pyridine (0.2 M) under argon atmosphere. POCl3 (3 equiv) was added 
dropwise at 0 °C and the reaction was stirred at 70 °C for 2‒12 h. When TLC showed full 
conversion of the starting material, the mixture was cooled to 0 °C and water was added (~ same 
amount as pyridine). Then the reaction was stirred at 90 °C for additional 2‒4 h. When TLC 
showed full conversion of the intermediate chloride, the reaction mixture was cooled to r.t. and 
CH2Cl2 was added. The layers were separated and the organic layer was washed with aq. HCl (1 
M), dried over Na2SO4, filtered and the solvents removed under reduced pressure. The crude 
product was purified by FCC (CH2Cl2/MeOH or CH2Cl2/acetone). The isolated compound was 
dissolved in CH2Cl2 and stirred with the same amount of aq. HCl (6 M) for 2 h. Separation of the 
layers and evaporation of the solvent under reduced pressure afforded the desired phosporic acid 
catalyst 
The title compound was prepared with 140 mg (0.18 mmol) of S9 according to the general 
procedure for phosphoric acid synthesis. Purification by FCC (CH2Cl2/MeOH as eluent). 
Appearance: yellowish solid; 128 mg (85%). 
The NMR spectra are complicated by the presence of three rotamers. Rapid interconversion was 
detected in CDCl3, however using DMSO-D6 interconversion was slow and all three structures 
could be fully assigned by H,F-HOESY experiments. 
[α]D
25
: +115.0 (c 0.20, CHCl3). 
1
H NMR (500 MHz, DMSO-d6): δ = 7.44‒7.40 (m, 4H), 3.29‒3.18 (m, 2H), 3.01‒2.89 (m, 2H), 
2.47‒2.39 (m, 2H), 2.07‒1.92 (m, 2H).  
13
C NMR ({1H}, {19F}, 125 MHz, DMSO-d6): δ = 149.9, 148.6, 148.2, 148.1, 148.1, 148.0, 
146.1, 145.1, 144.7, 144.7, 144.6, 144.6, 144.6, 141.0, 140.8, 140.4, 140.4, 140.4, 140.3, 140.3, 
140.2, 140.2, 139.8, 139.1, 139.0, 138.1, 138.1, 138.0, 130.7, 130.5, 121.8, 121.8, 121.7, 121.6, 
119.8, 119.8, 119.7, 119.7, 116.5, 116.5, 116.4, 116.4, 110.0, 110.0, 107.5, 106.5, 79.2, 79.0, 
78.7, 59.2, 59.2, 59.1, 38.6, 38.6, 38.5, 38.5, 30.1. 
31
P NMR (202 MHz, DMSO-d6): δ = ‒12.5, ‒12.6, ‒12.7. 
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19
F NMR (283 MHz, DMSO-d6): δ = ‒117.9 - ‒118.8 (m), ‒113.51 - ‒135.1 (m), ‒145.1 - ‒146.0 
(m), ‒147.6 - ‒148.2 (m), ‒151.4 - ‒152.8 (m), ‒153.6 - ‒154.1 (m), ‒156.2 - ‒156.9 (m). 
HRMS (ESIneg) m/z calculated for C37H12O4F14P [M‒H]
‒
: 817.0255, found: 817.0261. 
 
(S)-2-hydroxy-2-phenylcyclohexan-1-one (77a)
[118a]
 
 
Appearance: orange oil; 28.7 mg (60%) [Procedure B]; orange oil; 21.5 mg (56%) [Procedure 
C]. 
[α]D
25
: +166.0 (c 0.20, CHCl3, 98:2 er). 
1
H NMR (500 MHz, C6D6): δ = 7.18‒7.12 (m, 2H), 7.11‒7.01 (m, 3H), 4.61 (s, 1H), 2.73 (dq, J 
= 14.3, 3.2 Hz, 1H), 2.19 (dddd, J = 13.5, 4.1, 2.7, 1.6 Hz, 1H), 1.95 (td, J = 13.5, 6.3 Hz, 1H), 
1.69‒1.61 (m, 1H), 1.34 (ddt, J = 12.5, 6.3, 3.1 Hz, 1H), 1.29‒1.07 (m, 3H). 
13
C NMR (125 MHz, C6D6): δ = 211.9, 141.2, 129.1, 126.8, 80.1, 39.2, 38.8, 28.2, 23.1 (One 
aromatic signal missing due to overlap with solvent). 
HRMS (ESIpos): m/z calculated for C12H14O2Na [M+Na]
+
: 213.0886; found 213.0885. 
HPLC (Chiralpak AD-3, nHept/EtOH = 80:20, flowrate: 1.0 ml/min, λ = 206 nm): 
tr(major) = 6.88 min, tr(minor) = 9.73 min. 
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X-Ray data for 77a: 
 
Table 1.  Crystal data and structure refinement. 
Identification code  10854 
Empirical formula  C12 H14 O2 
Color  colorless 
Formula weight  190.23  g · mol-1  
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  ORTHORHOMBIC 
Space group  P212121,  (no. 19)  
Unit cell dimensions a = 6.3053(3) Å = 90°. 
 b = 10.5157(6) Å = 90°. 
 c = 14.6033(8) Å  = 90°. 
Volume 968.27(9) Å3 
Z 4 
Density (calculated) 1.305  Mg · m-3 
C6
O1
C8
C5C9
C1
C7
C4
C2
C10
O2
C12
C3
C11
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Absorption coefficient 0.701 mm-1 
F(000) 408 e 
Crystal size 0.304 x 0.113 x 0.070 mm3 
 range for data collection 5.183 to 71.909°. 
Index ranges -7  h  7, -12 k  12, -15  l  17 
Reflections collected 31568 
Independent reflections 1875 [Rint = 0.0420] 
Reflections with I>2(I) 1797 
Completeness to  = 67.679° 99.0 %  
Absorption correction Gaussian 
Max. and min. transmission 0.96 and 0.90 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1875 / 0 / 183 
Goodness-of-fit on F2 1.084 
Final R indices [I>2(I)] R1 = 0.0297 wR
2 = 0.0730 
R indices (all data) R1 = 0.0338 wR
2 = 0.0756 
Absolute structure parameter 0.01(6) 
Largest diff. peak and hole 0.2 and -0.2 e · Å-3 
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Table 2.   Bond lengths [Å] and angles [°]. 
______________________________________________________________________  
O(1)-H(1) 0.90(3)  O(1)-C(1) 1.422(2) 
O(2)-C(2) 1.220(2)  C(1)-C(2) 1.534(2) 
C(1)-C(6) 1.544(3)  C(1)-C(7) 1.530(2) 
C(2)-C(3) 1.509(3)  C(3)-H(3A) 1.03(3) 
C(3)-H(3B) 1.01(2)  C(3)-C(4) 1.542(3) 
C(4)-H(4A) 0.98(2)  C(4)-H(4B) 1.00(2) 
C(4)-C(5) 1.522(3)  C(5)-H(5A) 1.00(2) 
C(5)-H(5B) 0.99(2)  C(5)-C(6) 1.528(3) 
C(6)-H(6A) 0.99(2)  C(6)-H(6B) 0.98(2) 
C(7)-C(8) 1.396(3)  C(7)-C(12) 1.394(3) 
C(8)-H(8) 0.99(2)  C(8)-C(9) 1.389(3) 
C(9)-H(9) 0.97(3)  C(9)-C(10) 1.391(3) 
C(10)-H(10) 0.95(3)  C(10)-C(11) 1.386(3) 
C(11)-H(11) 0.98(3)  C(11)-C(12) 1.395(3) 
C(12)-H(12) 0.96(2)  
 
C(1)-O(1)-H(1) 108.5(17)  O(1)-C(1)-C(2) 111.18(14) 
O(1)-C(1)-C(6) 110.65(14)  O(1)-C(1)-C(7) 105.87(14) 
C(2)-C(1)-C(6) 104.93(14)  C(7)-C(1)-C(2) 111.15(14) 
C(7)-C(1)-C(6) 113.18(14)  O(2)-C(2)-C(1) 120.18(17) 
O(2)-C(2)-C(3) 123.11(18)  C(3)-C(2)-C(1) 116.50(16) 
C(2)-C(3)-H(3A) 108.0(14)  C(2)-C(3)-H(3B) 108.2(14) 
C(2)-C(3)-C(4) 110.99(17)  H(3A)-C(3)-H(3B) 109.5(19) 
C(4)-C(3)-H(3A) 111.6(14)  C(4)-C(3)-H(3B) 108.5(14) 
C(3)-C(4)-H(4A) 109.6(14)  C(3)-C(4)-H(4B) 109.3(13) 
H(4A)-C(4)-H(4B) 104.7(19)  C(5)-C(4)-C(3) 111.39(16) 
C(5)-C(4)-H(4A) 111.1(14)  C(5)-C(4)-H(4B) 110.4(14) 
C(4)-C(5)-H(5A) 111.2(13)  C(4)-C(5)-H(5B) 111.1(14) 
C(4)-C(5)-C(6) 110.17(16)  H(5A)-C(5)-H(5B) 106.4(18) 
C(6)-C(5)-H(5A) 109.0(13)  C(6)-C(5)-H(5B) 108.8(14) 
C(1)-C(6)-H(6A) 109.0(14)  C(1)-C(6)-H(6B) 105.9(14) 
C(5)-C(6)-C(1) 112.62(15)  C(5)-C(6)-H(6A) 111.4(14) 
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C(5)-C(6)-H(6B) 110.4(14)  H(6A)-C(6)-H(6B) 107.2(19) 
C(8)-C(7)-C(1) 120.55(16)  C(12)-C(7)-C(1) 121.06(16) 
C(12)-C(7)-C(8) 118.27(17)  C(7)-C(8)-H(8) 119.4(13) 
C(9)-C(8)-C(7) 120.98(18)  C(9)-C(8)-H(8) 119.6(13) 
C(8)-C(9)-H(9) 117.9(15)  C(8)-C(9)-C(10) 120.15(19) 
C(10)-C(9)-H(9) 121.9(15)  C(9)-C(10)-H(10) 121.6(15) 
C(11)-C(10)-C(9) 119.64(19)  C(11)-C(10)-H(10) 118.8(16) 
C(10)-C(11)-H(11) 121.1(15)  C(10)-C(11)-C(12) 119.96(19) 
C(12)-C(11)-H(11) 118.9(15)  C(7)-C(12)-C(11) 121.01(18) 
C(7)-C(12)-H(12) 119.5(13)  C(11)-C(12)-H(12) 119.4(13)  
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(S)-2-hydroxy-2-(naphthalen-1-yl)cyclohexan-1-one (77b) 
 
Appearance: orange oil; 36.2 mg (60%) [Procedure B]; orange oil; 18.5 mg (38%) [Procedure 
C]. 
[α]D
25
: +54.7 (c 0.15, CHCl3, 91:9 e.). 
1
H NMR (500 MHz, C6D6): δ = 8.34 (d, J = 8.6 Hz, 1H), 7.65‒7.57 (m, 2H), 7.43 (d, J = 7.1 Hz, 
1H), 7.30‒7.01 (m, 3H), 4.62 (s, 1H), 2.98 (dq, J = 14.2, 3.2 Hz, 1H), 2.14 (dtd, J = 11.9, 3.8, 1.7 
Hz, 1H), 1.82‒1.72 (m, 1H), 1.58 (ddd, J = 14.2, 13.2, 4.0 Hz, 1H), 1.49‒1.17 (m, 4H). 
13
C NMR (125 MHz, C6D6): δ = 215.0, 135.5, 135.3, 132.7, 129.7, 129.3, 126.8, 126.0, 125.8, 
125.7, 125.0, 82.0, 43.6, 39.2, 29.9, 23.5. 
HRMS (EI): m/z calculated for C16H16O2 [M]
+
: 240.1145; found 240.1143. 
HPLC (Chiralpak AD-3, nHept/EtOH = 80:20, flowrate: 1.0 ml/min, λ = 224 nm): 
tr(minor) = 5.81 min, tr(major) = 6.64 min. 
 
(S)-2-hydroxy-2-(naphthalen-2-yl)cyclohexan-1-one (77c) 
 
Appearance: orange oil; 34.7 mg (58%) [Procedure B]; orange oil; 27.9 mg (58%) [Procedure 
C]. 
[α]D
25
: +161.8 (c 0.11, CHCl3, 97.5:2.5 er). 
1
H NMR (500 MHz, C6D6): δ = 7.70 (d, J = 1.8 Hz, 1H), 7.63‒7.49 (m, 3H), 7.30 (dd, J = 8.6, 
1.8 Hz, 1H), 7.28‒7.18 (m, 2H), 4.69 (s, 1H), 2.89 (dq, J = 14.3, 3.2 Hz, 1H), 2.39‒2.14 (m, 1H), 
1.99 (td, J = 13.5, 6.1 Hz, 1H), 1.88‒1.60 (m, 1H), 1.50‒1.08 (m, 4H). 
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13
C NMR (125 MHz, C6D6): δ = 212.0, 138.6, 133.9, 133.4, 129.2, 128.6, 126.7, 126.5, 125.9, 
124.9, 80.3, 39.4, 38.9, 28.3, 23.2 
HRMS (ESIpos): m/z calculated for C16H16O2Na [M+Na]
+
: 263.1042; found 263.1042. 
HPLC (Chiralpak AD-3, nHept/EtOH = 80:20, flowrate: 1.0 ml/min, λ = 206 nm): 
tr(minor) = 10.22 min, tr(major) = 14.01 min. 
 
(S)-2-(benzo[d][1,3]dioxol-5-yl)-2-hydroxycyclohexan-1-one (77d) 
 
Appearance: orange oil; 23.4 mg (40%) [Procedure B]; orange solid; 25.0 mg (53%) [Procedure 
C]. 
[α]D
25
: +154.7 (c 0.15, CHCl3, 97:3 er). 
1
H NMR (500 MHz, CDCl3): δ = 6.83‒6.74 (m, 3H), 5.99‒5.95 (m, 2H), 4.43 (s, 1H), 2.94‒2.87 
(m, 1H), 2.55‒2.42 (m, 2H), 2.09‒2.02 (m, 1H), 1.89‒1.65 (m, 4H). 
13
C NMR (125 MHz, C6D6): δ = 212.7, 148.6, 147.7, 134.1, 120.2, 108.8, 107.1, 101.5, 79.9, 
39.2, 38.9, 28.5, 23.2. 
HRMS(EI): m/z calculated for C13H14O4 [M]
 ∙+
: 234.0887; found 234.0886. 
HPLC (Chiralpak AD-3, nHept/EtOH = 80:20, flowrate: 1.0 ml/min, λ = 205 nm): 
tr(major) = 23.38 min, tr(minor) = 25.60 min. 
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(S)-2-hydroxy-2-(p-tolyl)cyclohexan-1-one (77e) 
 
Appearance: orange oil; 29.9 mg (59%) [Procedure B]; orange oil; 22.0 mg (54%) [Procedure 
C]. 
[α]D
25
: +127.3 (c 0.11, CHCl3, 97.5:2.5 er). 
1
H NMR (500 MHz, C6D6): δ = 7.12‒7.08 (m, 2H), 6.95‒6.91 (m, 2H), 4.62 (s, 1H), 2.77 (dq, 
J = 14.2, 3.2 Hz, 1H), 2.25‒2.19 (m, 1H), 2.09‒1.98 (m, 4H), 1.71‒1.62 (m, 1H), 1.41‒1.13 (m, 
4H). 
13
C NMR (125 MHz, C6D6): δ = 212.1, 138.4, 137.7, 129.8, 126.8, 79.9, 39.3, 38.8, 28.3, 23.2, 
21.0. 
HRMS (ESIpos): m/z calculated for C13H16O2Na [M+Na]
+
: 227.1042; found 227.1042. 
HPLC (Chiralpak AD-3, nHept/EtOH = 80:20, flowrate: 1.0 ml/min, λ = 204 nm): 
tr(major) = 7.92 min, tr(minor) = 10.90 min. 
 
(S)-2-hydroxy-2-(4-(trifluoromethyl)phenyl)cyclohexan-1-one (77f) 
 
Appearance: orange oil; 36.6 mg (56%) [Procedure B]; orange solid; 15.2 mg (29%) [Procedure 
C]. 
1
H NMR (500 MHz, C6D6): δ = 7.28 (d, J = 8.2 Hz, 2H), 6.96 (d, J = 8.2 Hz, 2H), 4.46 (sbr, 1H), 
2.55‒2.49 (m, 1H), 2.19‒2.12 (m, 1H), 1.77‒1.66 (m, 1H), 1.60‒1.52 (m, 1H), 1.37‒1.29 (m, 
1H), 1.22‒0.98 (m, 3H). 
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13
C NMR (125 MHz, C6D6): δ = 210.6, 144.6, 126.9, 125.6 (q, J = 3.8 Hz), 79.2, 38.8, 38.3, 
27.7, 22.4 (Signals not visible due to overlap with solvent). 
19
F NMR (283 MHz, C6D6): δ = ‒62.4. 
HRMS (ESIpos): m/z calculated for C12H14O2Na [M+Na]
+
: 213.0886; found 213.0885. 
HPLC (Chiralpak AD-3, nHept/EtOH = 80:20, flowrate: 1.0 ml/min, λ = 206 nm): 
tr(major) = 4.43 min, tr(minor) = 7.05 min. 
 
2-([1,1'-biphenyl]-4-yl)-2-hydroxycyclohexan-1-one (77h) 
 
Appearance: orange oil; 31.0 mg (47%) [Procedure B]. 
1
H NMR (500 MHz, CDCl3):  = 7.64–7.55 (m, 4H), 7.48–7.42 (m, 2H), 7.40–7.33 (m, 3H), 
4.53 (sbr, 1H), 3.08–2.98 (m, 1H), 2.61–2.44 (m, 2H), 2.13–2.05 (m, 1H), 1.95–1.69 (m, 4H). 
13
C NMR (125 MHz, CDCl3):  = 212.8, 141.4, 140.5, 139.1, 129.0, 128.0, 127.7, 127.2, 127.0, 
80.0, 39.1, 39.0, 28.5, 23.3. 
HRMS (EI): m/z calculated for C18H18O2 [M]
+
 266.1301; found 266.1302. 
 
2-(4-chlorophenyl)-2-hydroxycyclohexan-1-one (77i) 
 
Appearance: orange oil; 29.1 mg (52%) [Procedure B]. 
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1
H NMR (500 MHz, CDCl3):  = 7.39–7.35 (m, 2H), 7.27–7.22 (m, 2H), 4.84 (sbr, 1H), 3.00–
2.92 (m, 1H), 2.59–2.51 (m, 1H), 2.45–2.34 (m, 1H), 2.11–2.02 (m, 1H), 1.92–1.82 (m, 2H), 
1.79–1.65 (m, 2H). 
13
C-NMR (125 MHz, CDCl3):  = 212.4, 138.2, 134.6, 129.5, 128.1, 79.9, 39.0, 38.9, 28.4, 23.1. 
HRMS (EI): m/z calculated for C12H13O2Cl [M]
+
 224.0599; found 224.0596. 
 
2-(4-bromophenyl)-2-hydroxycyclohexan-1-one (77j) 
 
Appearance: orange oil; 30.2 mg (45%) [Procedure B]. 
1
H NMR (500 MHz, CDCl3):  = 7.54–7.50 (m, 2H), 7.21–7.15 (m, 2H), 5.59 (sbr, 1H), 2.98–
2.90 (m, 1H), 2.59–2.51 (m, 1H), 2.44–2.33 (m, 1H), 2.12–2.02 (m, 1H), 1.92–1.92 (m, 2H), 
1.81–1.65 (m, 2H). 
13
C NMR (125 MHz, CDCl3):  = 212.3, 138.8, 132.5, 128.4, 122.8, 122.8, 79.9, 38.9, 28.4, 
23.1. 
HRMS (EI): m/z calculated for C12H13O2Br [M]
+
 268.0094; found 268.0091. 
 
2-(4-fluorophenyl)-2-hydroxycyclohexan-1-one (77k) 
 
Appearance: orange oil; 21.6 mg (41%) [Procedure B]. 
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1
H NMR (500 MHz, CDCl3):  = 7.32–7.26 (m, 2H), 7.11–7.04 (m, 2H), 4.28 (sbr, 1H), 3.00–
2.91 (m, 1H), 2.58–2.50 (m, 1H), 2.46–2.34 (m, 1H), 2.13–2.01 (m, 1H), 1.93–1.81 (m, 2H), 
1.80–1.66 (m, 2H). 
13
C NMR (125 MHz, CDCl3):  = 212.5, 162.6 (d, J = 247.9 Hz), 135.9, 128.5 (d, J = 8.2 Hz), 
116.2 (d, J = 21.4 Hz), 79.7, 39.2, 38.9, 28.5, 23.2. 
19
F NMR (283 MHz, CDCl3):  = ‒113.4. 
HRMS (ESIpos): m/z calculated for C12H13O2FNa [M+Na]
+
 231.0792; found 231.0793. 
 
(S)-2-hydroxy-2-(3-methoxyphenyl)cyclohexan-1-one (77l) 
 
Appearance: orange oil; 29.7 mg (54%) [Procedure B]; orange oil; 21.5 mg (49%) [Procedure 
C]. 
[α]D
25
: +124.3 (c 0.14, CHCl3, 97:3 er). 
1
H NMR (500 MHz, C6D6): δ =  7.03 (t, J = 8.0 Hz, 1H), 6.96 (t, J = 2.1 Hz, 1H), 6.80 (ddd, J = 
8.0, 2.1, 0.9 Hz, 1H), 6.66 (ddd, J = 8.0, 2.1, 0.9 Hz, 1H), 4.61 (s, 1H), 3.25 (s, 3H), 2.74 (dq, J = 
14.3, 3.2 Hz, 1H), 2.20 (ddt, J = 13.5, 4.5, 2.2 Hz, 1H), 2.01 (dt, J = 13.5, 6.1 Hz, 1H), 1.69‒1.59 
(m, 1H), 1.38‒1.27 (m, 2H), 1.26‒1.08 (m, 2H). 
13
C NMR (125 MHz, C6D6): δ = 211.9, 160.7, 142.8, 130.2, 119.1, 113.6, 112.9, 80.1, 54.8, 39.3, 
38.8, 28.2, 23.1. 
HRMS (ESIpos): m/z calculated for C13H16O3Na [M+Na]
+
: 243.0992; found 243.0992. 
HPLC (Chiralpak AD-3, nHept/EtOH = 80:20, flowrate: 1.0 ml/min, λ = 204 nm): 
tr(major) = 14.71 min, tr(minor) = 17.51 min. 
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(S)-2-([1,1'-biphenyl]-3-yl)-2-hydroxycyclohexan-1-one (77m) 
 
Appearance: orange oil; 37.6 mg (56%) [Procedure B]; orange solid; 23.2 mg (44%). 
[α]D
25
: +126.7 (c 0.15, CHCl3, 97.5:2.5 er). 
1
H-NMR (500 MHz, C6D6): δ = 7.63‒7.61 (m, 1H), 7.50‒7.41 (m, 2H), 7.38‒7.34 (m, 1H), 
7.25‒7.07 (m, 5H), 4.67 (s, 1H), 2.81 (dq, J = 14.2, 3.2 Hz, 1H), 2.21 (ddt, J = 13.5, 4.5, 2.3 Hz, 
1H), 1.99 (td, J = 13.5, 6.1 Hz, 1H), 1.68 (ddd, J = 14.2, 13.1, 4.5 Hz, 1H), 1.43‒1.08 (m, 4H). 
13
C-NMR (125 MHz, C6D6): δ = 212.0. 142.6, 141.8, 141.5, 129.7, 129.2, 127.7, 127.6, 127.2, 
125.8, 80.2, 39.3, 38.9, 28.3, 23.1 (one signal missing due to overlap with solvent). 
HRMS (EI): m/z calculated for C18H18O2 (M)
∙+
: 266.1301; found 266.1301. 
HPLC (Chiralpak AD-3, nHept/EtOH = 80:20, flowrate: 1.0 ml/min, λ = 207 nm): 
tr(major) = 7.50 min, tr(minor) = 7.96 min. 
 
2-(3-chlorophenyl)-2-hydroxycyclohexan-1-one (77n) 
 
Appearance: orange oil; 23.7 mg (42%) [Procedure B]. 
1
H NMR (500 MHz, CDCl3):  = 7.35–7.28 (m, 3H), 7.19–7.15 (m, 1H), 4.51 (s, 1H), 2.97–2.90 
(m, 1H), 2.60–2.52 (m, 1H), 2.45–2.35 (m, 1H), 2.13–2.02 (m, 1H), 1.93–1.82 (m, 2H), 1.80–
1.67 (m, 2H). 
13
C NMR (125 MHz, CDCl3):  = 212.1, 142.2, 135.2, 130.5, 128.7, 126.9, 124.8, 79.8, 39.0, 
28.4, 23.2. 
HRMS (EI): m/z calculated for C12H13O2Cl [M]
+
 224.0599; found 224.0596. 
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2-(3-bromophenyl)-2-hydroxycyclohexan-1-one (77o) 
 
Appearance: orange oil; 30.1 mg (45%) [Procedure B]. 
1
H NMR (500 MHz, CDCl3):  = 7.49–7.44 (m, 2H), 7.29–7.24 (m, 1H), 7.24–7.20 (m, 1H), 
4.51 (s, 1H), 2.98–2.89 (m, 1H), 2.60–2.53 (m, 1H), 2.45–2.35 (m, 1H), 2.14–2.04 (m, 1H), 1.94–
1.81 (m, 2H), 1.79–1.68 (m, 2H). 
13
C NMR (125 MHz, CDCl3):  = 212.0, 142.5, 131.6, 130.8, 129.8, 125.2, 123.4, 79.8, 39.0, 
29.4, 23.2. 
HRMS (EI): m/z calculated for C12H13O2Br [M]
+
 268.0094; found 268.0092. 
 
2-(2-chlorophenyl)-2-hydroxycyclohexan-1-one (77p) 
 
Appearance: orange oil; 35.1 mg (62%) [Procedure B]. 
1
H NMR (500 MHz, CDCl3):  = 7.69 (dd, J = 7.9, 1.6 . 
13
C NMR (125 MHz, CDCl3):  = 213.2, 137.3, 134.0, 131.4, 130.0, 128.8, 127.3, 80.8, 41.8, 
38.9, 29.5, 22.9. 
HRMS (EI): m/z calculated for C12H13O2Cl [M]
+
: 224.0597; found 224.0599. 
 
 
(S)-2-(3,5-dimethoxyphenyl)-2-hydroxycyclohexan-1-one (77q) 
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Appearance: orange oil; 20.3 mg (32%) [Procedure B]; orange oil; 22.8 mg (46%) [Procedure 
C]. 
[α]D
25
: +107.3 (c 0.11, CHCl3, 97:3 er). 
1
H NMR (500 MHz, C6D6): δ =  6.62 (d, J = 2.2 Hz, 2H), 6.45 (t, J = 2.2 Hz, 1H), 4.66 (s, 1H), 
3.28 (s, 6H), 2.76 (dq, J = 14.2, 3.2 Hz, 1H), 2.31‒2.19 (m, 1H), 2.10 (td, J = 13.5, 6.1 Hz, 1H), 
1.66 (td, J = 13.9, 4.0 Hz, 1H), 1.51‒1.33 (m, 2H), 1.30‒1.10 (m, 2H) . 
13
C NMR (125 MHz, C6D6): δ = 212.0, 162.0, 143.4, 105.2, 100.2, 80.1, 54.9, 39.3, 38.9, 28.1, 
23.1. 
HRMS (ESIpos): m/z calculated for C14H18O4Na [M+Na]
+
: 273.1097; found 273.1098. 
HPLC (Chiralpak AD-3, nHept/EtOH = 80:20, flowrate: 1.0 ml/min, λ = 206 nm): 
tr(major) = 27.32 min, tr(minor) = 34.65 min. 
 
(S)-2-hydroxy-2-phenylcycloheptan-1-one (77r) 
 
Appearance: orange oil; 29.9 mg (57%) [Procedure B]; orange oil; 11.4 mg (28%) [Procedure 
C]. 
1
H NMR (500 MHz, CDCl3): δ = 7.48‒7.42 (m, 2H), 7.40‒7.34 (m, 2H), 7.33‒7.27 (m, 1H), 
4.56 (d, J = 1.4 Hz, 1H), 2.88‒2.78 (m, 1H), 2.52‒2.44 (m, 1H), 2.37‒2.24 (m, 2H), 2.06‒1.86 
(m, 3H), 1.59‒1.35 (m 3H). 
13
C NMR (125 MHz, CDCl3): δ = 213.9, 141.8, 128.9, 128.1, 125.9, 82.6, 39.7, 36.6, 30.7, 28.1, 
23.9. 
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HRMS (ESIpos): m/z calculated for C13H16O2Na [M+Na]
+
: 227.1042; found 227.1041. 
HPLC (Chiralpak AD-3, nHept/EtOH = 80:20, flowrate: 1.0 ml/min, λ = 205 nm): 
tr(major) = 5.99 min, tr(minor) = 8.34 min. 
 
2-hydroxy-2-methyl-2,3-dihydro-1H-inden-1-one (77s) 
 
Appearance: orange oil; 26.2 mg (64%) [Procedure B]. 
1
H NMR (500 MHz, CDCl3):  = 7.79 (d, J = 7.8 Hz, 1H), 7.64 (dt, J = 7.6, 1.2 Hz, 1H), 7.46–
7.38 (m, 2H), 3.27 (d, J = 16.8 Hz, 1H), 3.22 (d, J = 16.8 Hz, 1 H), 2.34 (sbr, 1H), 1.44 (s, 3H). 
13
C NMR (125 MHz, CDCl3):  = 208.5, 151.3, 136.0, 133.7, 128.1, 126.9, 125.1, 77.6, 42.3, 
25.9. 
HRMS (ESIpos): m/z calculated for C10H10O2Na [M+Ma]
+
: 185.0573; found 185.0574. 
 
2-hydroxy-2-methyl-3,4-dihydronaphthalen-1(2H)-one (77t) 
 
Appearance: orange oil; 26.8 mg (61%) [Procedure B].  
1
H NMR (500 MHz, CDCl3):  = 8.03 (dd, J = 7.9, 1.3 Hz, 1H), 7.53 (dt, J = 7.6, 1.4 Hz, 1H), 
7.37–7.33 (m, 1H), 7.28–7.25 (m, 1H), 3.89 (s, 1H), 3.15–3.06 (m, 1H), 3.06–2.99 (m, 1H), 2.30–
2.18 (m, 2H), 1.40 (s, 3H). 
13
C NMR (125 MHz, CDCl3):  = 202.0, 143.6, 134.2, 130.1, 129.2, 128.2, 127.1, 73.7, 36.0, 
27.0, 24.1. 
HRMS (EI): m/z calculated for C11H12O2 [M)]: 176.0832; found 176.0832. 
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(S)-1-hydroxy-[1,1'-bi(cyclohexan)]-2-one (77u) 
 
Appearance: orange oil; 32.2 mg (66%) [Procedure B]; orange oil; 15.8 mg (40%) [Procedure 
C]. 
[α]D
25
: +75.0 (c 0.2, CHCl3, 94:6 er). 
1
H NMR (500 MHz, C6D6): δ = 4.05 (s, 1H), 2.29‒2.22 (m, 1H), 2.20‒2.14 (m, 1H), 1.97‒1.87 
(m, 1H), 1.77‒1.68 (m, 2H), 1.63‒1.51 (m, 3H), 2.14 (m, 2H), 1.30‒0.95 (m, 9H). 
13
C NMR (125 MHz, C6D6): δ = 214.2, 81.0, 41.0, 38.1, 37.9, 28.2, 26.9, 26.8, 26.5, 26.4, 25.1, 
22.1. 
HRMS (EI): m/z calculated for C12H20O2 [M]
 ∙+
: 196.1458; found 196.1458. 
GC (Astec® Chiraldex® G-TA, 30.0 m, i.D. 0.25 mm, 0.9 bar H2, FID, Injector 230 °C, 110 °C 
(iso) 50 min, ramp 8 °C/min to 170 °C, 3 min, 350 °C (iso)): tr(minor) = 40.60 min 
tr(major) = 41.56 min. 
 
(R)-2-hydroxy-2-propylcyclohexan-1-one (77v) 
 
Appearance: orange oil; 20.1 mg (51%) [Procedure B]; orange oil; 10.5 mg (34%) [Procedure 
C]. 
[α]D
25
: +24.0 (c 0.05, CHCl3, 85.5:14.5 er). 
1
H NMR (500 MHz, CDCl3): δ = 3.96 (s, 1H), 2.56‒2.43 (m, 2H), 2.19 (dq, J = 13.2, 3.0 Hz, 
1H), 2.15‒2.07 (m, 1H), 1.85 (ddd, J = 13.9, 11.9, 4.7 Hz, 1H), 1.82‒1.53 (m, 5H), 1.50‒1.37 (m, 
1H), 1.09‒0.96 (m, 1H), 0.91 (t, J = 7.3 Hz, 3H). 
13
C NMR (125 MHz, CDCl3): δ = 214.7, 79.3, 41.3, 39.7, 38.3, 28.1, 22.9, 16.2, 14.5. 
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HRMS (ESIpos): m/z calculated for C9H16O2Na [M+Na]
+
: 179.1042; found 179.1043. 
GC (BGB-178/BGB-15, 30.0 m, 0.5 bar H2, FID, Injector 230 °C, 95 °C (iso) 30 min, ramp 9 
°C/min to 220 °C, 3 min, 350 °C (iso)): tr(minor) = 21.91 min, tr(major) = 24.76 min. 
 
(S)-2-benzyl-2-hydroxycyclohexan-1-one (77w) 
 
Appearance: orange oil; 22.5 mg (44%) [Procedure B]; orange oil; 9.2 mg (23%) [Procedure C]. 
[α]D
25
: +177.0 (c 0.2, CHCl3, 92:8 er). 
1
H NMR (500 MHz, C6D6): δ = 7.22‒7.04 (m, 5H), 3.99 (s, 1H), 2.76 (d, J = 13.7 Hz, 1H), 2.68 
(d, J = 13.7 Hz, 1H), 2.21‒2.13 (m, 1H), 2.07 (td, J = 13.5, 6.2 Hz, 1H), 1.95 (dq, J = 13.5, 3.2 
Hz, 1H), 1.53‒1.37 (m, 2H), 1.32-1.04 (m, 3H). 
13
C NMR (125 MHz, C6D6): δ = 212.2, 136.2, 128.4, 127.1, 79.2, 43.4, 40.6, 38.3, 28.0, 22.7 
(one aromatic signal missing due to overlap with solvent). 
HRMS (EI): m/z calculated for C13H16O2 [M]
 ∙+
: 204.1145; found 204.1142. 
HPLC (Chiralpak AD-3, nHept/EtOH = 80:20, flowrate: 1.0 ml/min, λ = 205 nm): 
tr(major) = 6.65 min, tr(minor) = 13.71 min. 
 
 
 
 
(R)-2-hydroxy-2-methylcyclohexan-1-one (77z) 
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Appearance: n.d.; 87.5:12.5 er [Procedure C]. 
1
H NMR (500 MHz, CDCl3): δ = 4.82 (s, 1H), 2.60–2.44 (m, 2H), 2.18–2.05 (m, 2H), 1.88–1.79 
(m, 1H), 1.78–1.58 (m, 3H), 1.41 (s, 3H). 
13
C NMR (125 MHz, CDCl3): δ = 214.5, 76.8, 42.1, 37.9, 28.0, 25.1, 23.2. 
HRMS (ESIpos): m/z calculated for C7H12O2Na [M+Na]
+
: 151.0729; found 151.0730. 
GC (BGB-177/BGB-15, 30.0 m, 0.5 bar H2, FID, Injector 230 °C, 85 °C (iso) 35 min, ramp 8 
°C/min to 210 °C, 3 min, 350 °C (iso)): tr(minor) = 18.46 min, tr(major) = 19.30 min. 
 
(S)-2-hydroxy-2-phenylcyclopentan-1-one (77x) 
 
Appearance: orange oil; 5.0 mg (14%); 91.5:8.5 er [Procedure C]. 
1
H NMR (500 MHz, C6D6): δ = 7.38–7.35 (m, 4H), 7.34–7.30 (m, 1H), 2.88 (s, 1H), 2.56–2.40 
(m, 3H), 2.23 (ddd, J = 13.3, 9.4, 7.3 Hz, 1H), 2.07 (dtdd, J = 13.6, 7.5, 6.2, 4.4 Hz, 1H), 1.91–
1.77 (m, 1H). 
HRMS (ESIpos): m/z calculated for C11H12O2Na [M+Na]
+
: 199.0729; found 199.0729. 
HPLC (Chiralpak AD-3, nHept/EtOH = 80:20, flowrate: 1.0 ml/min, λ = 204 nm): 
tr(major) = 5.96 min, tr(minor) = 9.81 min. 
 
 
 
(S)-7-hydroxy-7-phenyl-1,4-dioxaspiro[4.5]decan-8-one (77y) 
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Appearance: orange oil; 12.4 mg (24%); >98:2 er; [Procedure C]. 
1
H NMR (500 MHz, CDCl3): δ = 7.42–7.34 (m, 4H), 7.33–7.28 (m, 1H), 4.83 (s, 1H), 4.13–3.78 
(m, 4H), 2.98 (ddd, J = 14.8, 9.4, 6.2 Hz, 1H), 2.82 (dd, J = 14.8, 1.5 Hz, 1H), 2.63 (ddd, J = 
14.8, 7.0, 5.7 Hz, 1H), 2.26 (dd, J = 14.8, 2.3 Hz, 1H), 2.22–2.05 (m, 2H). 
13
C NMR (125 MHz, CDCl3): δ = 209.1, 140.4, 128.3, 128.0, 126.2, 107.6, 78.5, 64.9, 64.8, 
46.3, 35.1, 34.7. 
HRMS (ESIpos): m/z calculated for C14H16O4Na [M+Na]
+
: 271.0941; found 271.0943. 
HPLC (Chiralpak AD-3, nHept/EtOH = 90:10, flowrate: 1.0 ml/min, λ = 206 nm): 
tr(major) = 24.69 min, tr(minor) = 26.14 min. 
 
(1S,2R)-1-phenylcyclohexane-1,2-diol (79) 
 
Procedure: In a flame-dried Schlenk tube, 2-hydroxy-2-phenylcyclohexan-1-one (50 mg, 0.26 
mmol, 1.0 equiv.) was dissolved in dry THF (2.5 mL) under an atmosphere of dry argon. The 
solution was cooled to ‒78 °C and K-Selectride® (1.0 m in THF, 1.30 mL, 1.31 mmol, 5.0 equiv.) 
was added dropwise. After addition was completed, the mixture was stirred for 10 min at ‒78 °C, 
then warmed up to 0 °C and stirred at this temperature for additional 2 h. The reaction was 
quenched by dropwise addition of 2 M aq. NaOH (1.5 mL) followed by H2O2 (35% in H2O, 1.5 
mL) at 0 °C. The resulting mixture was allowed to warm up to room temperature overnight. 
Afterwards, H2O was added and the mixture was extracted with CH2Cl2 (3x). The combined 
organic layers were dried over Na2SO4 and the solvent removed under reduced pressure. The 
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crude product was purified by column chromatography (SiO2, hexanes/EtOAc = 5/1) to give the 
title compound as a white solid (46.3 mg, 0.24 mmol, 83%, er = 98:2). 
[α]D
25
: ‒27.8 (c 0.18, CHCl3, 98:2 er). 
1
H NMR (500 MHz, CDCl3): δ = 7.61‒7.57 (m, 2H), 7.43‒7.36 (m, 2H), 7.34‒7.29 (m, 1H), 
3.83‒3.77 (m, 1H), 2.51‒2.42 (m, 1H), 2.11‒2.01 (m, 1H), 1.84‒1.73 (m, 2H), 1.71‒1.60 (m, 
4H), 1.54‒1.47 (m, 1H) 1.29‒1.24 (m, 1H). 
13
C NMR (125 MHz, CDCl3): δ = 146.0, 128.7, 127.9, 126.2, 74.8, 73.4, 31.6, 28.6, 21.3, 19.3. 
HRMS (EI): m/z calculated for C12H16O2 [M]
+
: 192.1145; found 192.1143. 
HPLC: Achiral pre-separation: MultoHigh U-Si, nHept/iPrOH = 95/5, flowrate: 1.0 min/min, 
λ = 220 nm, cut after 2.17 min. Chiral separation: Chiralpak IA-3, nHept/iPrOH = 90/10, 
flowrate: 1 ml/min, λ = 204 nm): tr(minor) = 8.80 min, tr(major) = 9.66 min. 
 
(1R,2S)-1-methyl-2-phenylcyclohexane-1,2-diol (80)  
 
Procedure: In a flame-dried Schlenk tube 2-hydroxy-2-phenylcyclohexan-1-one (30 mg, 0.16 
mmol, 1.0 equiv.) was dissolved in dry THF (1.5 mL). The solution was cooled down to ‒78 °C 
and methylmagnesium chloride (3 M in THF, 0.21 mL, 0.63 mmol, 4 equiv.) was added 
dropwise. The reaction mixture was allowed to warm up to room temperature and stirred 
overnight. The reaction was then quenched with sat. aq. NH4Cl at 0 °C, extracted with CH2Cl2 
(3x), dried over Na2SO4 and the solvent removed under reduced pressure. The crude product was 
purified by column chromatography (SiO2, hexanes/EtOAc = 20/1). The desired product was 
obtained as an inseparable mixture of product and unreacted starting material (25.6 mg, 79%, 
NMR-ratio ~ 5.8/1, er = 99.5:0.5). 
[α]D
25
: ‒45.3 (c 0.15, CHCl3, 99.5:0.5 er). 
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1
H NMR (500 MHz, CDCl3): δ = 7.63‒7.59 (m, 2H), 7.39‒7.34 (m, 2H), 7.30‒7.26 (m, 1H), 
2.69‒2.60 (m, 1H), 1.99‒1.90 (m, 1H), 1.82‒1.46 (m, 7H), 1.15 (s, 1H), 0.98 (s, 3H). 
13
C NMR (125 MHz, CDCl3): δ = 144.8, 127.9, 127.2, 127.0, 126.5, 72.7, 35.5, 34.7, 25.6, 21.2, 
21.1. 
HRMS (EI): m/z calculated for C13H18O2 [M]
+
 206.1301; found 206.1300. 
HPLC: (Chiralpak AD-3, nHept/EtOH = 90:10, flowrate: 1.0 ml/min, λ = 220 nm): 
tr(minor) = 4.04 min, tr(major) = 7.28 min. 
 
(trans)-2-(methylamino)-1-phenylcyclohexan-1-ol (78) 
 
Procedure: In a flame-dried Schlenk tube titanium isopropoxide (62 µL, 0.21 mmol, 2 equiv.) 
was given to PhMe (0.5 mL). After the solution was stirred for 10 min 2-hydroxy-2-
phenylcyclohexan-1-one (20 mg, 0.11 mmol, 1 equiv.) was added at once. Afterwards 
methylamine (33% in EtOH, 71 µL, 0.53 mmol, 5 equiv.) was added dropwise and stirred 
overnight at 80 °C. The resulting mixture was then cooled down to 0 °C and MeOH (0.5 mL) and 
NaBH4 (20 mg, 0.53 mmol, 5 equiv.) were added and the mixture stirred at this temperature for 
another hour. After quenching the reaction solution by addition of sat. aq. NaHCO3 (1.5 mL), the 
aqueous layer was extracted with CH2Cl2 (3x), dried over MgSO4 and the solvent removed under 
reduced pressure. The crude product was purified by column chromatography (SiO2, 
hexanes/EtOAc = 1/1 to 0/100) as white solid (17.0 mg, 0.83 mmol, 79%, trans/cis = 4:1). 
1
H NMR (500 MHz, CDCl3):  = 7.58–7.53 (m, 2H, major), 7.52–7.48 (m, 2H, minor), 7.39–
7.31 (m, 2H, major/minor), 7.30–7.25 (m, 1H, major), 7.25–7.21 (m, 1H, minor), 2.89–2.84 (m, 
1H, minor), 2.71–2.68 (m, 1H, major), 2.48–2.38 (m, 1H, major), 2.15 (s, 3H, major), 2.08 (s, 
3H, minor), 1.89–1.32 (m, 7H, major), 1.89–1.32 (m, 8H, minor). 
13
C NMR (125 MHz, CDCl3):  = 148.2 (minor), 146.6 (major), 128.5 (major), 128.3 (minor), 
127.5 (major), 126.7 (minor), 126.2 (major), 125.3 (minor), 74.9 (major), 74.5 (minor), 64.8 
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(major), 63.9 (minor), 39.1, 34.7, 32.8, 27.1, 24.8 (minor), 24.6 (major), 21.7 (major), 21.5 
(minor), 19.8. 
HRMS (EI): m/z calculated for C13H19N1O1 [M]
+
 205.1461; found 205.1460 
 
4,5-dihydro-[1,1'-biphenyl]-2(3H)-one and 5,6-dihydro-[1,1'-biphenyl]-2(1H)-one (81 and 
82) 
 
Procedure: In a 1.5 mL vial with cap 2-hydroxy-2-phenylcyclohexan-1-one (50 mg, 0.26 mmol, 
1.0 equiv.) and p-toluene sulfonic acid (50 mg, 1.0 mmol, 1.0 equiv.) were dissolved in dry PhMe 
(1.0 mL). The vial was closed and the resulting mixture was stirred overnight at 80 °C. After 
cooling down to room temperature the crude reaction mixture was directly purified by column 
chromatography (SiO2, hexanes/EtOAc = 100/0 to 100/5) to give the titled product as a clear oil 
(24.3 mg, 54%). The regioisomer 5,6-dihydro-[1,1'-biphenyl]-2(1H)-one could be obtained as 
clear oil (7.1 mg, 16%).  
1
H NMR (500 MHz, CDCl3):  = 7.40–7.28 (m, 5H), 7.05 (t, J = 4.3 Hz, 1H), 2.65–2-58 (m, 
2H), 2.55 (td, J = 6.1, 4.3 Hz, 2H), 2.13 (dq, J = 8.1, 6.1 Hz, 2H). 
13
C NMR (125 MHz, CDCl3):  = 198.1, 148.1, 140.6, 136.7, 128.8, 128.1, 127.7, 39.2, 26.8, 
23.1. 
HRMS (EI): m/z calculated for C12H12O1 [M]
+
: 172.0883; found 172.0883. 
 
 
7 Experimental Section 
 
 
184 
 
 
1
H NMR (500 MHz, CDCl3):  = 7.38–7.31 (m, 2H), 7.29–7.24 (m, 1H), 7.20–7.14 (m, 2H), 
7.04 (ddd, J = 10.1, 4.7, 3.5 Hz, 1H), 6.17 (ddd, J = 10.1, 2.4, 1.7 Hz, 1H), 3.82-3.50 (m, 1H), 
2.51–2.45 (m, 2H), 2.34–2.26 (m, 2H). 
13
C NMR (125 MHz, CDCl3):  = 199.6, 150.2, 139.5, 130.4, 128.7, 128.4, 127.1, 53.5, 30.9, 
25.7. 
HRMS (EI): m/z calculated for C12H12O1 [M]
+
: 172.0883; found 172.0883. 
 
(R)-7a-phenyl-5,6,7,7a-tetrahydrobenzofuran-2(4H)-one (83) 
 
Procedure: In a flame-dried Schlenk tube, 2-hydroxy-2-phenylcyclohexan-1-one (30 mg, 0.16 
mmol, 1.0 equiv.) and (Triphenylphosphoranylidene)ethenone (96 mg, 0.32 mmol, 2.0 equiv.) 
were dissolved in dry PhMe (1.5 mL) under an atmosphere of dry argon. The resulting mixture 
was stirred at 100 °C for 3d. The crude product was directly purified by column chromatography 
(SiO2, hexanes/EtOAc = 10/1) to give the title product as a clear oil (23.7 mg, 0.11 mmol, 70%). 
[α]D
25
: ‒92.7 (c 0.11, CHCl3, 97.5:2.5 er). 
1
H NMR (500 MHz, CDCl3): δ = 7.42‒7.31 (m, 5H), 5.96 (d, J = 1.7 Hz, 1H), 3.17‒3.10 (m, 
1H), 2.92‒2.84 (m, 1H), 2.29‒2.20 (m, 1H), 2.06‒1.99 (m, 1H), 1.89‒1.80 (m, 1H), 1.75‒1.67 
(m, 1H), 1.52‒1.37 (m, 2H). 
13
C NMR (125 MHz, CDCl3): δ [overlapping signals] = 174.5, 172.6, 136.1, 129.2, 127.0, 114.6, 
88.8, 38.0, 28.4, 28.1, 22.6.  
HRMS (EI): m/z calculated for C14H14O2 [M]
+
 214.0988; found 214.0986. 
HPLC (Chiralpak AD-3, nHept/EtOH = 90:10, flowrate: 1.0 ml/min, λ = 205 nm): 
tr(major) = 6.67 min, tr(minor) = 7.48 min. 
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2-phenyl-2-((phenylamino)oxy)cyclohexan-1-one (37) 
 
Procedure: In a flame dried Schlenk tube, a mixture of AgBF4 (9.7 mg, 10 mol%) and P(OPh)3 
(13.1 µL, 10 mol) were dried under vacuum for 10 min and then purged with dry argon. 
Anhydrous THF (2 mL) was added and after stirring for 30 min at room temperature the solution 
was cooled down to ‒78 °C and a solution of nitrosobenzene (53.6 mg, 0.5 mmol, 1 equiv) 
dissolved in anhydrous THF (1 mL) was added dropwise. After stirring for additional 5 min, the 
silyl enol ether (152.3 mg, 0.5 mmol, 1.0 equiv) was added dropwise. A solution of CsF 
(151.9 mg, 1.0 mmol, 2.0 equiv.) in anhydrous MeOH (1 mL) was then slowly added over 16 h at 
‒78 °C. After completion of the addition, the reaction mixture was diluted with nHex/EtOAc 
(3/1) and filtered through a plug of silica. After removing the solvent under reduced pressure the 
crude product was purified by flash column chromatography on silica gel using nHex/EtOAc as 
eluent to afford the desired product as a yellow solid (70.6 mg, 50%). 
Appearance: yellow solid; 70.6 mg (50%). 
1
H NMR (500 MHz, C6D6): δ = 7.56–7.49 (m, 2H), 7.46–7.39 (m, 3H), 7.39–7.34 (m, 1H), 7.22–
7.12 (m, 2H), 6.94–6.78 (m, 3H), 2.79–2.70 (m, 1H), 2.61–2.50 (m, 2H), 2.40–2.28 (m, 1H), 
2.06–1.92 (m, 2H), 1.86–1.72 (m, 2H). 
13
C NMR (125 MHz, C6D6): δ = 209.8, 148.7, 136.5, 129.1, 129.0, 128.9, 128.0, 121.8, 114.7, 
90.4, 41.2, 34.2, 27.3, 23.1. 
HRMS (ESIpos): m/z calculated for C18H19O2Na [M+Na]
+
: 304.1308; found 304.1308. 
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7.5 α-Oxidation of Cyclic Ketones with 1,4-Benzoquinones via Enol 
Catalysis 
7.5.1 General Procedures 
General procedure for the non-enantioselective reaction: In a screw-cap GC-vial diphenyl 
phosphate (25 mg, 0.1 mmol, 0.5 equiv.), the corresponding ketone (0.2 mmol, 1.0 equiv.) and 
the corresponding quinone (0.6 mmol, 3.0 equiv.) were dissolved in anhydrous toluene (0.4 mL) 
and the vial was closed. After stirring the resulting mixture overnight at room temperature the 
crude product was directly purified by flash column chromatography (SiO2, hexanes/EtOAc 20/1 
 5/1). 
 
General procedure for the enantioselective reaction: A screw-cap GC-vial equipped with the 
corresponding ketone 68 (0.2 mmol, 1.0 equiv) and quinone 86 (0.6 mmol, 3.0 equiv) in 
anhydrous benzene (0.4 mL) was placed in a cryostat (0 °C). After stirring the mixture for 10 
min, catalyst (R)-1u (6.3 mg, 0.01 mmol, 5 mol%) was added at once. After stirring the resulting 
solution at 0 °C for 24 h the crude product was directly purified by flash column chromatography 
(SiO2, hexanes/EtOAc 20/1  5/1). 
 
7.5.2 Characterization of Substrates 
(R)-2-(4-hydroxyphenoxy)-2-phenylcyclohexan-1-one (88a) 
 
Appearance: yellowish solid; 37.9 mg, 67%. 
[α]D
25
: –135.6 (c 0.18, CHCl3, 96:4 er). 
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1
H NMR (500 MHz, CDCl3): δ = 7.40‒7.27 (m, 5H), 6.58‒6.52 (m, 4H), 4.39 (s, 1H), 2.64 (ddd, 
J = 12.9, 10.4, 5.5 Hz, 1H), 2.40‒2.21 (m, 3H), 2.19‒2.08 (m, 1H), 2.05‒1.97 (m, 1H), 1.92‒1.80 
(m, 1H), 1.74‒1.65 (m, 1H). 
13
C NMR (125 MHz, CDCl3): δ =209.1, 150.5, 149.1, 138.3, 128.3, 127.9, 127.5, 120.6, 115.7, 
87.5, 42.1, 40.7, 28.5, 21.9. 
HRMS (ESIpos): m/z calculated for C18H18O3Na [M+Na]
+
: 305.1148; found 305.1145. 
HPLC: (Chiralcel OJ-3, nHept/iPrOH = 80:20, flowrate: 1.0 ml/min, λ = 204 nm): 
tr(major) = 6.84 min, tr(minor) = 8.11 min 
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X-Ray Data for (±)-88a: 
 
Table 1.  Crystal data and structure refinement. 
Identification code    10473 
Empirical formula    C18 H18 O3 
Color      colorless 
Formula weight    282.32  g · mol-1  
Temperature     100(2) K 
Wavelength     0.71073 Å 
Crystal system     MONOCLINIC 
Space group     P21/c,  (no. 14)  
Unit cell dimensions   a = 14.108(10) Å = 90°. 
     b = 8.608(5) Å = 114.75(7)°. 
     c = 13.108(9) Å   = 90°. 
Volume     1445.6(18) Å3 
Z     4 
Density (calculated)   1.297  Mg · m-3 
Absorption coefficient   0.087 mm-1 
C15
C16
C14
C3
C4
C17
C13
C5
C2
C18
C1
C6
C8
C9
O1
C7
C10
O3
O2
C12
C11
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F(000)     600 e 
Crystal size    0.09 x 0.06 x 0.03 mm3 
 range for data collection  2.851 to 31.934°. 
Index ranges    -20  h  20, -12 k  12, -19  l  19 
Reflections collected   25208 
Independent reflections   4970 [Rint = 0.1120] 
Reflections with I>2(I)   2889 
Completeness to  = 25.242°  99.9 %  
Absorption correction   Gaussian 
Max. and min. transmission  1.00 and 0.99 
Refinement method   Full-matrix least-squares on F2 
Data / restraints / parameters  4970 / 0 / 194 
Goodness-of-fit on F2   1.099 
Final R indices [I>2(I)]   R1 = 0.0786 wR
2 = 0.1724 
R indices (all data)   R1 = 0.1520 wR
2 = 0.2180 
Largest diff. peak and hole  0.5 and -0.5 e · Å-3 
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Table 2.   Bond lengths [Å] and angles [°]. 
______________________________________________________________________  
O(1)-C(1) 1.447(3)  O(1)-C(7) 1.396(2)   
O(2)-C(6) 1.213(3)  O(3)-C(10) 1.364(3)   
C(1)-C(2) 1.532(3)  C(1)-C(6) 1.535(3)   
C(1)-C(13) 1.525(3)  C(2)-C(3) 1.524(3)   
C(3)-C(4) 1.517(3)  C(4)-C(5) 1.534(4)   
C(5)-C(6) 1.498(3)  C(7)-C(8) 1.379(3)   
C(7)-C(12) 1.384(3)  C(8)-C(9) 1.391(3)   
C(9)-C(10) 1.381(3)  C(10)-C(11) 1.382(3)   
C(11)-C(12) 1.382(3)  C(13)-C(14) 1.391(3)   
C(13)-C(18) 1.388(3)  C(14)-C(15) 1.390(4)   
C(15)-C(16) 1.377(4)  C(16)-C(17) 1.377(4)   
C(17)-C(18) 1.386(4)  
 
C(7)-O(1)-C(1) 117.41(16)  O(1)-C(1)-C(2) 111.58(17)   
O(1)-C(1)-C(6) 103.73(16)  O(1)-C(1)-C(13) 108.59(17)   
C(2)-C(1)-C(6) 108.19(18)  C(13)-C(1)-C(2) 115.27(18)   
C(13)-C(1)-C(6) 108.82(18)  C(3)-C(2)-C(1) 113.35(19)   
C(4)-C(3)-C(2) 111.15(19)  C(3)-C(4)-C(5) 110.1(2)   
C(6)-C(5)-C(4) 110.8(2)  O(2)-C(6)-C(1) 121.2(2)   
O(2)-C(6)-C(5) 123.3(2)  C(5)-C(6)-C(1) 115.54(18)   
C(8)-C(7)-O(1) 120.8(2)  C(8)-C(7)-C(12) 120.1(2)   
C(12)-C(7)-O(1) 118.96(19)  C(7)-C(8)-C(9) 120.0(2)   
C(10)-C(9)-C(8) 119.7(2)  O(3)-C(10)-C(9) 123.3(2)   
O(3)-C(10)-C(11) 116.5(2)  C(9)-C(10)-C(11) 120.2(2)   
C(12)-C(11)-C(10) 120.1(2)  C(11)-C(12)-C(7) 119.9(2)   
7 Experimental Section 
 
 
191 
 
 
C(14)-C(13)-C(1) 123.0(2)  C(18)-C(13)-C(1) 118.3(2)   
C(18)-C(13)-C(14) 118.6(2)  C(15)-C(14)-C(13) 120.1(2)   
C(16)-C(15)-C(14) 120.6(2)  C(17)-C(16)-C(15) 119.8(2)   
C(16)-C(17)-C(18) 119.8(2)  C(17)-C(18)-C(13) 121.1(2)  
 
  
7 Experimental Section 
 
 
192 
 
 
(±)-2-(4-hydroxyphenoxy)-2-(p-tolyl)cyclohexan-1-one (88b) 
 
Appearance: red solid; 34.7 mg, 54%. 
1
H NMR (500 MHz, CDCl3): δ = 7.30–7.27 (m, 2H), 7.18 (d, J = 8.0 Hz, 1H), 6.63–6.51 (m, 
4H), 4.82 (sbr, 1H), 2.66 (ddd, J = 12.9, 10.0, 5.4 Hz, 1H), 2.40–2.27 (m, 6H), 2.13 (dtt, J = 13.6, 
9.1, 4.1 Hz, 1H), 2.03 (dqd, J = 18.1, 7.7, 7.0, 3.8 Hz, 1H), 1.89 (dtt, J = 14.0, 9.5, 4.5 Hz, 1H), 
1.72 (ddq, J = 13.2, 6.4, 3.3, 2.5 Hz, 1H). 
13
C NMR (125 MHz, CDCl3): δ = 209.6, 150.7, 149.0, 137.8, 135.2, 129.1, 127.5, 120.8, 115.6, 
87.5, 41.6, 40.7, 28.5, 22.0, 21.3. 
HRMS (ESIpos): m/z calculated for C19H20O3Na [M+Na]
+
: 319.1305; found 319.1305. 
 
(±)-2-(4-hydroxyphenoxy)-2-(4-(trifluoromethyl)phenyl)cyclohexan-1-one (88c) 
 
Appearance: red viscous oil; 34.7 mg, 53%; inseparable mixture of 1,6/1,4-addition 
products = 5:1 (by 
1
H NMR and 
19
F NMR); using (S)-6b: red viscous oil; 43.6 mg, 62%; 
inseperable mixture of 1,6/1,4-addition products = 1.4:1 (by 
1
H NMR and 
19
F NMR); 88:12 er1,6, 
81.5:18.5 er1,4. 
1
H NMR/mixture (500 MHz, CDCl3): δ = 7.69 (d, J = 8.0 Hz, 2H1,4), 7.60 (d, J = 8.3 Hz, 2H1,6), 
7.54–7.51 (m, 2H1,6), 7.47 (d, J = 8.1 Hz, 2H1,4), 6.79–6.75 (m, 1H1,4), 6.70–6.66 (m, 1H1,4), 
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6.61–6.57 (m, 2H1,6), 6.56–6.52 (m, 2H1,6), 5.68 (d, J = 2.5 Hz, 1H1,4), 4.71 (s, 1H1,6), 2.67 (td, J 
= 12.7, 5.9 Hz, 1H1,6), 2.62–2.54 (m, 1H1,4), 2.42 (dtd, J = 14.4, 3.7, 2.6 Hz, 1H1,6), 2.32 (dtd, J = 
12.8, 4.2, 1.3 Hz, 1H1,6), 2.28–2.17 (m, 1H1,6/1,4), 2.15–2.06 (m, 2H1,6/1,4), 1.92–1.79 (m, 1H1,6/1,4), 
1.76–1.67 (m, 1H1,6/1,4). 
13
C NMR (125 MHz, CDCl3): δ = 209.1, 150.6, 149.0, 142.9, 137.8, 135.7, 135.6, 130.0, 129.7, 
129.0, 127.7, 125.2, 125.1, 125.1, 125.1, 119.1, 116.0, 86.9, 44.0, 40.7, 40.1, 34.3, 28.6, 25.4, 
21.8, 21.4. 
19
F NMR (471 MHz, CDCl3): δ = –62.6 (1,6), –62.8 (1,4). 
HPLC: (Chiralcel OJ-3R, H2O/MeCN = 50:50, flowrate: 1.0 ml/min, λ = 224 nm): tr-
1,6(major) = 6.59 min, tr-1,6(minor) = 8.24 min; tr-1,4(major) = 7.14 min, tr-1,6(minor) = 7.40 min 
HRMS (ESIpos): m/z calculated for C19H17O3F3Na [M+Na]
+
: 373.1022; found 373.1023. 
 
(±)-2-(3,5-dimethoxyphenyl)-2-(4-hydroxyphenoxy)cyclohexan-1-one (88d) 
 
Appearance: colorless solid; 41.2 mg, 60%. 
1
H NMR (500 MHz, CDCl3): δ = 6.59–6.52 (m, 6H), 6.42–6.39 (m, 1H), 4.68 (sbr, 1H), 3.74 (s, 
6H), 2.64 (ddd, J = 12.9, 9.9, 5.5 Hz, 1H), 2.38–2.22 (m, 3H), 2.14–2.04 (m, 1H), 2.02–1.93 (m, 
1H), 1.91–1.81 (m, 1H), 1.76–1.67 (m, 1H). 
13
C NMR (125 MHz, CDCl3): δ = 208.9, 160.7, 150.7, 148.8, 140.8, 120.8, 115.6, 105.9, 99.9, 
87.3, 55.5, 41.2, 40.7, 28.3, 22.0. 
HRMS (ESIpos): m/z calculated for C20H22O5Na [M+Na]
+
: 365.1359; found 365.1360. 
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(±)-2-(3,5-dichloro-4-hydroxyphenoxy)-2-phenylcyclohexan-1-one (88f) 
 
Appearance: yellow viscous oil; 45.1 mg, 64% (corresponding hydroquinone as an inseparable 
impurity).  
1
H NMR (500 MHz, CDCl3): δ = 7.42–7.35 (m, 2H), 7.27–7.19 (m, 3H), 6.81 (s, 1H), 6.60 (s, 
2H), 3.05–2.97 (m, 1H), 2.69 (ddd, J = 13.2, 8.5, 4.1 Hz, 1H), 2.63–2.55 (m, 1H), 2.48–2.37 (m, 
1H), 2.17–2.07 (m, 1H), 2.01–1.78 (m, 3H). 
13
C NMR (125 MHz, CDCl3): δ = 209.6, 152.3, 149.2, 142.3, 134.6, 131.4, 129.1, 129.1, 128.1, 
121.2, 115.9, 90.9, 40.7, 37.0, 28.3, 22.9. 
HRMS (ESIpos): m/z calculated for C18H16O3Cl2Na [M+Na]
+
: 373.0369; found 373.0370. 
 
(±)-2-(2,5-dichloro-4-hydroxyphenoxy)-2-phenylcyclohexan-1-one (88g) 
 
Appearance: yellowish solid; 45.0 mg, 64%. Using (S)-1u: yellowish solid; 23.2 mg, 33%; 
67.5:23.5 er. 
1
H NMR (500 MHz, CDCl3): δ = 7.45–7.30 (m, 5H), 7.04 (s, 1H), 6.50 (s, 1H), 5.18 (s, 1H), 
2.72 (ddd, J = 13.2, 10.1, 5.5 Hz, 1H), 2.50 (dddd, J = 14.6, 6.0, 3.8, 1.9 Hz, 1H), 2.42–2.31 (m, 
2H), 2.17 (dtt, J = 13.8, 9.8, 4.0 Hz, 1H), 2.09–1.99 (m, 1H), 1.89 (ddq, J = 14.1, 9.7, 4.8 Hz, 
1H), 1.77–1.64 (m, 1H). 
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13
C NMR (125 MHz, CDCl3): δ =208.1, 146.7, 144.8, 137.2, 128.6, 128.5, 127.5, 125.3, 120.3, 
117.4, 117.4, 89.5, 41.1, 40.6, 28.2, 21.8. 
HPLC: (Chiralcel OJ-3R, H2O/MeCN = 50:50, flowrate: 1.0 ml/min, λ = 204 nm): 
tr(minor) = 9.64 min, t(major) = 10.65 min. 
HRMS (ESIpos): m/z calculated for C18H16O3Cl2Na [M+Na]
+
: 373.0369; found 373.0370. 
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X-Ray Data for (±)-88g: 
 
Table 1.  Crystal data and structure refinement. 
Identification code    11411 
Empirical formula    C18 H16 Cl2 O3 
Color      colorless 
Formula weight    351.21  g · mol-1  
Temperature     100(2) K 
Wavelength     1.54178 Å 
Crystal system     MONOCLINIC 
Space group     P21/c,  (no. 14)  
Unit cell dimensions   a = 11.4609(3) Å α= 90°. 
     b = 9.9326(3) Å  β= 90.2930(10)°. 
     c = 13.6207(4) Å γ = 90°. 
Volume     1550.51(8) Å3 
Z     4 
Density (calculated)   1.505  Mg · m-3 
Absorption coefficient   3.875 mm-1 
C16
C17
C15
C6 C18
C14
C5
C13
C1
O2
C4
Cl1
C2
C7
C3
O1
C8
C12
C9
C11
C10
Cl2
O3
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F(000)     728 e 
Crystal size    0.219 x 0.172 x 0.091 mm3 
θ range for data collection  5.512 to 63.542°. 
Index ranges    -13 ≤ h ≤ 13, -11≤ k ≤ 11, -15 ≤ l ≤ 15 
Reflections collected   22268 
Independent reflections   2538 [Rint = 0.0314] 
Reflections with  I>2σ(I)   2459 
Completeness to θ = 63.542°  99.5 %  
Absorption correction Gaussian 
Max. and min. transmission  0.8 and 0.6 
Refinement method   Full-matrix least-squares on F2 
Data / restraints / parameters  2538 / 0 / 212 
Goodness-of-fit on F2   1.059 
Final R indices [I>2σ(I)]   R1 = 0.0245 wR
2 = 0.0642 
R indices (all data)   R1 = 0.0253 wR
2 = 0.0648 
Largest diff. peak and hole  0.2 and -0.3 e · Å-3 
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Table 2.   Bond lengths [Å] and angles [°]. 
______________________________________________________________________  
Cl(1)-C(8) 1.7332(13)  Cl(2)-C(11) 1.7418(13)   
O(1)-C(2) 1.2121(17)  O(2)-C(1) 1.4481(16)   
O(2)-C(7) 1.3739(16)  O(3)-C(10) 1.3577(17)   
C(1)-C(2) 1.5513(18)  C(1)-C(6) 1.5464(18)   
C(1)-C(13) 1.5165(19)  C(2)-C(3) 1.504(2)   
C(3)-C(4) 1.5362(19)  C(4)-C(5) 1.523(2)   
C(5)-C(6) 1.5254(19)  C(7)-C(8) 1.400(2)   
C(7)-C(12) 1.3918(19)  C(8)-C(9) 1.380(2)   
C(9)-C(10) 1.393(2)  C(10)-C(11) 1.391(2)   
C(11)-C(12) 1.3927(19)  C(13)-C(14) 1.393(2)   
C(13)-C(18) 1.398(2)  C(14)-C(15) 1.390(2)   
C(15)-C(16) 1.386(2)  C(16)-C(17) 1.387(2)   
C(17)-C(18) 1.386(2)  
 
C(7)-O(2)-C(1) 122.46(10)  O(2)-C(1)-C(2) 108.55(10)   
O(2)-C(1)-C(6) 103.13(10)  O(2)-C(1)-C(13) 112.10(11)   
C(6)-C(1)-C(2) 107.72(10)  C(13)-C(1)-C(2) 115.93(11)   
C(13)-C(1)-C(6) 108.55(11)  O(1)-C(2)-C(1) 121.88(12)   
O(1)-C(2)-C(3) 123.41(12)  C(3)-C(2)-C(1) 114.69(11)   
C(2)-C(3)-C(4) 111.79(11)  C(5)-C(4)-C(3) 110.74(11)   
C(4)-C(5)-C(6) 110.94(11)  C(5)-C(6)-C(1) 113.14(11)   
O(2)-C(7)-C(8) 115.47(12)  O(2)-C(7)-C(12) 126.18(12)   
C(12)-C(7)-C(8) 118.31(12)  C(7)-C(8)-Cl(1) 118.65(10)   
C(9)-C(8)-Cl(1) 119.66(11)  C(9)-C(8)-C(7) 121.69(12)   
C(8)-C(9)-C(10) 120.33(13)  O(3)-C(10)-C(9) 117.64(12)   
O(3)-C(10)-C(11) 124.38(13)  C(11)-C(10)-C(9) 117.98(12)   
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C(10)-C(11)-Cl(2) 118.28(10)  C(10)-C(11)-C(12) 122.13(13)   
C(12)-C(11)-Cl(2) 119.59(11)  C(7)-C(12)-C(11) 119.54(13)   
C(14)-C(13)-C(1) 120.73(12)  C(14)-C(13)-C(18) 118.81(13)   
C(18)-C(13)-C(1) 119.89(12)  C(15)-C(14)-C(13) 120.71(14)   
C(16)-C(15)-C(14) 119.96(14)  C(15)-C(16)-C(17) 119.76(14)   
C(18)-C(17)-C(16) 120.38(14)  C(17)-C(18)-C(13) 120.32(14) 
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(±)-4-methyl-N-(4-((2-oxo-1-phenylcyclohexyl)oxy)phenyl)benzenesulfonamide (88e)
[201]
 
 
Appearance: yellowish solid; 38.7 mg, 44%. 
1
H NMR (500 MHz, CDCl3): δ = 7.52 (d, J = 8.3 Hz, 2H), 7.35–7.28 (m, 5H), 7.17 (d, J = 8.0 
Hz, 2H), 6.85–6.70 (m, 2H), 6.61–6.49 (m, 2H), 6.41 (s, 1H), 2.60 (ddd, J = 12.8, 10.9, 5.6 Hz, 
1H), 2.44–2.35 (m, 4H), 2.35–2.27 (m, 1H), 2.22 (ddd, J = 14.1, 10.4, 3.7 Hz, 1H), 2.12 (dtt, J = 
14.3, 10.4, 3.8 Hz, 1H), 2.03 (dddt, J = 11.4, 5.8, 3.8, 2.0 Hz, 1H), 1.90–1.81 (m, 1H), 1.74–1.65 
(m, 1H). 
13
C NMR (125 MHz, CDCl3): δ = 208.7, 153.6, 143.9, 137.9, 136.1, 130.4, 129.6, 128.3, 128.0, 
127.4, 127.3, 124.4, 119.8, 87.7, 42.6, 40.6, 28.5, 21.7 (2x). 
HRMS (ESIpos): m/z calculated for C25H25NO4SNa [M+Na]
+
: 458.1297; found 458.1399. 
 
(R)-2-(4-chlorophenyl)-2-(4-hydroxyphenoxy)cyclohexan-1-one (88h) 
 
Appearance: yellowish solid; 41.8 mg, 66%. 
[α]D
25
: –83.8 (c 0.16, CHCl3, 94:6 er). 
1
H NMR (500 MHz, CDCl3): δ = 7.37‒7.28 (m, 4H), 6.62‒6.49 (m, 4H), 4.82 (sbr, 1H), 2.66 (td, 
J = 12.2, 5.7 Hz, 1H), 2.45‒2.25 (m, 2H), 2.21‒2.01 (m, 3H), 1.90‒1.76 (m, 1H), 1.74‒1.63 (m, 
1H). 
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13
C NMR (125 MHz, CDCl3): δ = 204.4, 150.6, 148.9, 137.2, 133.8, 128.9, 128.5, 119.8, 115.9, 
86.9, 43.1, 40.6, 28.6, 21.6. 
HRMS (ESIpos): m/z calculated for C18H17ClO3Na [M+Na]
+
: 339.0758; found 339.0760. 
HPLC: (Chiralcel OJ-3R, MeCN/H2O = 50:50, flowrate: 1.0 ml/min, λ = 224 nm): 
tr(minor) = 7.46 min, tr(major) = 8.18 min. 
 
(R)-2-(4-fluorophenyl)-2-(4-hydroxyphenoxy)cyclohexan-1-one (88i) 
 
Appearance: red viscous oil; 44.1 mg, 73%. 
[α]D
25
: –127.3 (c 0.11, CHCl3, 93.5:6.5 er). 
1
H NMR (500 MHz, CDCl3): δ = 7.38‒7.32 (m, 2H), 7.06‒7.00 (m, 2H), 6.60‒6.50 (m, 4H), 
4.63 (sbr, 1H), 2.66 (ddd, J = 12.8, 11.2, 5.6 Hz, 1H), 2.41‒2.28 (m, 2H), 2.22‒2.10 (m, 2H), 
2.09‒2.00 (m, 1H), 1.90‒1.80 (m, 1H), 1.73‒1.64 (m, 1H). 
13
C NMR (125 MHz, CDCl3): δ = 209.4, 162.3 (d, J = 247.0 Hz), 150.6, 149.0, 134.3 (d, J = 3.6 
Hz), 129.3 (d, J = 8.0 Hz), 120.1, 115.8, 115.2 (d, J = 21.2 Hz), 87.0, 42.8, 40.6, 28.5, 21.7. 
19
F NMR (471 MHz, CDCl3): δ = ‒114.6. 
HRMS (ESIpos): m/z calculated for C18H17O3FNa [M+Na]
+
: 323.1054; found 323.1057. 
HPLC: (Chiralpak AD-3R, MeCN/H2O = 50:50, flowrate: 1.0 ml/min, λ = 286 nm): 
tr(majorr) = 10.56 min, tr(minor) = 11.54 min. 
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(R)-2-([1,1'-biphenyl]-4-yl)-2-(4-hydroxyphenoxy)cyclohexan-1-one (88j) 
 
Appearance: colorless solid; 46.4 mg, 65%. 
[α]D
25
: –82.5 (c 0.24, CHCl3, 93.5:6.5 er). 
1
H NMR (500 MHz, CDCl3): δ = 7.62‒7.55 (m, 4H), 7.47‒7.40 (m, 4H), 7.37‒7.33 (m, 1H), 
6.61‒6.51 (m, 4H), 4.80 (s, 1H), 2.71‒2.61 (m, 1H), 2.46‒2.24 (m, 3H), 2.22‒2.11 (m, 1H), 2.10‒
2.00 (m, 1H), 1.93‒1.80 (m, 1H), 1.77‒1.65 (m, 1H). 
13
C NMR (125 MHz, CDCl3): δ = 209.6, 150.7, 149.1, 140.7, 137.4, 128.9, 127.9, 127.6 (2x), 
127.2, 127.0, 120.4, 115.8, 87.4, 42.4, 40.7, 28.5, 21.8. 
HRMS (ESIpos): m/z calculated for C24H22O3Na [M+Na]
+
: 381.1461; found 381.1461. 
HPLC: (Chiralcel OJ-3R, MeCN/H2O = 50:50, flowrate: 1.0 ml/min, λ = 254 nm): 
tr(minor) = 18.20 min, tr(major) = 23.75 min. 
 
(R)-2-(3-chlorophenyl)-2-(4-hydroxyphenoxy)cyclohexan-1-one (88k) 
 
Appearance: red solid; 22.3 mg; 35%; 96:4 er. 
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1
H NMR (500 MHz, CDCl3): δ =7.40 (q, J = 1.4 Hz, 1H), 7.28–7.20 (m, 3H), 6.60–6.50 (m, 
4H), 4.75 (s, 1H), 2.64 (ddd, J = 12.9, 11.9, 5.8 Hz, 1H), 2.45–2.35 (m, 1H), 2.34–2.28 (m, 1H), 
2.22–2.01 (m, 3H), 1.89–1.77 (m, 1H), 1.68 (dq, J = 13.4, 4.4 Hz, 1H). 
13
C NMR (125 MHz, CDCl3): δ = 209.0, 150.6, 148.9, 140.9, 134.2, 129.5, 128.0, 127.6, 125.6, 
119.7, 115.9, 86.8, 43.1, 40.7, 28.5, 21.6.. 
HPLC: (Chiralcel OJ-3R, MeCN/H2O = 40:60, flowrate: 1.0 ml/min, λ = 224 nm): 
tr(minor) = 18.39 min, tr(major) = 19.43 min. 
 
(R)-2-(3-bromophenyl)-2-(4-hydroxyphenoxy)cyclohexan-1-one (88l) 
 
Appearance: red solid; 34.9 mg, 48%. 
[α]D
25
: –77.5 (c 0.24, CHCl3, 95:5 er). 
1
H NMR (500 MHz, CDCl3): δ = 7.56 (t, J = 1.9 Hz, 1H), 7.43 (ddd, J = 7.9, 2.0, 1.0 Hz, 1H), 
7.32 (ddd, J = 7.9, 1.7, 1.1 Hz, 1H), 7.21 (t, J = 7.9 Hz, 1H), 6.77‒6.19 (m, 4H), 2.65 (ddd, J = 
12.8, 11.9, 5.7 Hz, 1H), 2.47‒2.36 (m, 1H), 2.36‒2.28 (m, 1H), 2.23‒1.99 (m, 3H), 1.91‒1.78 (m, 
1H), 1.70 (dq, J = 13.0, 4.5 Hz, 1H). 
13
C NMR (125 MHz, CDCl3): δ = 208.9, 150.6, 148.9, 141.2, 130.9, 130.5, 129.8, 126.0, 122.4, 
119.7, 115.9, 86.8, 43.2, 40.7, 28.5, 21.6. 
HRMS (ESIpos): m/z calculated for C18H17BrO3Na [M+Na]
+
: 385.0253; found 385.0254. 
HPLC: (Chiralcel OJ-3R, MeCN/H2O = 40:60, flowrate: 1.0 ml/min, λ = 224 nm): 
tr(minor) = 22.04 min, tr(major) = 23.95 min. 
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(R)-2-(4-hydroxyphenoxy)-2-(3-methoxyphenyl)cyclohexan-1-one (88m) 
 
Appearance: yellowish solid; 29.0 mg, 46%. 
[α]D
25
: –107.6 (c 0.21, CHCl3, 95:5 er). 
1
H NMR (500 MHz, CDCl3): δ = 7.34–7.17 (m, 1H), 7.01–6.94 (m, 1H), 6.93 (t, J = 2.1 Hz, 
1H), 6.84 (ddd, J = 8.2, 2.6, 0.9 Hz, 1H), 6.58–6.50 (m, 4H), 5.00 (sbr, 1H), 3.76 (s, 3H), 2.64 
(ddd, J = 13.0, 10.2, 5.5 Hz, 1H), 2.44–2.20 (m, 3H), 2.11 (dtt, J = 13.8, 9.8, 4.0 Hz, 1H), 2.03–
1.95 (m, 1H), 1.86 (dtt, J = 14.3, 9.8, 4.5 Hz, 1H), 1.75–1.65 (m, 1H). 
13
C NMR (125 MHz, CDCl3): δ = 209.4, 159.6, 150.8, 148.8, 139.9, 129.4, 120.6, 119.9, 115.7, 
113.5, 113.3, 87.3, 55.4, 41.7, 40.7, 28.4, 21.9. 
HRMS (ESIpos): m/z calculated for C19H20O4Na [M+Na]
+
: 335.1254; found 335.1252. 
HPLC: (Chiralcel OJ-3R, MeCN/H2O = 40:60, flowrate: 1.0 ml/min, λ = 220 nm): 
tr(minor) = 9.89 min, tr(major) = 10.71 min. 
 
(R)-2-([1,1'-biphenyl]-3-yl)-2-(4-hydroxyphenoxy)cyclohexan-1-one (88n) 
 
Appearance: colorless solid; 19.6 mg, 55% (0.1 mmol scale). 
[α]D
25
: –105.6 (c 0.18, CHCl3, 96.5:3.5 er). 
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1
H NMR (500 MHz, CDCl3): δ = 7.59 (t, J = 1.8 Hz, 1H), 7.55–7.51 (m, 3H), 7.45–7.39 (m, 
3H), 7.37–7.31 (m, 2H), 4.63 (sbr, 1H), 2.67 (ddd, J = 13.0, 10.6, 5.6 Hz, 1H), 2.47–2.26 (m, 3H), 
2.17 (dtt, J = 14.0, 10.1, 3.9 Hz, 1H), 2.08–1.99 (m, 1H), 1.93–1.83 (m, 1H), 1.77–1.68 (m, 1H). 
13
C NMR (125 MHz, CDCl3): δ = 209.3, 150.6, 149.1, 141.3, 141.1, 138.9, 128.9, 128.7, 127.5, 
127.4, 126.8, 126.5, 126.4, 120.5, 115.7, 87.6, 42.4, 40.8, 28.5, 21.9. 
HRMS (ESIpos): m/z calculated for C24H22O3Na [M+Na]
+
: 381.1461; found 381.1463. 
HPLC: (Chiralcel OJ-3R, MeCN/H2O = 50:50, flowrate: 1.0 ml/min, λ = 249 nm): 
tr(minor) = 12.64 min, tr(major) = 15.08 min. 
 
(R)-2-(4-hydroxyphenoxy)-2-(naphthalen-2-yl)cyclohexan-1-one (88o) 
 
Appearance: yellowish solid; 47.8 mg, 72%. 
[α]D
25
: –91.1 (c 0.18, CHCl3, 93.5:6.5 er). 
1
H NMR (500 MHz, CDCl3): δ = 7.87 (d, J = 1.8 Hz, 1H), 7.84‒7.77 (m, 3H), 7.55‒7.43 (m, 
3H), 6.62‒6.47 (m, 4H), 2.70 (ddd, J = 13.1, 10.5, 5.5 Hz, 1H), 2.48‒2.30 (m, 3H), 2.18 (dtt, J = 
13.9, 9.9, 4.1 Hz, 1H), 2.08‒2.01 (m, 1H), 1.90 (tdt, J = 14.8, 10.6, 4.7 Hz, 1H), 1.76 (dtd, J = 
11.8, 6.2, 3.1 Hz, 1H). 
13
C NMR (125 MHz, CDCl3): δ = 209.5, 150.7, 148.9, 136.0, 133.1, 132.9, 128.5, 128.0, 127.7, 
126.7, 126.5, 126.2, 125.4, 120.6, 115.7, 87.6, 41.8, 40.8, 28.5, 21.9. 
HRMS (ESIpos): m/z calculated for C22H20O3Na [M+Na]
+
: 355.1305; found 355.1305. 
HPLC: (Chiralcel OJ-3R, MeCN/H2O = 50:50, flowrate: 1.0 ml/min, λ = 226 nm): 
tr(minor) = 9.53 min, tr(major) = 12.99 min. 
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2,2'-(1,4-phenylenebis(oxy))bis(2-(4-methoxyphenyl)cyclohexan-1-one) (90) 
 
Procedure: The product can be obtained using the standard procedure (0.2 mmol scale) as a 
colorless solid (24.5 mg, 48%, 75:25 er, 1:1 dr). The diastereomeres can only be differentiated by 
HPLC. Only traces of the targeted monomeric compound were obtained. 
1
H NMR (500 MHz, CDCl3): δ = 7.24–7.19 (m, 4H), 6.87–6.80 (m, 4H), 6.39 (d, J = 2.8 Hz, 
4H), 3.80 (s, 6H), 2.59 (ddd, J = 12.8, 9.6, 5.4 Hz, 2H), 2.35–2.18 (m, 6H), 2.09–1.91 (m, 4H), 
1.89–1.77 (m, 2H), 1.69–1.61 (m, 2H). 
13
C NMR (125 MHz, CDCl3): δ = 209.2, 159.2, 150.1, 150.1, 130.1, 130.1, 128.9, 128.8, 120.3, 
120.3, 113.7, 87.4, 87.3, 55.3, 41.3, 41.2, 40.5, 28.4, 22.0 (2x). 
HRMS (ESIpos): m/z calculated for C32H34O6Na [M+Na]
+
: 537.2248; found 537.2249. 
 
(±)-methyl 2-(2,5-dihydroxyphenyl)-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (89) 
 
Appearance: red viscous oil; 39.7 mg, 70% (mixture with hydroquinone). 
1
H NMR (500 MHz, CDCl3): δ = 7.84 (dt, J = 7.7, 1.0 Hz, 1H), 7.68 (td, J = 7.5, 1.2 Hz, 1H), 
7.49 (dt, J = 7.8, 0.9 Hz, 1H), 7.45 (ddd, J = 8.0, 7.2, 0.9 Hz, 1H), 6.83 (d, J = 10.1 Hz, 1H), 
6.80–6.76 (m, 1H), 6.65 (d, J = 2.3 Hz, 1H), 4.30 (d, J = 17.7 Hz, 1H), 3.73 (s, 3H), 3.11 (d, J = 
17.7 Hz, 1H). 
13
C NMR (125 MHz, CDCl3): δ = 198.4, 187.0, 186.4, 168.4, 152.8, 146.7, 136.8, 136.7, 136.7, 
136.5, 134.6, 133.1, 128.4, 126.6, 125.3, 62.7, 53.7, 39.8. 
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HRMS (ESIpos): m/z calculated for C17H12O5Na [M+Na]
+
: 319.0577; found 319.0573. 
 
(R)-2-hydroxy-2-phenylcyclohexan-1-one (77a) 
 
Procedure: To a solution of 88a (50 mg, 0.18 mmol, 1.0 equiv) in MeCN (1 mL) at –20 °C was 
added a solution of CAN (388 mg, 0.71 mmol, 4.0 equiv) in MeCN/H2O (1/1, 4 mL). The 
resulting mixture was stirred for an additional hour at –20 °C, then quenched with aqueous 
Na2CO3 solution and diluted with CH2Cl2. The layers were separated and the aqueous layer was 
washed with CH2Cl2 (2x). The combined organic layers were dried over Na2SO4 and 
concentrated under reduced pressure. Purification by flash column chromatography (SiO2, 
hexanes/EtOAc = 10/1) gave the targeted product as a yellow solid (17.3 mg, 51% yield). 
[α]D
25
: —144.0 (c 0.20, CHCl3, 95:5 er). 
1
H NMR (500 MHz, CDCl3): δ = 7.42–7.36 (m, 2H), 7.35–7.28 (m, 2H), 4.49 (sbr, 1H), 3.04–
2.96 (m, 1H), 2.58–2.50 (m, 1H), 2.47–2.40 (m, 1H), 2.11–2.01 (m, 1H), 1.91–1.65 (m, 4H). 
13
C NMR (125 MHz, CDCl3): δ =212.9, 140.1, 129.3, 128.5, 126.5, 80.2, 39.0, 39.0, 28.5, 23.2. 
HRMS (ESIpos): m/z calculated for C12H14O3Na [M+Na]
+
: 213.0886; found 213.0885. 
HPLC (Chiralpak AD-3, nHept/EtOH = 80:20, flowrate: 1.0 ml/min, λ = 206 nm): 
tr(minor) = 6.76 min, tr(major) = 9.52 min. 
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4-(((1R,2S)-2-hydroxy-1-phenylcyclohexyl)oxy)phenol (91) 
 
Procedure: To a solution of 88a (56.5 mg, 0.2 mmol, 1.0 equiv) in anhydrous THF (5 mL) was 
added K-Selectride (1 M in THF, 0.8 mL, 0.4 mmol, 4.0 equiv) at –78 °C. The cold bath was 
removed and the resulting mixture was stirred for 2 h. The reaction was quenched by addition of 
1 M NaOH and H2O2 (30%) and stirred at room temperature overnight. The layers were separated 
and the aqueous layer was extracted with CH2Cl2. The combined organic layers were dried over 
Na2SO4 and concentrated under reduced pressure. Purification by flash column chromatography 
(SiO2, hexanes/EtOAc) afforded the targeted product as a colorless solid (49.0 mg, 86%, dr > 
20:1).  
1
H NMR (500 MHz, CDCl3): δ = 7.55–7.49 (m, 2H, 9, 13), 7.40 (t, J = 8.4, 6.9 Hz, 2H, 10, 12), 
7.37–7.29 (m, 1H, 11), 6.54 (d, J = 9.0 Hz, 2H, 16, 18), 6.46 (d, J = 9.0 Hz, 2H, 15, 19), 4.29 (d, 
J = 1.7 Hz, 1H, 20), 3.96–3.90 (m, 1H, 2), 2.35 (ddd, J = 14.3, 9.9, 7.2 Hz, 1H, 6b), 2.30 (d, J = 
13.8 Hz, 1H, 3b), 2.24 (dm, J = 14.3 Hz, 1H, 6a), 1.86 (dq, J = 13.7, 3.0 Hz, 1H, 3a), 1.67 (dt, J = 
5.8, 3.1 Hz, 1H, 4b), 1.53–1.45 (m, 3H, 4a, 5a, 5b), 1.23 (dd, J = 2.9, 1.7 Hz, 1H, 1). 
13
C NMR (125 MHz, CDCl3): δ =149.9 (17), 149.2 (14), 144.0 (8), 129.2 (12, 10), 128.2 (11), 
127.0 (13, 9), 120.3 (19, 15), 115.8 (18, 16), 82.0 (7), 77.6, 77.4, 77.10, 74.3 (2), 28.5 (3), 24.9 
(6), 21.0 (5), 19.3 (4). 
HRMS (ESIpos): m/z calculated for C18H20O3Na [M+Na]
+
: 307.1305; found 307.1306. 
HPLC (Chiralcel OD-3R, MeCN/H2O = 60:40, flowrate: 1.0 ml/min, λ = 220 nm): 
tr(minor) = 3.66 min, tr(major) = 4.27 min. 
 
The structure was confirmed by 2D-NMR experiments. Obtained NOEs and couplings are 
depicted below: 
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2-oxo-1-phenylcyclohexyl 2,2,2-trifluoroacetate (92) 
 
Procedure: To a solution of 88a (30 mg, 0.11 mmol, 1.0 equiv) in CH2Cl2 (0.3 mL) was added 
TFA (81 µL, 1.05 mmol, 10.0 equiv) at room temperature. The solution was stirred for further 6 h 
and then quenched by slow addition of aq. sat. NaHCO3 solution. After extraction with CH2Cl2, 
the combined organic layers were dried over Na2SO4 and the solvent was removed under reduced 
pressure. The crude product was purified by FCC (SiO2, hexanes/EtOAc = 10/1) to give 92 (9.7 
mg, 32%) as clear oil.  
1
H NMR (500 MHz, CDCl3): δ = 7.54–7.37 (m, 5H), 2.95 (dq, J = 13.8, 3.5 Hz, 1H), 2.74–2.58 
(m, 2H), 2.40 (ddd, J = 14.4, 12.0, 5.7 Hz, 1H), 2.05–1.75 (m, 4H). 
13
C NMR (125 MHz, CDCl3): δ = 202.1, 134.4, 129.8, 129.2, 127.7, 90.9, 40.3, 35.1, 26.6, 23.1 
(some signals not visible due to noise).  
19
F NMR (471 MHz, CDCl3): δ = –75.34. 
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HRMS (ESIpos): m/z calculated for C14H13O3F3Na [M+Na]
+
: 307.0709; found 307.0712. 
HPLC (Chiralcel OD-3, nHept/iPrOH = 98:2, flowrate: 1.0 ml/min, λ = 220 nm): tr1 = 3.85 min, 
tr2 = 4.32 min. 
 
7.5.3 Details on Hammett Plot Anaylsis 
 
Procedure: A screw-cap GC-vial equipped with 2-phyenyl cyclohexanone (76, 0.05 mmol, 
0.5 equiv), the corresponding ketone (0.05 mmol, 0.5 equiv) and 1,4-benzoquinone (86, 32.4 mg, 
0.3 mmol, 3.0 equiv) in anhydrous C6D6 (0.2 mL) was placed in a cryostat (0 °C). After stirring 
the mixture for 10 min, a 0 °C cold solution of DPP (12.5 mg, 0.05 mmol, 25 mol%) and 
triphenylmethane (internal standard, 12.2 mg, 0.05 mmol, 0.25 equiv) in anhydrous C6D6 
(0.2 mL) was added. Aliquots were taken every 30 min for the next 150 min using a glass pipet 
and analyzed by 
1
H-NMR. Note: The reaction stops under high dilution. 
The kinetic data was analyzed by comparison of product formation to an internal standard, using 
the aromatic signals of the formed hydroquinone as handle for integration:  
X = CF3 ~6.58 ppm (m, 2H) 
X = Me The signal at ~6.30 ppm (overlap of both substrates) was subtracted 
by twice the integral of the signal at ~6.70 ppm (due to overlap this one equals 1/2 
of X = H) 
X = Cl ~6.62 ppm (m, 2H) 
X = F ~6.25 ppm (m, 1H) compared to 6.29 (X = H, m, 1H) 
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The determined NMR ratios were used to plot the relative initial rates of the two competing 
substrates. Using Excel the slope for each pair was determined. Except X = Me each experiment 
was performed twice. The log(kX/kH) was calculated from the corresponding slopes. 
Using EXCEL, the slope of each relative kinetic profile was determined (when X = H; k = 0.401, 
when X = CF3; k = 0.089) and therefore log(kCl/kH) = –0.665. This procedure was performed on 
the relative kinetic data with the remaining substrates in comparison to the standard substrate (X 
= H) to obtain the log(kX/kH) for each substrate. The log(kX/kH) for each substrate was then plotted 
against the corresponding σ, σ+ and σ- values taken from the literature. 
 
8 Bibliography 
 
 
212 
 
 
8 Bibliography 
[1] a) W. S. Knowles, Angew. Chem. Int. Ed. 2002, 41, 1998–2007; b) R. Noyori, Angew. 
Chem. Int. Ed. 2002, 41, 2008–2022; c) K. B. Sharpless, Angew. Chem. Int. Ed. 2002, 41, 
2024–2032. 
[2] a) B. List, Angew. Chem. Int. Ed. 2010, 49, 1730–1734; b) G. Bredig, P. S. Fiske, 
Biochem. Z. 1912, 46, 7; c) V. Prelog, M. Wilhelm, Helv. Chim. Acta 1954, 37, 1634–
1660; d) H. Pracejus, Liebigs Ann. Chem. 1960, 634, 9–22. 
[3] B. List, R. A. Lerner, C. F. Barbas, J. Am. Chem. Soc. 2000, 122, 2395–2396. 
[4] K. A. Ahrendt, C. J. Borths, D. W. C. MacMillan, J. Am. Chem. Soc. 2000, 122, 4243–
4244. 
[5] B. List, Asymmetric Organocatalysis, Vol. 291, Springer-Verlag Berlin Heidelberg, 2009. 
[6] J. Seayad, B. List, Org. Biomol. Chem. 2005, 3, 719–724. 
[7] M. R. Monaco, G. Pupo, B. List, Synlett 2016, 27, 1027–1040. 
[8] a) J. N. Brönsted, Recueil des Travaux Chimiques des Pays-Bas 1923, 42, 718-728; b) T. 
M. Lowry, Journal of the Society of Chemical Industry 1923, 42, 43-47. 
[9] D. Parmar, E. Sugiono, S. Raja, M. Rueping, Chemical Reviews 2014, 114, 9047-9153. 
[10] D. Kampen, C. M. Reisinger, B. List, in Asymmetric Organocatalysis (Ed.: B. List), 
Springer Berlin Heidelberg, Berlin, Heidelberg, 2009, pp. 1-37. 
[11] M. Fleischmann, D. Drettwan, E. Sugiono, M. Rueping, M. Gschwind Ruth, Angew. 
Chem. Int. Ed. 2011, 50, 6364–6369. 
[12] M. S. Sigman, E. N. Jacobsen, J. Am. Chem. Soc. 1998, 120, 4901–4902. 
[13] Y. Huang, A. K. Unni, A. N. Thadani, V. H. Rawal, Nature 2003, 424, 146. 
[14] A. G. Doyle, E. N. Jacobsen, Chem. Rev. 2007, 107, 5713–5743. 
[15] T. Akiyama, J. Itoh, K. Yokota, K. Fuchibe, Angew. Chem. Int. Ed. 2004, 43, 1566–1568. 
[16] D. Uraguchi, M. Terada, J. Am. Chem. Soc. 2004, 126, 5356–5357. 
[17] a) M. Hatano, K. Moriyama, T. Maki, K. Ishihara, Angew. Chem. Int. Ed. 2010, 49, 3823–
3826; b) M. Klussmann, L. Ratjen, S. Hoffmann, V. Wakchaure, R. Goddard, B. List, 
Synlett 2010, 2010, 2189–2192. 
[18] S. Hoffmann, M. Seayad Abdul, B. List, Angew. Chem. Int. Ed. 2005, 44, 7424–7427. 
[19] T. Akiyama, Y. Saitoh, H. Morita, K. Fuchibe, Adv. Synt. Catal. 2005, 347, 1523–1526. 
[20] X.-H. Chen, X.-Y. Xu, H. Liu, L.-F. Cun, L.-Z. Gong, J. Am. Chem. Soc. 2006, 128, 
14802–14803. 
[21] G. B. Rowland, H. Zhang, E. B. Rowland, S. Chennamadhavuni, Y. Wang, J. C. Antilla, 
J. Am. Chem. Soc. 2005, 127, 15696–15697. 
[22] K. Mori, K. Ehara, K. Kurihara, T. Akiyama, J. Am. Chem. Soc. 2011, 133, 6166–6169. 
[23] a) I. Čorić, S. Müller, B. List, J. Am. Chem. Soc. 2010, 132, 17370–17373; b) F. Xu, D. 
Huang, C. Han, W. Shen, X. Lin, Y. Wang, J. Org. Chem. 2010, 75, 8677–8680. 
[24] D. Nakashima, H. Yamamoto, J. Am. Chem. Soc. 2006, 128, 9626–9627. 
[25] K. Kaupmees, N. Tolstoluzhsky, S. Raja, M. Rueping, I. Leito, Angew. Chem. Int. Ed. 
2013, 52, 11569–11572. 
[26] a) G. Pousse, A. Devineau, V. Dalla, L. Humphreys, M.-C. Lasne, J. Rouden, J. Blanchet, 
Tetrahedron 2009, 65, 10617–10622; b) N. D. Shapiro, V. Rauniyar, G. L. Hamilton, J. 
Wu, F. D. Toste, Nature 2011, 470, 245. 
[27] a) P. García‐García, F. Lay, P. García‐García, C. Rabalakos, B. List, Angew. Chem. Int. 
Ed. 2009, 48, 4363–4366; b) S. Prévost, N. Dupré, M. Leutzsch, Q. Wang, V. Wakchaure, 
B. List, Angew. Chem. Int. Ed. 2014, 53, 8770–8773; c) N. Wakchaure Vijay, S. J. Kaib 
8 Bibliography 
 
 
213 
 
 
Philip, M. Leutzsch, B. List, Angew. Chem. Int. Ed. 2015, 54, 11852–11856; d) N. 
Wakchaure Vijay, B. List, Angew. Chem. Int. Ed. 2016, 55, 15775–15778. 
[28] a) I. Čorić, B. List, Nature 2012, 483, 315; b) J. H. Kim, I. Čorić, S. Vellalath, B. List, 
Angew. Chem. Int. Ed. 2013, 52, 4474–4477; c) S. Liao, I. Čorić, Q. Wang, B. List, J. Am. 
Chem. Soc. 2012, 134, 10765–10768; d) G. Chit Tsui, L. Liu, B. List, Angew. Chem. Int. 
Ed. 2015, 54, 7703–7706; e) L. Liu, M. Leutzsch, Y. Zheng, M. W. Alachraf, W. Thiel, 
B. List, J. Am. Chem. Soc. 2015, 137, 13268–13271; f) S. Das, L. Liu, Y. Zheng, M. W. 
Alachraf, W. Thiel, C. K. De, B. List, J. Am. Chem. Soc. 2016, 138, 9429–9432. 
[29] L. Liu, P. S. J. Kaib, A. Tap, B. List, J. Am. Chem. Soc. 2016, 138, 10822–10825. 
[30] P. S. J. Kaib, L. Schreyer, S. Lee, R. Properzi, B. List, Angew. Chem. Int. Ed. 2016, 55, 
13200–13203. 
[31] a) L. Liu, H. Kim, Y. Xie, C. Farès, P. S. J. Kaib, R. Goddard, B. List, J. Am. Chem. Soc. 
2017, 139, 13656–13659; b) N. Tsuji, J. L. Kennemur, T. Buyck, S. Lee, S. Prévost, P. S. 
J. Kaib, D. Bykov, C. Farès, B. List, Science 2018, 359, 1501. 
[32] I. Fleming, Molecular Orbitals and Organic Chemical Reactions - Student Edition, John 
Wiley & Sons Ltd., 2009. 
[33] A. Lapworth, J. Soc. Chem. Trans. 1904, 85, 30–42. 
[34] J. Clayden, N. Greeves, S. Warren, P. Wothers, Organic Chemistry, Oxford University 
Press, New York, 2001. 
[35] F. G. Bordwell, Acc. Chem. Res. 1988, 21, 456–463. 
[36] a) E. V. Anslyn, D. A. Dougherty, Modern Physical Organic Chemistry, University 
Science Books, 2006; b) J. R. Keeffe, A. J. Kresge, N. P. Schepp, J. Am. Chem. Soc. 
1990, 112, 4862–4868. 
[37] H. Hart, Chem. Rev. 1979, 79, 515–528. 
[38] a) G. S. Hammond, J. Am. Chem. Soc. 1955, 77, 334–338; b) J. E. Leffler, Science 1953, 
117, 340. 
[39] C. Rappe, W. H. Sachs, J. Org. Chem. 1967, 32, 3700–3703. 
[40] M. A. Yamada Yoichi, N. Yoshikawa, H. Sasai, M. Shibasaki, Angew. Chem. Int. Ed. 
1997, 36, 1871–1873. 
[41] H. Sasai, T. Suzuki, N. Itoh, K. Tanaka, T. Date, K. Okamura, M. Shibasaki, J. Am. 
Chem. Soc. 1993, 115, 10372–10373. 
[42] a) Y. M. A. Yamada, M. Shibasaki, Tetrahedron Lett. 1998, 39, 5561–5564; b) N. 
Yoshikawa, Y. M. A. Yamada, J. Das, H. Sasai, M. Shibasaki, J. Am. Chem. Soc. 1999, 
121, 4168–4178. 
[43] a) M. Shibasaki, M. Kanai, S. Matsunaga, N. Kumagai, Acc. Chem. Res. 2009, 42, 1117–
1127; b) H. Gröger, Eur. J. Org. Chem. 2016, 2016, 4116–4123; c) N. Kumagai, M. 
Kanai, H. Sasai, ACS Catal. 2016, 6, 4699–4709. 
[44] N. Kumagai, S. Matsunaga, T. Kinoshita, S. Harada, S. Okada, S. Sakamoto, K. 
Yamaguchi, M. Shibasaki, J. Am. Chem. Soc. 2003, 125, 2169–2178. 
[45] a) B. M. Trost, H. Ito, J. Am. Chem. Soc. 2000, 122, 12003–12004; b) B. M. Trost, H. Ito, 
E. R. Silcoff, J. Am. Chem. Soc. 2001, 123, 3367–3368. 
[46] B. M. Trost, M. J. Bartlett, Acc. Chem. Res. 2015, 48, 688–701. 
[47] a) B. M. Trost, T. Saget, C.-I. Hung, J. Am. Chem. Soc. 2016, 138, 3659–3662; b) B. M. 
Trost, J. S. Tracy, T. Saget, Chem. Sci. 2018, 9, 2975–2980. 
[48] a) H. Inoue, M. Kikuchi, J.-i. Ito, H. Nishiyama, Tetrahedron 2008, 64, 493–499; b) M. 
Mizuno, H. Inoue, T. Naito, L. Zhou, H. Nishiyama, Chem. Eur. J. 2009, 15, 8985–8988. 
[49] R. Mahrwald, B. Ziemer, Tetrahedron Lett. 2002, 43, 4459–4461. 
8 Bibliography 
 
 
214 
 
 
[50] W. Li, X. Liu, X. Hao, X. Hu, Y. Chu, W. Cao, S. Qin, C. Hu, L. Lin, X. Feng, J. Am. 
Chem. Soc. 2011, 133, 15268–15271. 
[51] a) M. Shang, M. Cao, Q. Wang, M. Wasa, Angew. Chem. Int. Ed. 2017, 56, 13338–13341; 
b) M. Shang, X. Wang, S. M. Koo, J. Youn, J. Z. Chan, W. Yao, B. T. Hastings, M. 
Wasa, J. Am. Chem. Soc. 2017, 139, 95–98. 
[52] A. Ting, J. M. Goss, N. T. McDougal, S. E. Schaus, in Asymmetric Organocatalysis (Ed.: 
B. List), Springer Berlin Heidelberg, Berlin, Heidelberg, 2009, pp. 201–232. 
[53] a) T. Takeda, M. Terada, J. Am. Chem. Soc. 2013, 135, 15306–15309; b) H. Krawczyk, 
M. Dzięgielewski, D. Deredas, A. Albrecht, Ł. Albrecht, Chem. Eur. J. 2015, 21, 10268–
10277. 
[54] a) S. Mukherjee, J. W. Yang, S. Hoffmann, B. List, Chem. Rev. 2007, 107, 5471–5569; b) 
P. M. Pihko, I. Majander, A. Erkkilä, in Asymmetric Organocatalysis (Ed.: B. List), 
Springer Berlin Heidelberg, Berlin, Heidelberg, 2009, pp. 145–200; c) L. Zhang, N. Fu, S. 
Luo, Acc. Chem. Res. 2015, 48, 986–997. 
[55] P. Melchiorre, Angew. Chem. Int. Ed. 2012, 51, 9748–9770. 
[56] a) J. Y. Kang, R. G. Carter, Org. Lett. 2012, 14, 3178–3181; b) J. Y. Kang, R. C. 
Johnston, K. M. Snyder, P. H.-Y. Cheong, R. G. Carter, J. Org. Chem. 2016, 81, 3629–
3637. 
[57] X. Yang, R. J. Phipps, F. D. Toste, J. Am. Chem. Soc. 2014, 136, 5225–5228. 
[58] a) H. Liu, L.-F. Cun, A.-Q. Mi, Y.-Z. Jiang, L.-Z. Gong, Org. Lett. 2006, 8, 6023–6026; 
b) M. Rueping, C. Azap, Angew. Chem. Int. Ed. 2006, 45, 7832–7835. 
[59] Q.-X. Guo, H. Liu, C. Guo, S.-W. Luo, Y. Gu, L.-Z. Gong, J. Am. Chem. Soc. 2007, 129, 
3790–3791. 
[60] K. Mori, T. Katoh, T. Suzuki, T. Noji, M. Yamanaka, T. Akiyama, Angew. Chem. Int. Ed. 
2009, 48, 9652–9654. 
[61] L. Song, Q. X. Guo, X. C. Li, J. Tian, Y. G. Peng, Angew. Chem. Int. Ed. 2012, 124, 
1935–1938. 
[62] G. Pousse, F. L. Cavelier, L. Humphreys, J. Rouden, J. Blanchet, Org. Lett. 2010, 12, 
3582–3585. 
[63] I. Felker, G. Pupo, P. Kraft, B. List, Angew. Chem. Int. Ed. 2015, 54, 1960–1964. 
[64] a) A. R. Burns, A. G. E. Madec, D. W. Low, I. D. Roy, H. W. Lam, Chem. Sci. 2015, 6, 
3550–3555; b) L.-D. Zhang, L.-R. Zhong, J. Xi, X.-L. Yang, Z.-J. Yao, J. Org. Chem. 
2016, 81, 1899–1904. 
[65] X. Yang, F. D. Toste, Chem. Sci. 2016, 7, 2653–2656. 
[66] G. Pupo, R. Properzi, B. List, Angew. Chem. Int. Ed. 2016, 55, 6099–6102. 
[67] a) W. S. Rapson, R. Robinson, J. Chem. Soc. 1935, 1285–1288; b) E. C. du Feu, F. J. 
McQuillin, R. Robinson, J. Chem. Soc. 1937, 53–60; c) R. E. Gawley, Synthesis 1976, 
1976, 777–794. 
[68] C. H. Heathcock, J. E. Ellis, J. E. McMurry, A. Coppolino, Tetrahedron Lett. 1971, 12, 
4995–4996. 
[69] A. J. Frontier, S. Raghavan, S. J. Danishefsky, J. Am. Chem. Soc. 2000, 122, 6151–6159. 
[70] J. D. White, P. Hrnciar, F. Stappenbeck, J. Org. Chem. 1999, 64, 7871–7884. 
[71] B. Shi, N. A. Hawryluk, B. B. Snider, J. Org. Chem. 2003, 68, 1030–1042. 
[72] American Chemical Society International Historic Chemical Landmarks. The “Marker 
Degradation” and Creation of the Mexican Steroid Hormone Industry 1938-1945. 
http://www.acs.org/content/acs/en/education/whatischemistry/landmarks/progesteronesyn
thesis.html (accessed May 8th, 2018). 
8 Bibliography 
 
 
215 
 
 
[73] C. Djerassi, Steroids 1992, 57, 631-641. 
[74] a) S. Ramachandran, M. S. Newman, Org. Synth. 1961, 41, 38–41; b) S. Swaminathan, 
M. S. Newman, Tetrahedron 1958, 2, 88–99. 
[75] a) W. Acklin, V. Prelog, A. P. Prieto, Helv. Chim. Acta 1958, 41, 1416–1424; b) Z. G. 
Hajos, D. R. Parrish, E. P. Oliveto, Tetrahedron 1968, 24, 2039–2046; c) L. Velluz, J. 
Mathieu, G. Nominé, Tetrahedron 1966, 22, 495–505. 
[76] Z. G. Hajos, D. R. Parrish, German Patent DE 2102623 1971 
[77] Z. G. Hajos, D. R. Parrish, J. Org. Chem. 1974, 39, 1615–1621. 
[78] U. Eder, G. Sauer, R. Wiechert, Angew. Chem. Int. Ed. 1971, 10, 496–497. 
[79] L. Kürti, B. Czako, Strategic Applications of Named Reactions in Organic Synthesis, 
Elsevier Academic Press, 2005. 
[80] S. Bahmanyar, K. N. Houk, H. J. Martin, B. List, J. Am. Chem. Soc. 2003, 125, 2475–
2479. 
[81] a) C. F. Barbas, Angew. Chem. Int. Ed. 2008, 47, 42–47; b) D. W. C. MacMillan, Nature 
2008, 455, 304. 
[82] B. W. Katona, N. P. Rath, S. Anant, W. F. Stenson, D. F. Covey, J. Org. Chem. 2007, 72, 
9298–9307. 
[83] C. D. Dzierba, K. S. Zandi, T. Möllers, K. J. Shea, J. Am. Chem. Soc. 1996, 118, 4711–
4712. 
[84] H. M. Lee, C. Nieto-Oberhuber, M. D. Shair, J. Am. Chem. Soc. 2008, 130, 16864–16866. 
[85] S. P. Waters, Y. Tian, Y.-M. Li, S. J. Danishefsky, J. Am. Chem. Soc. 2005, 127, 13514–
13515. 
[86] B. Bradshaw, J. Bonjoch, Synlett 2012, 2012, 337-356. 
[87] T. Akiyama, T. Katoh, K. Mori, Angew. Chem. Int. Ed. 2009, 48, 4226–4228. 
[88] G. Zhong, T. Hoffmann, R. A. Lerner, S. Danishefsky, C. F. Barbas, J. Am. Chem. Soc. 
1997, 119, 8131–8132. 
[89] T. Bui, C. F. Barbas, Tetrahedron Lett. 2000, 41, 6951–6954. 
[90] B. Bradshaw, G. Etxebarría‐Jardi, J. Bonjoch, F. Viózquez Santiago , G. Guillena, C. 
Nájera, Adv. Synt. Catal. 2009, 351, 2482-2490. 
[91] C. Xu, L. Zhang, P. Zhou, S. Luo, J.-P. Cheng, Synthesis 2013, 45, 1939–1945. 
[92] a) J. M. Janey, Angew. Chem. Int. Ed. 2005, 44, 4292–4300; b) A. M. R. Smith, K. K. Hii, 
Chem. Rev. 2011, 111, 1637–1656; c) T. Vilaivan, W. Bhanthumnavin, Molecules 2010, 
15, 917; d) D. J. Ager, I. Prakash, D. R. Schaad, Chem. Rev. 1996, 96, 835–876. 
[93] Ketamine is part of the 18th WHO model list of essential medicines. More information 
can be found on the website of the WHO: http://www.who.int  
[94] a) S. Reardon, Nature 2015, 517, 130–131; b) C. J. A. Morgan, H. V. Curran, Addiction 
2012, 107, 27–38; c) M. I. Blonk, B. G. Koder, P. M. L. A. Bemt, F. J. P. M. Huygen, 
Eur. J. Pain 2010, 14, 466–472. 
[95] a) H. A. Adams, C. Werner, Der Anaesthesist 1997, 46, 1026–1042; b) G. Hempelmann, 
D. F. M. Kuhn, Der Anaesthesist 1997, 46, S3–S7. 
[96] a) G. Li, H. T. Chang, K. B. Sharpless, Angew. Chem. Int. Ed. 1996, 35, 451–454; b) J. A. 
Bodkin, M. D. McLeod, J. Chem. Soc., Perkin Trans. 1  2002, 2733–2746. 
[97] a) W. Oppolzer, O. Tamura, G. Sundarababu, M. Signer, J. Am. Chem. Soc. 1992, 114, 
5900A Modular Strategy for the Direct Catalytic Asymmetric α-Amination of Carbonyl 
Compounds 
5902; b) C. Greck, B. Drouillat, C. Thomassigny, Eur. J. Org. Chem. 2004, 2004, 1377–1385. 
8 Bibliography 
 
 
216 
 
 
[98] a) S. Saaby, M. Bella, K. A. Jørgensen, J. Am. Chem. Soc. 2004, 126, 8120–8121; b) X. 
Xu, T. Yabuta, P. Yuan, Y. Takemoto, Synlett 2006, 2006, 137–140; c) M. Terada, M. 
Nakano, H. Ube, J. Am. Chem. Soc. 2006, 128, 16044–16045; d) R. He, X. Wang, T. 
Hashimoto, K. Maruoka, Angew. Chem. Int. Ed. 2008, 47, 9466–9468; e) C. Xu, L. 
Zhang, S. Luo, Angew. Chem. Int. Ed. 2014, 53, 4149–4153; f) X. Han, F. Zhong, Y. Lu, 
Adv. Synt. Catal. 2010, 352, 2778–2782; g) M. Terada, D. Tsushima, M. Nakano, Adv. 
Synt. Catal. 2009, 351, 2817–2821; h) C. Xu, L. Zhang, S. Luo, J. Org. Chem. 2014, 79, 
11517–11526; i) F. Zhou, F.-M. Liao, J.-S. Yu, J. Zhou, Synthesis 2014, 46, 2983–3003; 
j) H. M. Nelson, J. S. Patel, H. P. Shunatona, F. D. Toste, Chem. Sci. 2015, 6, 170–173; k) 
N. Momiyama, H. Yamamoto, J. Am. Chem. Soc. 2004, 126, 5360–5361; l) K. Ohmatsu, 
Y. Ando, T. Nakashima, T. Ooi, Chem 2016, 1, 802–810. 
[99] D. A. Evans, S. G. Nelson, J. Am. Chem. Soc. 1997, 119, 6452–6453. 
[100] B. List, J. Am. Chem. Soc. 2002, 124, 5656–5657. 
[101] A. Bøgevig, K. Juhl, N. Kumaragurubaran, W. Zhuang, K. A. Jørgensen, Angew. Chem. 
Int. Ed. 2002, 41, 1790–1793. 
[102] A. Bøgevig, H. Sundén, A. Córdova, Angew. Chem. Int. Ed. 2004, 43, 1109–1112. 
[103] T.-Y. Liu, H.-L. Cui, Y. Zhang, K. Jiang, W. Du, Z.-Q. He, Y.-C. Chen, Org. Lett. 2007, 
9, 3671–3674. 
[104] M. Shang, X. Wang, S. M. Koo, J. Youn, J. Z. Chan, W. Yao, B. T. Hastings, M. Wasa, J. 
Am. Chem. Soc. 2017, 139, 95-98. 
[105] a) H. Vogt, S. Vanderheiden, S. Bräse, Chem. Commun. 2003, 2448–2449; b) C. E. 
Hartmann, T. Baumann, M. Bächle, S. Bräse, Tetrahedron: Asymmetry 2010, 21, 1341–
1349. 
[106] J.-Y. Fu, X.-Y. Xu, Y.-C. Li, Q.-C. Huang, L.-X. Wang, Org. Biomol. Chem. 2010, 8, 
4524–4526. 
[107] a) J.-Y. Fu, Q.-C. Yang, Q.-L. Wang, J.-N. Ming, F.-Y. Wang, X.-Y. Xu, L.-X. Wang, J. 
Org. Chem. 2011, 76, 4661–4664; b) C. Liu, Q. Zhu, K.-W. Huang, Y. Lu, Org. Lett. 
2011, 13, 2638–2641. 
[108] a) N. S. Chowdari, C. F. Barbas, Org. Lett. 2005, 7, 867–870; b) J. T. Suri, D. D. Steiner, 
C. F. Barbas, Org. Lett. 2005, 7, 3885–3888. 
[109] Z.-Q. Zhang, T. Chen, F.-M. Zhang, Org. Lett. 2017, 19, 1124–1127. 
[110] a) M. G. Edwards, M. N. Kenworthy, R. R. A. Kitson, M. S. Scott, R. J. K. Taylor, 
Angew. Chem. Int. Ed. 2008, 47, 1935–1937; b) S. Kusumi, H. Nakayama, T. Kobayashi, 
H. Kuriki, Y. Matsumoto, D. Takahashi, K. Toshima, Chem. Eur. J. 2016, 22, 18733–
18736; c) C. Palomo, M. Oiarbide, J. M. Garcia, Chem. Soc. Rev. 2012, 41, 4150–4164; 
d) R. A. Taj, J. R. Green, J. Org. Chem. 2010, 75, 8258–8270. 
[111] F. A. Davis, B. C. Chen, Chem. Rev. 1992, 92, 919–934. 
[112] E. Vedejs, D. A. Engler, J. E. Telschow, J. Org. Chem. 1978, 43, 188–196. 
[113] G. M. Rubottom, M. A. Vazquez, D. R. Pelegrina, Tetrahedron Lett. 1974, 15, 4319–
4322. 
[114] M. Schulz, R. Kluge, L. Sivilai, B. Kamm, Tetrahedron 1990, 46, 2371–2380. 
[115] T. Chen, R. Peng, W. Hu, F.-M. Zhang, Org. Biomol. Chem. 2016, 14, 9859–9867. 
[116] G. J. Chuang, W. Wang, E. Lee, T. Ritter, J. Am. Chem. Soc. 2011, 133, 1760–1762. 
[117] A. S. K. Tsang, A. Kapat, F. Schoenebeck, J. Am. Chem. Soc. 2016, 138, 518–526. 
[118] a) Y. F. Liang, N. Jiao, Angew. Chem. Int. Ed. 2014, 53, 548–552; b) M. B. Chaudhari, Y. 
Sutar, S. Malpathak, A. Hazra, B. Gnanaprakasam, Org. Lett. 2017, 19, 3628–3631. 
[119] A. Russo, C. De Fusco, A. Lattanzi, RSC Advances 2012, 2, 385-397. 
8 Bibliography 
 
 
217 
 
 
[120] a) E. J. Corey, A. Marfat, G. Goto, F. Brion, J. Am. Chem. Soc. 1980, 102, 7984–7985; b) 
Y. Hayashi, J. Kanayama, J. Yamaguchi, M. Shoji, J. Org. Chem. 2002, 67, 9443–9448. 
[121] a) D. Enders, U. Reinhold, Synlett 1994, 1994, 792–794; b) C. Agami, F. Couty, C. 
Lequesne, Tetrahedron Lett. 1994, 35, 3309–3312; c) A. Alexakis, J.-P. Tranchier, N. 
Lensen, P. Mangeney, J. Am. Chem. Soc. 1995, 117, 10767–10768. 
[122] a) T. Hashiyama, K. Morikawa, K. B. Sharpless, J. Org. Chem. 1992, 57, 5067–5068; b) 
K. Morikawa, J. Park, P. G. Andersson, T. Hashiyama, K. B. Sharpless, J. Am. Chem. 
Soc. 1993, 115, 8463–8464; c) M. Lopp, A. Paju, T. Kanger, T. Pehk, Tetrahedron Lett. 
1997, 38, 5051–5054; d) A. Paju, T. Kanger, T. Pehk, M. Lopp, Tetrahedron 2002, 58, 
7321–7326. 
[123] a) W. Zhang, J. L. Loebach, S. R. Wilson, E. N. Jacobsen, J. Am. Chem. Soc. 1990, 112, 
2801–2803; b) T. Fukuda, T. Katsuki, Tetrahedron Lett. 1996, 37, 4389–4392; c) M. 
Koprowski, J. Łuczak, E. Krawczyk, Tetrahedron 2006, 62, 12363–12374. 
[124] a) Y. Zhu, T. Yong, Y. Hongwu, S. Yian, Tetrahedron Lett. 1998, 39, 7819–7822; b) Y. 
Zhu, L. Shu, Y. Tu, Y. Shi, J. Org. Chem. 2001, 66, 1818–1826. 
[125] a) N. Momiyama, H. Yamamoto, Angew. Chem. Int. Ed. 2002, 41, 2986–2988; b) N. 
Momiyama, H. Yamamoto, Org. Lett. 2002, 4, 3579–3582; c) N. Momiyama, H. 
Yamamoto, J. Am. Chem. Soc. 2003, 125, 6038–6039; d) M. Kawasaki, P. Li, H. 
Yamamoto, Angew. Chem. Int. Ed. 2008, 47, 3795–3797. 
[126] D. A. Dieterich, I. C. Paul, D. Y. Curtin, J. Am. Chem. Soc. 1974, 96, 6372–6380. 
[127] P. Merino, T. Tejero, I. Delso, R. Matute, Synthesis 2016, 48, 653–676. 
[128] S. P. Brown, M. P. Brochu, C. J. Sinz, D. W. C. MacMillan, J. Am. Chem. Soc. 2003, 125, 
10808–10809. 
[129] Y. Hayashi, J. Yamaguchi, K. Hibino, M. Shoji, Tetrahedron Lett. 2003, 44, 8293–8296. 
[130] G. Zhong, Angew. Chem. Int. Ed. 2003, 42, 4247–4250. 
[131] a) Y. Hayashi, J. Yamaguchi, T. Sumiya, M. Shoji, Angew. Chem. Int. Ed. 2004, 43, 
1112–1115; b) A. Córdova, H. Sundén, A. Bøgevig, M. Johansson, F. Himo, Chem. Eur. 
J. 2004, 10, 3673–3684; c) Y. Hayashi, J. Yamaguchi, T. Sumiya, K. Hibino, M. Shoji, J. 
Org. Chem. 2004, 69, 5966–5973. 
[132] a) S.-G. Kim, T.-H. Park, Tetrahedron Lett. 2006, 47, 9067–9071; b) H.-M. Guo, L. 
Cheng, L.-F. Cun, L.-Z. Gong, A.-Q. Mi, Y.-Z. Jiang, Chem. Commun. 2006, 429–431. 
[133] a) N. Momiyama, H. Yamamoto, J. Am. Chem. Soc. 2005, 127, 1080–1081; b) C. Palomo, 
S. Vera, I. Velilla, A. Mielgo, E. Gómez‐Bengoa, Angew. Chem. Int. Ed. 2007, 46, 8054–
8056. 
[134] D. B. Ramachary, C. F. Barbas, Org. Lett. 2005, 7, 1577–1580. 
[135] M. Lu, D. Zhu, Y. Lu, X. Zeng, B. Tan, Z. Xu, G. Zhong, J. Am. Chem. Soc. 2009, 131, 
4562–4563. 
[136] a) M. Masui, A. Ando, T. Shioiri, Tetrahedron Lett. 1988, 29, 2835–2838; b) E. F. J. de 
Vries, L. Ploeg, M. Colao, J. Brussee, A. van der Gen, Tetrahedron: Asymmetry 1995, 6, 
1123–1132; c) E. V. Dehmlow, S. Wagner, A. Müller, Tetrahedron 1999, 55, 6335–6346; 
d) M. Lian, Z. Li, Y. Cai, Q. Meng, Z. Gao, Chem. Eur. J. 2012, 7, 2019–2023; e) S.-B. 
D. Sim, M. Wang, Y. Zhao, ACS Catalysis 2015, 5, 3609–3612. 
[137] N. Demoulin, O. Lifchits, B. List, Tetrahedron 2012, 68, 7568–7574. 
[138] M. R. Witten, E. N. Jacobsen, Org. Lett. 2015, 17, 2772–2775. 
[139] a) B. Schweitzer‐Chaput, J. Demaerel, H. Engler, M. Klussmann, Angew. Chem. Int. Ed. 
2014, 53, 8737–8740; b) X. Q. Chu, H. Meng, Y. Zi, X. P. Xu, S. J. Ji, Chem. Eur. J. 
2014, 20, 17198–17206. 
8 Bibliography 
 
 
218 
 
 
[140] a) M. Schmittel, Top. Curr. Chem. 1994, 183–230; b) A. G. Csaky, J. Plumet, Chem. Soc. 
Rev. 2001, 30, 313–320; c) M. Schmittel, A. Haeuseler, J. Organomet. Chem. 2002, 661, 
169–179; d) P. S. Baran, N. B. Ambhaikar, C. A. Guerrero, B. D. Hafensteiner, D. W. 
Lin, J. M. Richter, ARKIVOC 2006, vii, 310–325; e) M. Schmittel, M. Lal, R. Lal, M. 
Röck, A. Langels, Z. Rappoport, A. Basheer, J. Schlirf, H.-J. Deiseroth, U. Flörke, G. 
Gescheidt, Tetrahedron 2009, 65, 10842-10855. 
[141] a) Y. Kobayashi, T. Taguchi, T. Morikawa, Tetrahedron Lett. 1978, 19, 3555–3556; b) L. 
A. Paquette, R. A. Snow, J. L. Muthard, T. Cynkowski, J. Am. Chem. Soc. 1978, 100, 
1600–1602; c) U. Jahn, P. Hartmann, E. Kaasalainen, Org. Lett. 2004, 6, 257–260. 
[142] a) Y. Ito, T. Konoike, T. Saegusa, J. Am. Chem. Soc. 1975, 97, 2912–2914; b) Y. Ito, T. 
Konoike, T. Harada, T. Saegusa, J. Am. Chem. Soc. 1977, 99, 1487–1493; c) R. H. 
Frazier, R. L. Harlow, J. Org. Chem. 1980, 45, 5408–5411; d) L. A. Paquette, E. I. 
Bzowej, B. M. Branan, K. J. Stanton, J. Org. Chem. 1995, 60, 7277–7283; e) U. Jahn, M. 
Müller, S. Aussieker, J. Am. Chem. Soc. 2000, 122, 5212–5213; f) J. Ullrich, H. Philip, D. 
Ina, J. Peter G., Eur. J. Org. Chem. 2001, 2001, 3333–3355; g) J. Ullrich, H. Philip, D. 
Ina, J. Peter G., Eur. J. Org. Chem. 2002, 2002, 718–735; h) A. A. Gevorkyan, A. S. 
Arakelyan, S. V. Barsegyan, K. A. Petrosyan, G. A. Panosyan, Russ. J. Organ. Chem. 
2003, 39, 1204–1205; i) M. Lal, M. Schmittel, M. Schlosser, H. J. Deiseroth, Acta Cryst. 
C 2004, 60, o589–o591; j) M. P. DeMartino, K. Chen, P. S. Baran, J. Am. Chem. Soc. 
2008, 130, 11546–11560. 
[143] T. Cohen, K. McNamara, M. A. Kuzemko, K. Ramig, J. J. Landi, Y. Dong, Tetrahedron 
1993, 49, 7931–7942. 
[144] J. M. Richter, B. W. Whitefield, T. J. Maimone, D. W. Lin, M. P. Castroviejo, P. S. 
Baran, J. Am. Chem. Soc. 2007, 129, 12857–12869. 
[145] Q. Li, P. Hurley, H. Ding, A. G. Roberts, R. Akella, P. G. Harran, J. Org. Chem. 2009, 
74, 5909–5919. 
[146] M. Meciarova, P. Tisovsky, R. Sebesta, New J. Chem. 2016, 40, 4855–4864. 
[147] a) S. Tatsuya, M. Yoshihiro, H. Hiroshi, I. Tamotsu, Y. Kaoru, Bull. Chem. Soc. Jpn. 
1978, 51, 2179–2180; b) K. Dietrich, S. Hans, S. Eberhard, Chem. Ber. 1974, 107, 3640–
3657; c) Y. N. Ogibin, A. O. Terent’ev, A. I. Ilovaiskii, G. I. Nikishin, Russ. J. 
Electrochem. 2000, 36, 193–202; d) Y. Okada, R. Akaba, K. Chiba, Org. Lett. 2009, 11, 
1033–1035; e) K. D. Moeller, Synlett 2009, 2009, 1208–1218; f) D. A. Frey, S. H. 
Krishna Reddy, K. D. Moeller, J. Org. Chem. 1999, 64, 2805–2813. 
[148] a) M. Schmittel, M. Kelley, A. Burghart, J. Chem. Soc., Perkin Trans. 2 1995, 2327–
2333; b) M. Schmittel, A. Burghart, W. Malisch, J. Reising, R. Söllner, J. Org. Chem. 
1998, 63, 396–400; c) M. Schmittel, A. Burghart, H. Werner, M. Laubender, R. Söllner, J. 
Org. Chem. 1999, 64, 3077–3085; d) Jens O. Bunte, Eike K. Heilmann, B. Hein, J. 
Mattay, Eur. J. Org. Chem. 2004, 2004, 3535–3550; e) J. B. Sperry, C. R. Whitehead, I. 
Ghiviriga, R. M. Walczak, D. L. Wright, J. Org. Chem. 2004, 69, 3726–3734; f) K. 
Uneyama, H. Tanaka, S. Kobayashi, M. Shioyama, H. Amii, Org. Lett. 2004, 6, 2733–
2736; g) A. K. Miller, C. C. Hughes, J. J. Kennedy-Smith, S. N. Gradl, D. Trauner, J. Am. 
Chem. Soc. 2006, 128, 17057–17062; h) M. D. Clift, C. N. Taylor, R. J. Thomson, Org. 
Lett. 2007, 9, 4667–4669; i) J. Jiao, Y. Zhang, J. J. Devery, L. Xu, J. Deng, R. A. 
Flowers, J. Org. Chem. 2007, 72, 5486–5492; j) C. T. Avetta, L. C. Konkol, C. N. Taylor, 
K. C. Dugan, C. L. Stern, R. J. Thomson, Org. Lett. 2008, 10, 5621–5624. 
[149] a) T. Shono, Y. Matsumura, Y. Nakagawa, J. Am. Chem. Soc. 1974, 96, 3532–3536; b) T. 
Shono, M. Okawa, I. Nishiguchi, J. Am. Chem. Soc. 1975, 97, 6144–6147; c) M. 
8 Bibliography 
 
 
219 
 
 
Schmittel, J. Heinze, H. Trenkle, J. Org. Chem. 1995, 60, 2726–2733; d) M. Schmittel, J.-
P. Steffen, A. Burghart, Acta Chem. Scand. 1999, 53, 781–791; e) A. G. Csákÿ, M. B. 
Mula, M. Mba, J. n. Plumet, Tetrahedron: Asymmetry 2002, 13, 753–757. 
[150] a) W. J. Bouma, J. K. MacLeod, L. Radom, J. Am. Chem. Soc. 1979, 101, 5540–5545; b) 
J. L. Holmes, F. P. Lossing, J. Am. Chem. Soc. 1980, 102, 1591–1595; c) J. L. Holmes, F. 
P. Lossing, J. Am. Chem. Soc. 1982, 104, 2648–2649; d) N. Heinrich, W. Koch, G. 
Frenking, H. Schwarz, J. Am. Chem. Soc. 1986, 108, 593–600; e) M. Czerwiñska, A. 
Sikora, P. Szajerski, J. Adamus, A. Marcinek, J. Gȩbicki, P. Bednarek, J. Chem. Phys. A 
2006, 110, 7272–7278. 
[151] G. Frenking, N. Heinrich, J. Schmidt, H. Schwarz, Z. Naturforsch. 1982, 37b, 1597–1601. 
[152] M. Schmittel, U. Baumann, Angew. Chem. Int. Ed. 1990, 29, 541–543. 
[153] M. Lal, A. Langels, H. J. Deiseroth, J. Schlirf, M. Schmittel, J. Phys. Org. Chem. 2003, 
16, 373–379. 
[154] M.-A. Orliac-Le Moing, G. Le Guillanton, J. Simonet, Electrochim. Acta 1982, 27, 1775–
1779. 
[155] a) J.-i. Yoshida, K. Sakaguchi, S. Isoe, Tetrahedron Lett. 1986, 27, 6075–6078; b) J. 
Yoshida, K. Sakaguchi, S. Isoe, J. Org. Chem. 1988, 53, 2525–2533. 
[156] a) M. Schmittel, M. Röck, Chem. Ber. 1992, 125, 1611–1620; b) M. Schmittel, A. 
Abufarag, O. Luche, M. Levis, Angew. Chem. Int. Ed. 1990, 29, 1144–1146; c) M. 
Schmittel, G. Gescheidt, M. Röck, Angew. Chem. Int. Ed. 1994, 33, 1961–1963. 
[157] J. Choi, M. E. Pulling, D. M. Smith, J. R. Norton, J. Am. Chem. Soc. 2008, 130, 4250–
4252. 
[158] D. C. Miller, K. T. Tarantino, R. R. Knowles, Top. Curr. Chem. 2016, 374, 30. 
[159] F. G. Bordwell, J. P. Cheng, J. A. Harrelson, J. Am. Chem. Soc. 1988, 110, 1229–1231. 
[160] J. J. Warren, T. A. Tronic, J. M. Mayer, Chem. Rev. 2010, 110, 6961–7001. 
[161] X. Zhang, J. Ma, S. Li, M.-D. Li, X. Guan, X. Lan, R. Zhu, D. L. Phillips, J. Org. Chem. 
2016, 81, 5330–5336. 
[162] E. C. Gentry, R. R. Knowles, Acc. Chem. Res. 2016, 49, 1546–1556. 
[163] a) S. Y. Reece, J. M. Hodgkiss, J. Stubbe, D. G. Nocera, Philos. Trans. Royal Soc. B 
2006, 361, 1351; b) S. Hammes-Schiffer, Acc. Chem. Res. 2009, 42, 1881–1889; c) D. R. 
Weinberg, C. J. Gagliardi, J. F. Hull, C. F. Murphy, C. A. Kent, B. C. Westlake, A. Paul, 
D. H. Ess, D. G. McCafferty, T. J. Meyer, Chem. Rev. 2012, 112, 4016–4093. 
[164] N. Hoffmann, Eur. J. Org. Chem. 2017, 2017, 1982–1992. 
[165] K. T. Tarantino, P. Liu, R. R. Knowles, J. Am. Chem. Soc. 2013, 135, 10022–10025. 
[166] a) K. T. Tarantino, D. C. Miller, T. A. Callon, R. R. Knowles, J. Am. Chem. Soc. 2015, 
137, 6440–6443; b) G. J. Choi, R. R. Knowles, J. Am. Chem. Soc. 2015, 137, 9226–9229; 
c) D. C. Miller, G. J. Choi, H. S. Orbe, R. R. Knowles, J. Am. Chem. Soc. 2015, 137, 
13492–13495; d) Q. Zhu, D. E. Graff, R. R. Knowles, J. Am. Chem. Soc. 2018, 140, 741–
747. 
[167] H. G. Yayla, H. Wang, K. T. Tarantino, H. S. Orbe, R. R. Knowles, J. Am. Chem. Soc. 
2016, 138, 10794–10797. 
[168] a) K. Qvortrup, D. A. Rankic, D. W. C. MacMillan, J. Am. Chem. Soc. 2014, 136, 626–
629; b) D. Hager, D. W. C. MacMillan, J. Am. Chem. Soc. 2014, 136, 16986–16989. 
[169] L. J. Rono, H. G. Yayla, D. Y. Wang, M. F. Armstrong, R. R. Knowles, J. Am. Chem. 
Soc. 2013, 135, 17735–17738. 
[170] E. C. Gentry, L. J. Rono, M. E. Hale, R. Matsuura, R. R. Knowles, J. Am. Chem. Soc. 
2018, 140, 3394–3402. 
8 Bibliography 
 
 
220 
 
 
[171] Z. Zhou, Y. Li, B. Han, L. Gong, E. Meggers, Chem. Sci. 2017, 8, 5757–5763. 
[172] G. J. Choi, Q. Zhu, D. C. Miller, C. J. Gu, R. R. Knowles, Nature 2016, 539, 268. 
[173] a) J. C. K. Chu, T. Rovis, Nature 2016, 539, 272; b) W. Yuan, Z. Zhou, L. Gong, E. 
Meggers, Chem. Commun. 2017, 53, 8964–8967. 
[174] G. Pupo, Universität zu Köln (Köln), 2017. 
[175] X. Zhang, Y.-H. Chen, B. Tan, Tetrahedron Lett. 2018, 59, 473–486. 
[176] a) J. Bredt, J. Houben, P. Levy, Ber.  Dtsch. Chem. Ges. 1902, 35, 1286–1292; b) G. L. 
Buchanan, Chem. Soc. Rev. 1974, 3, 41–63; cJ. Y. W. Mak, R. H. Pouwer, C. M. 
Williams, Angew. Chem. Int. Ed. 2014, 53, 13664–13688. 
[177] S. Vellalath, I. Čorić, B. List, Angew. Chem. Int. Ed. 2010, 49, 9749–9752. 
[178] K. Horiguchi, E. Yamamoto, K. Saito, M. Yamanaka, T. Akiyama, Chem. Eur. J. 2016, 
22, 8078–8083. 
[179] X. H. Huo, J. H. Xie, Q. S. Wang, Q. L. Zhou, Adv. Synt. Catal. 2007, 349, 2477–2484. 
[180] G. A. Shevchenko, G. Pupo, B. List, Synlett 2015, 26, 1413–1416. 
[181] X. Yang, F. D. Toste, J. Am. Chem. Soc. 2015, 137, 3205–3208. 
[182] M. R. Monaco, R. Properzi, B. List, Synlett 2016, 27, 591–594. 
[183] a) P. Magnus, N. Garizi, K. A. Seibert, A. Ornholt, Org. Lett. 2009, 11, 5646–5648; b) P. 
Magnus, A. J. Brozell, Org. Lett. 2012, 14, 3952–3954. 
[184] a) A. Córdova, H. Sundén, M. Engqvist, I. Ibrahem, J. Casas, J. Am. Chem. Soc. 2004, 
126, 8914–8915; b) H. Sundén, M. Engqvist, J. Casas, I. Ibrahem, A. Córdova, Angew. 
Chem. Int. Ed. 2004, 43, 6532–6535; c) I. Ibrahem, G.-L. Zhao, H. Sundén, A. Córdova, 
Tetrahedron Lett. 2006, 47, 4659–4663. 
[185] J. Walaszek Dominika, K. Rybicka‐Jasińska, S. Smoleń, M. Karczewski, D. Gryko, Adv. 
Synt. Catal. 2015, 357, 2061–2070. 
[186] H. J. Bestmann, Angew. Chem. Int. Ed. 1977, 16, 349–364. 
[187] a) J. R. Rocca, J. H. Tumlinson, B. M. Glancey, C. S. Lofgren, Tetrahedron Lett. 1983, 
24, 1889–1892; b) G. M. Rubottom, H. D. Juve, J. Org. Chem. 1983, 48, 422–425; c) S. 
Yao, M. Johannsen, R. G. Hazell, K. A. Jørgensen, J. Org. Chem. 1998, 63, 118–121; d) 
K. F. Eidman, B. S. MacDougall, J. Org. Chem. 2006, 71, 9513–9516. 
[188] H. Yi, M. Albrecht, A. Valkonen, K. Rissanen, New J. Chem. 2015, 39, 746–749. 
[189] G. Shevchenko, A., B. Oppelaar, B. List, Angew. Chem. Int. Ed. 2018, 0. 
[190] a) A. Bhattacharya, L. M. DiMichele, U. H. Dolling, E. J. J. Grabowski, V. J. Grenda, J. 
Org. Chem. 1989, 54, 6118–6120; b) S. Fukuzumi, M. Fujita, G.-e. Matsubayashi, J. 
Otera, Chem. Lett. 1993, 22, 1451–1454; c) X. Guo, H. Mayr, J. Am. Chem. Soc. 2013, 
135, 12377–12387. 
[191] E. Kumli, F. Montermini, P. Renaud, Org. Lett. 2006, 8, 5861–5864. 
[192] M. T. Huynh, C. W. Anson, A. C. Cavell, S. S. Stahl, S. Hammes-Schiffer, J. Am. Chem. 
Soc. 2016, 138, 15903–15910. 
[193] L. Bernardi, G. Bolzoni, M. Fochi, M. Mancinelli, A. Mazzanti, Eur. J. Org. Chem. 2016, 
2016, 3208–3216. 
[194] P. G. M. Wuts, T. W. Greene, Greene's Protective Groups in Organic Synthesis, 4 ed., 
John Wiley & Sons, Inc. , 2007. 
[195] C. Hansch, A. Leo, R. W. Taft, Chem. Rev. 1991, 91, 165–195. 
[196] a) N. Vignola, B. List, J. Am. Chem. Soc. 2004, 126, 450–451; b) D. A. Nagib, M. E. 
Scott, D. W. C. MacMillan, J. Am. Chem. Soc. 2009, 131, 10875–10877; c) B. List, I. 
Čorić, O. Grygorenko Oleksandr, S. J. Kaib Philip, I. Komarov, A. Lee, M. Leutzsch, S. 
Chandra Pan, V. Tymtsunik Andrey, M. van Gemmeren, Angew. Chem. Int. Ed. 2013, 53, 
8 Bibliography 
 
 
221 
 
 
282–285; d) R. Cano, A. Zakarian, P. McGlacken Gerard, Angew. Chem. Int. Ed. 2017, 
56, 9278–9290. 
[197] a) Y. Inokoishi, N. Sasakura, K. Nakano, Y. Ichikawa, H. Kotsuki, Org. Lett. 2010, 12, 
1616–1619; b) H. Yang, R. G. Carter, Org. Lett. 2010, 12, 3108–3111; c) M. Yoshida, H. 
Ukigai, K. Shibatomi, S. Hara, Tetrahedron Lett. 2015, 56, 3890–3893. 
[198] Y. Han, S. Breitler, S.-L. Zheng, E. J. Corey, Org. Lett. 2016, 18, 6172–6175. 
[199] R. Pedrosa, J. M. Andrés, R. Manzano, C. Pérez-López, Tetrahedron Lett. 2013, 54, 
3101–3104. 
[200] C. Beattie, M. North, P. Villuendas, Molecules 2011, 16, 3420–3432. 
[201] L. Liao, C. Shu, M. Zhang, Y. Liao, X. Hu, Y. Zhang, Z. Wu, W. Yuan, X. Zhang, 
Angew. Chem. Int. Ed. 2014, 53, 10471-10475. 
 
9 Appendix 
 
 
222 
 
 
9 Appendix 
9.1 Erklärung 
 
„Ich versichere, dass ich die von mir vorgelegte Dissertation selbständig angefertigt, die 
benutzten Quellen und Hilfsmittel vollständig angegeben und die Stellen der Arbeit ‐ 
einschließlich Tabellen, Karten und Abbildungen ‐, die anderen Werken im Wortlaut oder 
dem Sinn nach entnommen sind, in jedem Einzelfall als Entlehnung kenntlich gemacht habe; 
dass diese Dissertation noch keiner anderen Fakultät oder Universität zur Prüfung 
vorgelegen hat; dass sie ‐ abgesehen von unten angegebenen Teilpublikationen ‐ noch nicht 
veröffentlicht worden ist sowie, dass ich eine solche Veröffentlichung vor Abschluss des 
Promotionsverfahrens nicht vornehmen werde. Die Bestimmungen dieser 
Promotionsordnung sind mir bekannt. Die von mir vorgelegte Dissertation ist von Prof. Dr. 
Benjamin List betreut worden." 
 
(Grigory André Shevchenko) 
Mülheim an Ruhr, Mai 2018 
 
Bisher sind folgede Teilpublikationen veröffentlicht worden: 
 
„Catalytic Asymmetric α-Amination of α-Branched Ketones via Enol Catalysis”, G. A. 
Shevchenko, G. Pupo, B. List, Synlett 2015, 26, 1413–1416. 
 
“An Unexpected α-Oxidation of Cyclic Ketones with 1,4-Benzoquinone via Enol Catalysis”, G. 
A. Shevchenko, B. Oppelaar, B. List. Angew. Chem. Int. Ed. 2018, 10.1002/anie.201804445; 
Angew. Chem. 2018, 10.1002/ange.201804445. 
 
   
9 Appendix 
 
 
223 
 
 
9.2 Lebenslauf 
 
Grigory André Shevchenko 
Geboren am 01. September 1989 in Leningrad/Russland 
Staatsangehörigkeit: Deutsch 
 
Akademischer Werdegang 
02.2014–07.2018 Promotion am Max-Planck-Institut für Kohlenforschung, Mülheim an der 
Ruhr unter der Leitung von Prof. B. List zum Thema 
Enol Catalysis – Enantioselective Transformations via Bifunctional 
Brønsted Acid Promoted Enolization 
10.2011–10.2013 Studium der Chemie an der Georg-August-Universität Göttingen 
   Abschluss: Master of Science 
   Masterarbeit unter der Leitung von Prof. L. Ackermann zum Thema 
Cobalt-Catalyzed C–H Bond Functionalizations with Secondary 
Alkylchlorides 
 
10.2008–10.2011 Studium der Chemie an der Georg-August-Universität Göttingen 
   Abschluss: Bachelor of Science 
   Bachelorarbeit unter der Leitung von Dr. D. B. Werz zum Thema 
Stereoselektive Synthese einer trisaccharidischen Untereinheit eines 
Heptasaccharids aus Providencia rustigianii 
 
Schulausbildung 
09.2001–07.2008 Martin-Andersen-Nexö Gymansium Dresden (vertieft mathematisch-
naturwissenschaftliches Profil) 
 Abschluss: Abitur 
